[go: up one dir, main page]

EP2056789A1 - Antiperspirant and deodorant compositions with improved care effect - Google Patents

Antiperspirant and deodorant compositions with improved care effect

Info

Publication number
EP2056789A1
EP2056789A1 EP07802740A EP07802740A EP2056789A1 EP 2056789 A1 EP2056789 A1 EP 2056789A1 EP 07802740 A EP07802740 A EP 07802740A EP 07802740 A EP07802740 A EP 07802740A EP 2056789 A1 EP2056789 A1 EP 2056789A1
Authority
EP
European Patent Office
Prior art keywords
oil
yoghurt
composition
weight
protein
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
EP07802740A
Other languages
German (de)
French (fr)
Inventor
Gertraud Teckenbrock
Barbara Heide
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Henkel AG and Co KGaA
Original Assignee
Henkel AG and Co KGaA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Henkel AG and Co KGaA filed Critical Henkel AG and Co KGaA
Publication of EP2056789A1 publication Critical patent/EP2056789A1/en
Withdrawn legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q15/00—Anti-perspirants or body deodorants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/64—Proteins; Peptides; Derivatives or degradation products thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
    • A61K8/98—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution of animal origin
    • A61K8/981—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution of animal origin of mammals or bird
    • A61K8/986—Milk; Derivatives thereof, e.g. butter
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/80—Process related aspects concerning the preparation of the cosmetic composition or the storage or application thereof
    • A61K2800/85—Products or compounds obtained by fermentation, e.g. yoghurt, beer, wine

Definitions

  • the present application relates to cosmetic and dermatological antiperspirant and deodorant compositions which have an improved care effect and / or a reduced irritation potential.
  • antiperspirant compositions hereinafter also referred to as antiperspirants, contain as antiperspirant active ingredient at least one water-soluble astringent inorganic and organic salts of aluminum, zinc or selected aluminum-zirconium mixed salts.
  • deodorant compositions also referred to below as deodorants, frequently contain at least one antibacterial active substance as the deodorant active ingredient.
  • the antiperspirant active ingredients have no direct influence on the activity of the sweat glands, but minimize the narrowing of the discharge channels sweat secretion.
  • the AI salts cause thereby on the treated skin surfaces a sweat inhibition by superficial blockage of the sweat gland ducts as a result of Al-Mucopolysaccharid precipitation.
  • Antiperspirant and deodorant compositions are usually applied and applied in the armpit area.
  • the armpit skin has a weak barrier function due to its location and function.
  • the skin in the underarm area is therefore more sensitive than the rest of the skin, often at least as sensitive as the skin of the face.
  • Many consumers consider a hairless armpit skin to be more aesthetically pleasing and hygienic, as hair growth increases the sweat-bearing surface in the armpit area and thus contributes to an increased body odor development. Accordingly, a regular shave of underarm hair is part of the routine of hygiene for many consumers.
  • the underarm shave mechanically irritates the skin and additionally weakens the barrier function.
  • a sweat-inhibiting and / or deodorizing cosmetic for example as a deodorant spray or deodorant stick, is usually applied to the underarm skin.
  • the antiperspirant and / or deodorant active ingredients have, for example, due to their acidic pH, usually a considerable irritation potential, which can cause reddening of the skin on the - mechanically irritated - armpit skin, an unpleasant burning, feeling of tension and / or itching.
  • the object of the present invention was to find active substances and / or carriers for cosmetic and dermatological antiperspirant and deodorant compositions with particularly high skin tolerance.
  • a further object of the present invention was to find active substances and / or carriers for cosmetic and dermatological antiperspirant and deodorant compositions with particularly high skin compatibility, in particular for mechanically irritated skin.
  • a further object of the present invention was to find active substances and / or carriers for cosmetic and dermatological antiperspirant and deodorant compositions which can make the skin-irritant antiperspirant and deodorant active ingredients more skin-friendly or can alleviate their irritative effect.
  • a further object of the present invention was to find active substances and / or carriers for cosmetic and dermatological antiperspirant and deodorant compositions which reduce the burning and / or itching of the skin when applied.
  • An object of the present application is therefore a cosmetic or dermatological deodorant or antiperspirant composition
  • a cosmetically or dermatologically acceptable carrier at least one deodorant or antiperspirant active, at least one yoghurt protein and / or at least one hydrolyzate of a yoghurt protein and / or at least one NC 2 -C 24 acyl derivative and / or at least one C 2 -C 24 ester and / or at least one physiologically acceptable salt of these P red in-active substances, and mixtures of these P red in-active substances.
  • Another object of the present application is the use of at least one yoghurt protein and / or at least one hydrolyzate of a yoghurt protein and / or at least one NC 2 -C 24 acyl derivative and / or at least one C 2 -C 24 ester and / or at least one physiologically acceptable salt of these substances, as well as mixtures of these P red in-active substances, in a cosmetically or dermatologically acceptable carrier containing at least one deodorant or antiperspirant active, for improving the skin compatibility and / or the conditioning effect of the composition and / or for reducing or preventing skin burning, a feeling of tightness, itching and / or visible irritations, such as skin redness, the / caused by contact of the skin with the composition.
  • Another object of the present application is the use of at least one yoghurt protein and / or at least one hydrolyzate of a yoghurt protein and / or at least one NC 2 -C 24 acyl derivative and / or at least one C 2 -C 24 ester and or at least one physiologically acceptable salt of these substances, and mixtures of these protein active ingredients, in combination with at least one further active ingredient selected from monosaccharides having 5 or 6 carbon atoms and disaccharides, in a cosmetically or dermatologically acceptable carrier, containing at least one deodorant or Antiperspirant active, to improve the skin compatibility and / or the care effect of the composition and / or to reduce or avoid burning skin, a feeling of tightness, itching and / or visible irritations, such as skin redness, which is caused by contact of the skin with the composition /become.
  • a preferred embodiment of the invention is characterized in that the at least one yoghurt protein, at least one hydrolyzate of a yoghurt protein and / or the at least one NC 2 -C 24 acyl derivative and / or the at least one C 2 -C 24 ester and / or the at least one physiologically acceptable salt of these substances is contained in the form of yoghurt.
  • a further preferred embodiment of the invention is characterized in that the at least one yoghurt protein, at least one hydrolyzate of a yoghurt protein and / or the at least one NC 2 -C 24 -acyl derivative and / or the at least one C 2 -C 24 - Ester and / or the at least one physiologically acceptable salt of these substances in the form of dried yogurt, especially in the form of spray-dried yogurt, freeze-dried yogurt or lyophilized yogurt is included.
  • the yoghurt contained is dried in a manner other than that stated above.
  • a hydrolyzate of a yoghurt protein means an oligopeptide of at least three amino acids, preferably of at least 5 peptides, more preferably of at least 8 peptides, which is obtainable by hydrolysis of native yoghurt protein.
  • a further preferred embodiment of the invention is characterized in that an NC 2 -C 24 acyl derivative of a yoghurt protein or a yoghurt protein hydrolyzate is contained.
  • the C 2 -C 24 -acyl radical with which the at least one yoghurt protein or at least one yoghurt protein Protein hydrolyzate is derivatized on at least one amino group is preferably selected from an acetyl, propanoyl, butanoyl, pentanoyl, hexanoyl, heptanoyl, octanoyl, nonanoyl, decanoyl, undecanoyl, lauroyl, tridecanoyl , Myristoyl, pentadecanoyl, cetoyl, palmitoyl, stearoyl, elaidoyl, arachidoyl or behenoyl residue.
  • Mixtures of C 8 -C 18 acyl radicals are also
  • a further preferred embodiment of the invention is characterized in that the at least one yoghurt protein or at least one yoghurt protein hydrolyzate at those amino acids which carry a hydroxyl group with the aforementioned C 2 - C 24 -acyl radicals on at least one of these hydroxyl group an ester bond is linked.
  • a further preferred embodiment of the invention is characterized in that the at least one yoghurt protein or at least one yoghurt protein hydrolyzate, its NC 2 -C 24 acyl derivative or its C 2 -C 24 ester in the form of at least one physiologically acceptable salt is present.
  • Physiologically acceptable salts of the protein active ingredients which are preferred according to the invention are selected from the ammonium, alkali metal, magnesium, calcium, aluminum, zinc and manganese salts. Particularly preferred according to the invention are the sodium, potassium, magnesium, aluminum, zinc and manganese salts.
  • the yoghurt protein or yoghurt protein hydrolyzate substituted with the abovementioned C 2 -C 24 -acyl radicals can have a further improvement in the anti-irritative action against the unsubstituted yoghurt protein or yoghurt-protein hydrolyzate.
  • a further preferred embodiment of the invention is characterized in that the yoghurt protein, the yoghurt protein hydrolyzate, the NC 2 -C 24 acyl derivative, the C 2 -C 24 ester derivative and / or their physiologically acceptable salt in a total amount of 0.001 to 0.1 wt .-%, preferably 0.005 - 0.07 wt .-%, particularly preferably 0.01 - 0.05 wt .-% and exceptionally preferably 0.02 - 0.04 wt .-%, each based on the entire composition, is included.
  • total amounts of yoghurt protein active ingredients of more than 0.1 to 1 wt .-% may be preferred according to the invention.
  • Total quantities of yoghurt protein active substances of more than 0.1 to 1% by weight may be preferred according to the invention in particular if the composition contains no aluminum salt.
  • a yoghurt protein raw material particularly preferred according to the invention is available under the trade name "Yoghurt Protein GBU” from Cosmetochem. Antiperspirant components
  • preferred antiperspirant active substances are selected from aluminum chlorohydrates, especially aluminum chlorohydrates having the general formula [Al 2 (OH) 5 CI 2-3 ⁇ H 2 O] n, which may be present in non-activated or activated in (depolymerized) Form , furthermore aluminum sesquichlorohydrate, aluminum chlorohydrex-propylene glycol (PG) or polyethylene glycol (PEG), aluminum sesquichlorohydrex PG or PEG, aluminum PG-dichlorhydrex or aluminum PEG-dichlorhydrex, aluminum hydroxide, furthermore selected from the aluminum zirconium chlorohydrates, such as aluminum zirconium trichlorohydrate, aluminum zirconium tetrachlorohydrate , Aluminum zirconium pentachlorohydrate, aluminum zirconium octachlorohydrate, aluminum zirconium chlorohydrate glycine complexes such as aluminum zirconium trichlorohydrex glycine, aluminum zirconium
  • a solubility of at least 5 wt .-% at 20 0 C is understood according to the invention, solubility in water, that is, amounts of at least 5 g of the antiperspirant active ingredient in 95 g of water are soluble at 20 0 C.
  • the antiperspirant active ingredients can be used as aqueous solutions.
  • Particularly preferred deodorant or antiperspirant compositions according to the invention are characterized in that the at least one antiperspirant active ingredient is present in a total amount of 3 to 25 wt.%, Preferably 5 to 22 wt.% And in particular 10 to 20 wt. contained, based on the total weight of the active substance in the overall composition.
  • the amount of antiperspirant salt (s) indicated in the instant application is to be calculated according to the method of US Pharmacopoeia (USP), after which bound water of crystallization and other ligands, e.g. As glycine, are excluded.
  • the composition comprises an astringent aluminum salt, especially aluminum chlorohydrate, for example, in powder form as Micro Dry ® Ultrafine or Micro Dry ® SUF from Reheis, in the form of an aqueous solution as Locron ® L from Clariant, as Chlorhydrol ® as well as in activated form sold as Reach® 103 or Reach® 501 from Reheis. Under the name Reach® 301 an aluminum sesquichlorohydrate from Reheis is offered, which is likewise particularly preferred.
  • the use of aluminum-zirconium Tetrachlorohydrex glycine complexes which are, for example, by Reheis under the name Rezal ® 36G or Reach ® 908 commercially, may be particularly preferred according to the invention.
  • the compositions according to the invention may contain both at least one deodorant and at least one antiperspirant active.
  • Deodorant active ingredients which are preferred according to the invention are odor absorbers, deodorizing ion exchangers, germ-inhibiting agents, prebiotic active components and also enzyme inhibitors or, particularly preferred, combinations of said active substances.
  • Silicates serve as odor absorbers, which at the same time advantageously support the rheological properties of the composition according to the invention.
  • silicates particularly preferred according to the invention are, in particular, phyllosilicates and, among these, in particular montmorillonite, kaolinite, mit, beidellite, nontronite, saponite, hectorite, bentonite, smectite and talcum.
  • Other preferred odor absorbers are, for example, zeolites, Zinkricinoleat, cyclodextrins, certain metal oxides, such as. As alumina, and chlorophyll. They are preferably used in an amount of 0.1-10% by weight, more preferably 0.5-7% by weight and most preferably 1-5% by weight, based in each case on the overall composition.
  • germ-inhibiting or antimicrobial active ingredients are understood as meaning those active substances which reduce the number of skin germs participating in the formation of the odor or inhibit their growth.
  • These organisms include, among others, various species from the group of staphylococci, the group of Corynebacteria, anaerococci and micrococci.
  • Preferred antimicrobial or antimicrobial agents according to the invention are in particular organohalogen compounds and halides, quaternary ammonium compounds, a number of plant extracts and zinc compounds.
  • triclosan chlorhexidine and chlorohexadione gluconate
  • 3,4,4'-trichlorocarbanilide bromochlorophene, dichlorophen, chlorothymol, chloroxylenol, hexachlorophene, dichloro-m-xylenol, dequalinium chloride, domiphenbromide, ammonium phenolsulfonate, benzalkonium halides, benzalkonium cetyl phosphate, benzalkonium saccharinates, Benzethonium chloride, cetylpyridinium chloride, laurylpyridinium chloride, laurylisoquinolinium bromide, methylbenzethonium chloride.
  • phenol phenoxyethanol, disodium dihydroxyethylsulfosuccinyl-cylindonate, sodium bicarbonate, zinc lactate, sodium phenolsulfonate and zinc phenolsulfonate, ketoglutaric acid, terpene alcohols such as.
  • chlorophyllin copper complexes ⁇ -monoalkyl glycerol ether with a branched or linear saturated or unsaturated, optionally hydroxylated C 6 - C 22 alkyl, particularly preferably ⁇ - (2-ethylhexyl) glycerol, commercially available as Sen- siva ® SC 50 (ex Schülke & Mayr), carboxylic esters of mono-, di- and triglycerol (eg glycerol) monolaurate, diglycerol monocaprinate), lantibiotics and plant extracts (eg green tea and components of lime blossom oil).
  • Sen- siva ® SC 50 Ex Schülke & Mayr
  • lantibiotics and plant extracts eg green tea and components of lime blossom oil.
  • deodorant active substances are selected from so-called prebiotically active components, which according to the invention are to be understood as meaning those components which inhibit only or at least predominantly the odor-causing germs of the skin microflora, but not the desired ones, that is, the non-odor-forming germs that lead to a include healthy skin microflora.
  • active substances which are disclosed in the published patent applications DE 10333245 and DE 10 2004 011 968 as being prebiotically effective; These include conifer extracts, in particular from the group of Pinaceae, and plants extra kte from the group of Sapindaceae, Araliaceae, Lamiaceae and Saxifragaceae, in particular extracts of Picea spp., Paullinia sp., Panax sp., Lamium album or Ribes nigrum and mixtures thereof substances. Further preferred deodorant active ingredients are selected from the germ-inhibiting active perfume oils and Deosafe ® -Par colmölen that, Haarmann and Reimer, by the company Symrise previously available.
  • the enzyme inhibitors include substances which inhibit the enzymes responsible for the sweat decomposition, in particular the arylsulfatase, .beta.-glucuronidase, aminoacylase, esterases, lipases and / or lipoxygenase, eg. B. trialkylcitric acid, in particular triethyl citrate, or zinc glycinate.
  • Preferred deodorant or antiperspirant compositions according to the invention are characterized in that the at least one deodorant active ingredient is selected from arylsulfatase inhibitors, ⁇ -glucuronidase inhibitors, aminoacylase inhibitors, esterase inhibitors, lipase inhibitors and lipoxigenase inhibitors.
  • Inhibitors ⁇ -Monoalkylglycerinethern with a branched or linear saturated or unsaturated, optionally hydroxylated C 6 - C 22 alkyl, especially ⁇ - (2-ethylhexyl) glycerol ether, phenoxyethanol, germ-inhibiting perfume oils, Deosafe ® -Ppar Stahl Stahl (Deosafe ® a registered trademark of the company Symrise, formerly Haarmann & Reimer), prebiotic active components, trialkylcitric acid esters, in particular triethyl citrate, active substances which reduce or inhibit the growth of the number of skin microorganisms from the group of staphylococci, corynebacteria, anaerococci and micrococci , Zinc compound compounds, in particular zinc phenolsulfonate and zinc ricinoleate, organohalogen compounds, in particular triclosan, chlorhexidine, chlorhexidine gluconate and benzalkonium hal
  • deodorant or antiperspirant compositions are characterized in that the at least one deodorant active ingredient is present in a total amount of 0.1-10% by weight, preferably 0.2-7% by weight, particularly preferably 0.3 5% by weight and extraordinarily preferably 0.4 to 1.0% by weight, in each case based on the total weight of the active substance of the deodorant active ingredient or of the deodorant active ingredients in the overall composition.
  • compositions according to the invention can contain both at least one deodorant and at least one antiperspirant active ingredient.
  • composition according to the invention or used according to the invention contains at least one monosaccharide having 5 or 6 carbon atoms and / or at least one disaccharide.
  • a particularly preferred embodiment of the invention is characterized in that the monosaccharide having 5 or 6 carbon atoms is selected from glucose, fructose, galactose, arabinose, ribose, xylose, lyxose, allose, altrose, mannose, gulose, idose, talose, fucose and rhamnose , Exceptionally preferred are glucose, galactose, fructose, fucose and rhamnose, in particular glucose and galactose.
  • Another particularly preferred embodiment of the invention is characterized in that the disaccharide having 5 or 6 carbon atoms is selected from sucrose, lactose and trehalose. Exceptionally preferred are sucrose and lactose, especially lactose.
  • a further particularly preferred embodiment of the invention is characterized in that at least one monosaccharide having 5 or 6 carbon atoms and / or at least one disaccharide in a total amount of 0.001 to 2.0 wt .-%, preferably 0.005 - 1, 0 wt .-% , Particularly preferably 0.01 to 0.5 wt .-% and most preferably 0.03 to 0.1 wt .-%, each based on the total composition is included.
  • Another particularly preferred embodiment of the invention is characterized by an active ingredient combination of yoghurt protein and lactose.
  • Another particularly preferred embodiment of the invention is characterized by an active ingredient combination of yoghurt protein hydrolyzate and lactose.
  • Another particularly preferred embodiment of the invention is characterized by an active ingredient combination of yoghurt protein and galactose.
  • Another particularly preferred embodiment of the invention is characterized by an active ingredient combination of yoghurt protein hydrolyzate and galactose.
  • Another particularly preferred embodiment of the invention is characterized by an active ingredient combination of yoghurt protein and glucose.
  • Another particularly preferred embodiment of the invention is characterized by an active ingredient combination of yoghurt protein hydrolyzate and glucose.
  • cosmetically or dermatologically acceptable carrier is present as powder, in stick form, as aerosol spray, pump spray, liquid or gel roll-on application, cream, lotion, solution, gel or on a substrate.
  • Deodorant or antiperspirant sticks can be in gelled, anhydrous, based on a W / O emulsion, based on an O / W emulsion, based on a water-oil multiple emulsion, based on a nanoemulsion and on Basis of a microemulsion, wherein the oil phase contain at least one silicone component or may consist of at least one silicone component.
  • the compositions according to the invention, which are formulated as deodorant or antiperspirant sticks may be based on an oil-in-oil emulsion based on a polyol-oil-based emulsion based on a polyol-in-oil emulsion based on an oil-in-oil emulsion.
  • Gel sticks can be formulated on the basis of fatty acid soaps, alditols, in particular dibenzylidene sorbitol, N-acylamino acid amides, 12-hydroxystearic acid, polyamides, polyamide derivatives, polysaccharides such as xanthan, polyglucomannans, guar, konjac, celluloses or starches, polyacrylates, polyacrylate derivatives and other gel formers become.
  • Aerosol sprays, pump sprays, roll-on applications and creams may be in the form of a water-in-oil emulsion, water-in-silicone oil emulsions, oil-in-water emulsion, silicone oil-in-water emulsion, water-in-oil Microemulsion, oil-in-water microemulsion, silicone oil-in-water microemulsion, polyol-in-oil emulsion, oil-in-polyol emulsion, polyol-oil multiple emulsion, anhydrous suspension, preferably anhydrous oil-based suspension , alcoholic solution, in particular ethanolic solution, hydroalcoholic solution, in particular solutions with more than 50 wt .-% of a water-ethanol mixture, glycole solution, especially as a solution in propylene glycol, glycerol, dipropylene glycol and (under normal conditions) liquid Polyethylene glycols, hydroglycolic solution, polyol solution, water Polyol solution, a
  • compositions may be thickened, for example based on fatty acid soaps, dibenzylidenesorbitol, N-acylamino acid amides, 12-hydroxystearic acid, carbomer and Carbopol type polyacrylates, polyacrylamides and polysaccharides, which may be chemically and / or physically modified.
  • the compositions may be transparent, translucent or opaque.
  • compositions according to the invention be in the form of a pin, they contain a wax matrix preferably comprising at least one wax component with a melting point of> 50 0 C.
  • waxes of solid to brittle hard consistency coarse to fine crystalline, translucent to opaque, but not glassy, and melt above 50 0 C without decomposition. They are already slightly above the melting point low viscosity and show a strong temperature-dependent consistency and solubility.
  • Preference according to the invention for example, natural vegetable waxes, z. Candelilla wax, carnauba wax, Japan wax, sugarcane wax, ouricoury wax, cork wax, sunflower wax, fruit waxes such as orange waxes, lemon waxes, grapefruit wax, and animal waxes, e.g. Beeswax, shellac wax and spermaceti.
  • it may be particularly preferred to use hydrogenated or hardened waxes.
  • a wax component and chemically modified waxes especially the hard waxes, such as.
  • montan ester waxes hydrogenated jojoba waxes and Sasol waxes used.
  • Synthetic waxes which are also preferable in the invention include, for example, polyalkylene waxes and polyethylene glycol waxes, C 2 4 oC o-dialkyl esters of dimer acids, C 30 - 50 alkyl and alkylaryl esters of -Alkylbienenwachs and dimer fatty acids.
  • a particularly preferred wax component is selected from at least one ester of a saturated, monohydric C 16 -C 6 o-alcohol and a saturated Cs-Cs ⁇ monocarboxylic acid.
  • lactides the cyclic double esters of ⁇ -hydroxycarboxylic acids of the corresponding chain length, also belong thereto.
  • Esters of fatty acids and long-chain alcohols have proved to be particularly advantageous for the composition according to the invention because they give the antiperspirant preparation excellent sensory properties and pins a high stability.
  • the esters are composed of saturated branched or unbranched monocarboxylic acids and saturated branched or unbranched monohydric alcohols.
  • esters of aromatic carboxylic acids and hydroxycarboxylic acids eg., 12-hydroxystearic acid
  • saturated branched or unbranched alcohols are used according to the invention, provided that the wax component has a melting point of> 50 0 C. It is particularly preferred to choose the wax components from the group of esters of saturated branched or unbranched alkanecarboxylic acids having a chain length of 12 to 24 carbon atoms and the saturated branched or unbranched alcohols having a chain length of 16 to 50 carbon atoms and having a melting point> 50 ° C have.
  • the wax component C 16-36 alkyl stearates and C eighteenth 38 Alkylhydroxystearoylstea- rate C 2O - 4 o-alkyl erucate and Cetearylbehenat be advantageous.
  • the wax or the wax components have a melting point> 50 0 C, preferably> 60 0 C, on.
  • a particularly preferred embodiment of the invention in stick form contains as wax component a C 2 oC 4O alkyl stearate.
  • This ester is known under the name Kester ® ® K82H or Kesterwachs K80H, sold by Koster Keunen Inc.. It is the synthetic imitation of the monoester fraction of beeswax and is characterized by its hardness, oil gelability and broad compatibility with lipid components.
  • This wax can be used as a stabilizer and consistency regulator for W / O and O / W emulsions.
  • Kester wax has the advantage that it has an excellent oil gelability even at low concentrations and so does not make the pencil mass too heavy and allows a velvety abrasion.
  • Another particularly preferred embodiment of the invention in stick form contains as wax component cetearyl behenate, ie mixtures of cetyl behenate and stearyl behenate.
  • This ester is known under the name Kester ® K62 and is sold by Koster Keunen Inc..
  • More preferred wax components with a melting point of> 50 0 C are the triglycerides of saturated and optionally hydroxylated C 12 - 3 o-fatty acids such as hydrogenated triglyceride fats (hydrogenated palm oil, hydrogenated coconut oil, hydrogenated castor oil), glyceryl tribehenate (tribehenin), or glyceryl tri-12-hydroxystearate, further synthetic Vollester of fatty acids and glycols or polyols containing 2 - 6 carbon atoms as long as they have a melting point above 50 ° C, for example, preferably C 18 - C 36 acid triglyceride (Syncrowax HGL-C ®).
  • the hydrogenated castor oil as a wax component available for example as a commercial product Cutina ® HR, is particularly preferred. More preferred wax components with a melting point of> 50 0 C, the saturated linear C 14 - C 36 -Ca rbonsä u reindeer, in particular myristic acid, palmitic acid, stearic acid and behenic acid, and mixtures of these compounds, for example.
  • Preferred deodorant or antiperspirant compositions according to the invention, in particular sticks, are characterized in that the wax component is selected from esters of a saturated, monohydric C 16 -C 60 -alkanol and a saturated C 8 -C 36 -monocarboxylic acid, in particular cetyl behenate, stearyl behenate and C 2 oC 4 o-alkyl stearate, glycerol triesters of saturated linear C 12 -C 30 -carboxylic acids which may be hydroxylated, candelilla wax, carnauba wax, beeswax, saturated linear C 14 -C 36 -carboxylic acids and mixtures of the abovementioned substances.
  • the wax component is selected from esters of a saturated, monohydric C 16 -C 60 -alkanol and a saturated C 8 -C 36 -monocarboxylic acid, in particular cetyl behenate, stearyl behenate and C
  • Particularly preferred wax component blends are selected from mixtures of cetyl behenate, stearyl behenate, hardened castor oil, palmitic acid and stearic acid. More special Preferred wax component mixtures are selected from mixtures of C 2O- C 40 -alkyl stearate, hardened castor oil, palmitic acid and stearic acid.
  • Preferred deodorant or antiperspirant sticks according to the invention based on an oil-in-water emulsion are characterized in that the wax component (s) is generally taken in amounts of 4 to 20% by weight, preferably 8 to 15% by weight, based on the total composition is included.
  • the ester (s) of a saturated monohydric C 6 -C 6 o-alcohol and a saturated C 8 -C 36 monocarboxylic acid representing the wax component (s) are / are in total amounts 2 - 10 wt .-%, preferably 2 - 6 wt .-%, based on the total composition.
  • Oil-in-water emulsifiers oil-in-water emulsifiers
  • compositions according to the invention which are formulated as an emulsion, in particular as an oil-in-water emulsion or a polyol-in-water emulsion, preferably contain at least one nonionic oil-in-water emulsifier having an HLB value of more as 7.
  • nonionic oil-in-water emulsifier having an HLB value of more as 7.
  • nonionic oil-in-water emulsifiers which are suitable according to the invention, it is particularly preferable to use a mixture of nonionic oil-in-water emulsifiers in order to optimally adjust the stability of O / W emulsion compositions according to the invention.
  • the individual emulsifier components deliver a proportion to the total HLB value or mean HLB value of the oil-in-water emulsifier mixture in accordance with their proportion of the total amount of oil-in-water emulsifiers.
  • the average HLB value of the oil-in-water emulsifier mixture is 10-19, preferably 12-18 and particularly preferably 14-17.
  • oil-in-water emulsifiers preference is given to oil-in-water emulsifiers from the HLB value ranges 10 - 14, 14 - 16 and possibly 16 - 19 combined.
  • the oil-in-water emulsifier mixtures may also contain nonionic emulsifiers with HLB values in the range of> 7-10 and 19-20; Such emulsifier mixtures may also be preferred according to the invention.
  • the deodorant or antiperspirant compositions of the present invention may also contain only a single oil-in-water emulsifier having an HLB in the range of 10-19.
  • Preferred deodorant or antiperspirant compositions according to the invention are characterized in that the nonionic oil-in-water emulsifiers are selected from ethoxylated C 8 -C 24 -alkanols with an average of 10 to 100 moles of ethylene oxide per mole of ethoxylated C 8 -C 24 - carbon acids containing on average 10-100 moles of ethylene oxide per mole, silicone copolyols having ethylene oxide units or with ethylene oxide and propylene oxide units, alkyl mono- and oligoglycosides having 8 to 22 carbon atoms in the alkyl radical and their ethoxylated analogs, ethoxylated sterols, partial esters of polyglycerols having 2 to 10 glycerol units and having 1 to 4 saturated or unsaturated, linear or branched, optionally hydroxylated C 8 - C 30 fatty acid residues esterified, provided they have an HLB value of more than 7, and mixtures of
  • the ethoxylated C 8 -C 24 -alkanols have the formula R 1 O (CH 2 CH 2 O) n H, where R 1 is a linear or branched alkyl and / or alkenyl radical having 8-24 carbon atoms and n, the middle one Number of ethylene oxide units per molecule, for numbers from 10 to 100, preferably 10 to 30, moles of ethylene oxide to 1 mole of caprylic alcohol, 2-ethylhexyl alcohol, capric alcohol, lauryl alcohol, isotridecyl alcohol, myristyl alcohol, cetyl alcohol, isocetyl alcohol, palmitoleyl alcohol, stearyl alcohol, isostearyl alcohol, Oleyl alcohol, elaidyl alcohol, petroselinyl alcohol, arachyl alcohol, gadoleyl alcohol, behenyl alcohol, erucyl alcohol and brassidyl alcohol, and technical mixtures thereof. Adducts of 10 to 100 mol of ethylene oxide onto
  • the ethoxylated C 8 -C 24 -carboxylic acids have the formula R 1 (OCH 2 CH 2 ) n OH, where R 1 is a linear or branched saturated or unsaturated acyl radical having 8-24 carbon atoms and n, the average number of ethylene oxide Units per molecule, for numbers from 10 to 100, preferably 10 to 30, mol of ethylene oxide to 1 mol of caprylic acid, 2-ethylhexanoic acid, capric acid, lauric acid, isotridecanoic acid, myristic acid, cetylic acid, palmitoleic acid, stearic acid, isostearic acid, oleic acid, elaidic acid, Petroselinic acid, arachidic acid, gadoleic acid, behenic acid, erucic acid and brassidic acid and their technical mixtures.
  • Adducts of 10 to 100 mol of ethylene oxide with technical fatty acids containing 12 to 18 carbon atoms, such as coconut, palm, palm kernel or tallow fatty acid, are also suitable. Particularly preferred are PEG-50 monostearate, PEG-100 monostearate, PEG-50 monooleate, PEG-100 monooleate, PEG-50 monolaurate and PEG-100 monolaurate.
  • C 8 -C 22 -alkyl mono- and -oligoglycosides preference is given to using C 8 -C 22 -alkyl mono- and -oligoglycosides.
  • C 8 -C 22 -alkyl mono- and oligoglycosides are known, commercially available surfactants and emulsifiers. They are prepared in particular by reacting glucose or oligosaccharides with primary alcohols having 8-22 carbon atoms.
  • the glycoside radical monoglycosides in which a cyclic sugar residue is glycosidically bound to the fatty alcohol, as well as oligomeric glycosides having a degree of oligomerization of up to about 8, preferably 1-2, are suitable.
  • the degree of oligomerization is a statistical mean, which is based on a homolog distribution typical for such technical products.
  • Products sold under the trademark Planta- care ® contain a glucosidically bound C 8 -C 16 alkyl group on a Oligo- glucosidrest whose average degree of oligomerization at 1 - 2, in particular 1, 1 - 1, 4, lies.
  • Particularly preferred C 8 -C 22 alkyl mono- and oligoglycosides are selected from octyl glucoside, decyl glucoside, lauryl glucoside, palmityl glucoside, isostearyl glucoside, stearyl glucoside, arachidyl glucoside and behenyl glucoside and mixtures thereof.
  • the glucamine-derived acylglucamides are also suitable as nonionic oil-in-water emulsifiers.
  • Ethoxylated sterols in particular ethoxylated soy sterols, are also suitable oil-in-water emulsifiers according to the invention.
  • the degree of ethoxylation must be greater than 5, preferably at least 10, in order to have an HLB value greater than 7.
  • Suitable commercial products are, for. PEG-10 Soy Sterol, PEG-16 Soy Sterol and PEG-25 Soy Sterol.
  • Diglycerinmonocaprylat Particularly preferred Diglycerinmonocaprylat, Diglycerinmonocaprat, diglycerol, Triglycerinmonocaprylat, Triglycerinmonocaprat, triglycerol, Tetraglycerinmonocaprylat, Tetraglycerinmonocaprat, Tetraglycerinmonolaurat, Pentaglycerinmonocaprylat, Pentaglycerinmono- caprate, Pentaglycerinmonolaurat, Hexaglycerinmonocaprylat, Hexaglycerinmonocaprat, hexa glycerol- monolaurate, Hexaglycerinmonomyristat, Hexaglycerinmonostearat, Decaglycerinmonocaprylat, deca are glycerol monocaprate, decaglyceryl monolaurate, decaglyceryl monomyristate, rat Decaglycerinmonoiso
  • Particularly preferred deodorant or antiperspirant compositions according to the invention are characterized in that the nonionic oil-in-water emulsifier in a total amount of 0.5 to 10 wt .-%, particularly preferably 1 to 4 wt .-% and most preferably 1 , 5 - 3 wt .-%, based on the total composition is included.
  • compositions according to the invention which are formulated as an emulsion or stick, preferably furthermore comprise at least one nonionic water-in-oil emulsifier having an HLB value greater than 1.0, and less than or equal to 7.0, selected from the mono- and diesters of Ethylene glycol and the mono-, di-, tri- and tetra-esters of pentaerythritol with linear saturated fatty acids having 12-30, in particular 14-22 carbon atoms, which may be hydroxylated, and mixtures thereof, as consistency regulator and / or water binder.
  • the mono- and diesters are preferred.
  • Ci 2 -C 3 o-fatty acid radicals which are preferred according to the invention are selected from lauric acid, myristic acid, palmitic acid, stearic acid, arachic acid and behenic acid radicals; particularly preferred is the stearic acid residue.
  • Particularly preferred nonionic water-in-oil emulsifiers according to the invention having an HLB value greater than 1.0 and less than or equal to 7.0 are selected from pentaerythrityl monostearate, pentaerythrityl distearate, pentaerythrityl tristearate, pentaerythrityl tetrastearate, ethylene glycol monostearate, ethylene glycol distearate and mixtures thereof.
  • particularly preferred water-in-oil emulsifiers having an HLB value greater than 1, 0 and less than / equal to 7.0, for example as commercial products Cutina ® PES (INCI: Pentaerythrityl distearate), Cutina ® AGS (INCI: distearate Glycol) or Cutina ® EGMS (INCI: glycol stearate) available.
  • Cutina ® PES INCI: Pentaerythrityl distearate
  • Cutina ® AGS INCI: distearate Glycol
  • Cutina ® EGMS INCI: glycol stearate
  • the compositions according to the invention comprise mixtures, in particular technical mixtures, of at least two water-in-oil emulsifiers.
  • a commercial product such as Cutina ® PES is meant, for example, a technical mixture.
  • At least one further nonionic water-in-oil emulsifier having an HLB value greater than 1, 0 and less than or equal to 7, 0 should be included, the proportion of the total weight of nonionic water-in-oil emulsifiers with an HLB value greater than 1, 0 and less than or equal to 7.0 preferably, but should not be greater than 80%.
  • compositions according to the invention contain the at least one additional water-in-oil emulsifier having an HLB value greater than 1.0, and less than or equal to 7.0 only in a proportion by weight of not more than 10% or are free of additional water in oil emulsifiers.
  • additional suitable emulsifiers are listed, for example, in Kirk-Othmer, "Encyclopedia of Chemical Technology” 3rd Ed., 1979, Vol. 8, page 913.
  • the HLB value can also be calculated.
  • Suitable water-in-oil emulsifiers are preferably: linear saturated alkanols having 12 to 30 carbon atoms, in particular 16 to 22 carbon atoms, in particular cetyl alcohol, stearyl alcohol, arachidyl alcohol, behenyl alcohol and lanolin alcohol or mixtures of these alcohols, as used in the industrial hydrogenation of vegetable and animal fatty acids are available,
  • Such esters or partial esters are, for.
  • Alkanols and carboxylic acids each having 8-24 C atoms, in particular having 16-22 C atoms, in the alkyl group and 1-4 ethylene oxide units per molecule which have an HLB value of greater than 1.0, and less than or equal to 7.0 exhibit,
  • Partial ester of polyglycerols having n 2 to 10 glycerol units and esterified with 1 to 5 saturated or unsaturated, linear or branched, optionally hydroxylated C 8 - C 30 fatty acid residues, if they have an HLB value of 7 or less, and mixtures of aforementioned substances.
  • compositions according to the invention comprise mixtures, in particular technical mixtures, of at least two additional water-in-oil emulsifiers.
  • a commercial product such as Cutina GMS ® is understood to be a technical mixture, which is a mixture of glyceryl monostearate and glyceryl distearate.
  • Particularly advantageous additional water-in-oil emulsifiers are stearyl alcohol, cetyl alcohol, glyceryl monostearate, in particular in the form of the commercial products Cutina ® GMS and Cutina ® MD (ex Cognis), glyceryl distearate, glyceryl monocaprinate, glyceryl monocaprylate, glyceryl monolaurate, glyceryl monomyristate, glyceryl monopalmitate, glyceryl monohydroxystearate , glyceryl monooleate, glyceryl rylmonolanolat, Glyceryldimyristat, Glyceryldipalmitat, glyceryl dioleate, propylene glycol monostearate, pro pylenglycolmonolaurat, sorbitan monocaprylate, sorbitan monolaurate, sorbitan monomyristate, sorbitan monopalmitate
  • Particularly preferred deodorant or antiperspirant compositions according to the invention are characterized in that at least one water-in-oil emulsifier is present in a total amount of 0.1-15% by weight, preferably 0.5-8.0% by weight, and particularly preferably 1 to 4 wt .-%, based on the total composition, are included. Furthermore, amounts of 2 - 3 - 3.5 wt .-%, based on the total weight of the composition, according to the invention be extremely preferred.
  • W / O emulsifiers are silicone-free polymeric water-in-oil emulsifiers, in particular PEG-30 dipolyhydroxystearate, available for. B. under the trade name Arlacel P 135 from Uniqema.
  • this emulsifier can be formulated low-viscous and even sprayable water-in-oil emulsions.
  • compositions which are particularly preferred according to the invention and which are formulated as a water-in-oil emulsion preferably furthermore comprise at least one water-in-oil emulsifier based on silicone.
  • the at least one silicone-based water-in-oil emulsifier is preferably present in an amount of from 0.5 to 5% by weight, more preferably from 0.1 to 1.5 to 2.5 to 3.5% by weight. %, in each case based on the total weight of the emulsion.
  • PEG / PPG-18/18 dimethicones which are commercially available in a 1: 9 mixture with cyclomethicone as DC 3225 C or DC 5225 C
  • PEG / PPG-4/12 dimethicone sold under the name Abil B 8852 is available as well as Bis-PEG / PPG-14/14 Dimethicone, which is commercially available in a mixture with Cyclomethicone as Abil EM 97 (Goldschmidt)
  • Bis-PEG / PPG-20/20 Dimethicone under the name Abil B 8832 is available, PEG / PPG-5/3 trisiloxanes (Silsoft 305), and PEG / PPG-20/23 dimethicones (Silsoft 430 and Silsoft 440).
  • silicone-based w / o emulsifiers which are preferred according to the invention are poly (C 2 -C 3 ) -alkylene glycol-modified silicones which are hydrophobically modified with C 4 -C 18 -alkyl groups, particularly preferably cetyl PEG / PPG-10/1 Dimethicone (formerly: Cetyl Dimethicone Copolyol, available as Abil EM 90 or in a mixture of polyglyceryl-4-isostearate, Cetyl PEG / PPG-10/1 dimethicone and Hexyl laurate under the trade name Abil WE 09), further alkyl methicone copolyols and alkyl dimethicone ethoxy glucosides.
  • poly (C 2 -C 3 ) -alkylene glycol-modified silicones which are hydrophobically modified with C 4 -C 18 -alkyl groups, particularly preferably cetyl PEG / PPG-10/1 Dime
  • HLB values can also be calculated according to Griffin, as described, for example, in the R ⁇ MPP Chemie Lexikon, in particular in the online version of November 2003, and the manuals cited by Fiedler, Kirk-Othmer, and "HLB-System" there If there is different information on the HLB value of a substance in the literature, the HLB value for the teaching according to the invention which comes closest to the value calculated according to Griffin should be used If no clear HLB value can be determined, the HLB value given by the manufacturer of the emulsifier must be used for the teaching according to the invention. If this too is not possible, the HLB value must be determined experimentally.
  • polyoxyethylene (2) oleyl alcohol polyoxyethylene (2) oleyl ether
  • polyoxyethylene (2) stearyl alcohol polyoxyethylene (2) stearyl ether
  • Polyglyceryl-3-isostearates eg Isolan Gl 34 from Tego
  • Polyethylene glycol (200) dioleate 1 diethylene glycol monolaurate (diglycollaurate), 3 polyethylene glycol (300) dilaurate, 4 glycerol monoricinoleate
  • Glycerol sorbitan monolaurate 5-diethylene glycol monolaurate
  • Glycerol monolaurate 0 polyoxyethylene (2) C 10 -C 4 fatty alcohol ether, laureth-2 (Dehydol LS 2)
  • sucrose dipalmitate 5 sucrose dipalmitate, 6 glycerol sorbitan laurate, 8 polyethylene glycol (400) distearate, 9 polyethylene glycol (200) monostearate
  • PEG-40 Castor OiI eg Eumulgin RO 40
  • Decylglucoside Oramix NS 10
  • Dodecylglucoside Planten APG 600
  • Dodecyltrimethylammonium chloride Nonylphenol ethoxylated with 15 moles EO
  • Polyethylene glycol 1000
  • Monostearate Polyoxyethylene 600
  • Monooleate 15-17 Eumulgin HRE 60 (Castor oil, ethoxylated with 60 EO and hydrogenated)
  • compositions according to the invention are characterized in that the total content of nonionic and ionic emulsifiers and / or surfactants having an HLB value more than 8 not more than 20% by weight, preferably not more than 15% by weight, more preferably not more than 10% by weight, more preferably not more than 7% by weight, still more preferably not more than 4% by weight and exceptionally preferably not more than 3% by weight .-%, in each case based on the total composition of the invention is.
  • compositions according to the invention which are present as emulsion, suspension or stick, preferably furthermore contain at least one oil which is liquid at 20 ° C. and which does not represent a perfume component and does not represent an essential oil.
  • Oils preferred according to the invention are selected from branched saturated or unsaturated fatty alcohols having 6 to 30 carbon atoms. These alcohols are also often referred to as Guerbet alcohols, as they are obtainable by the Guerbet reaction.
  • Preferred alcohol oils are Hexyldecanol (Eutanol ® G 16, Guerbitol ® T 16) Octyldodecanol (Eutanol ® G, Guerbitol ® 20), 2-ethylhexyl alcohol and the commercial products Guerbitol ® 18, Isofol ® 12, Isofol ® 16, Isofol ® 24, Isofol ® 36, Isocarb 12 ®, ® Isocarb 16 or Isocarb ® 24.
  • Further preferred oil components are mixtures of Guerbet alcohols and Guerbet alcohol esters, for example the commercial product Cetiol ® PGL (hexyldecanol and hexyldecyl laurate).
  • preferred oils are selected from the triglycerides of linear or branched, saturated or unsaturated, optionally hydroxylated C 8 - 3 o-fatty acids.
  • Particularly suitable may be the use of natural oils, for example soybean oil, cottonseed oil, sunflower oil, palm oil, palm kernel oil, linseed oil, almond oil, castor oil, corn oil, olive oil, rapeseed oil, sesame oil, thistle oil, wheat germ oil, peach kernel oil and the liquid portions of coconut oil and the like.
  • natural oils for example soybean oil, cottonseed oil, sunflower oil, palm oil, palm kernel oil, linseed oil, almond oil, castor oil, corn oil, olive oil, rapeseed oil, sesame oil, thistle oil, wheat germ oil, peach kernel oil and the liquid portions of coconut oil and the like.
  • synthetic triglyceride oils in particular Capric / Caprylic triglycerides, z.
  • Myritol ® 318 Myritol ® 331 (Cognis) or Miglyol ® 812 (Hüls) with unbranched fatty acid residues and glyceryl triisostearin
  • Estol ® GTEH 3609 Uniqema
  • Myritol ® GTEH Cognis
  • particularly preferred oils are selected from the dicarboxylic acid esters of linear or branched C 2 -C 0 alkanols, especially diisopropyl adipate, di-n-butyl adipate, di- (2-ethylhexyl) adipate, dioctyl adipate, diethyl / di-n-butyl / Dioctyl sebacate, diisopropyl sebacate, dioctyl malate, dioctyl maleate, dicaprylyl maleate, diisooctyl succinate, di-2-ethylhexyl succinate and di (2-hexyldecyl) succinate.
  • dicarboxylic acid esters of linear or branched C 2 -C 0 alkanols especially diisopropyl adipate, di-n-butyl adipate, di- (2-ethylhexyl)
  • particularly preferred oils are selected from the addition products of from 1 to 5 propylene oxide units onto mono- or polyhydric C 8-22 alkanols, such as octanol, decanol, decanediol, lauryl alcohol, myristyl alcohol and stearyl alcohol, eg. B. PPG-2 myristyl ether and PPG-3-myristyl ether (Witconol APM ®).
  • mono- or polyhydric C 8-22 alkanols such as octanol, decanol, decanediol, lauryl alcohol, myristyl alcohol and stearyl alcohol, eg. B. PPG-2 myristyl ether and PPG-3-myristyl ether (Witconol APM ®).
  • Further oil components which are preferred according to the invention are selected from the esters of linear or branched saturated or unsaturated fatty alcohols having 2 to 30 carbon atoms with linear or branched saturated or unsaturated fatty acids having 2 to 30 carbon atoms, which are hydroxylated. can be liert.
  • these include, hexyldecyl stearate (Eutanol G 16 S), hexyldecyl, Isodecylneopen- tanoat, isononyl isononanoate, 2-ethylhexyl palmitate (Cegesoft ® C 24) and 2-ethylhexyl stearate (Cetiol ® 868).
  • preferred oil components are selected from the addition products of at least 6 ethylene oxide and / or propylene oxide units onto mono- or polyhydric C. 3 22 - alkanols such as butanol, butanediol, myristyl alcohol and stearyl alcohol, e.g. As PPG-14 butyl ether (Ucon Fluid ® AP), PPG-9-butyl ether (Breox B25 ®), PPG-10 butanediol (Macol ® 57) and PPG-15 stearyl ether (Arlamol ® E).
  • PPG-14 butyl ether Ucon Fluid ® AP
  • PPG-9-butyl ether Breox B25 ®
  • PPG-10 butanediol Macol ® 57
  • PPG-15 stearyl ether Arlamol ® E
  • Further oil components preferred according to the invention are selected from the C 8 -C 22 -fatty alcohol esters of monohydric or polyhydric C 2 -C 7 -hydroxycarboxylic acids, in particular the esters of glycolic acid, lactic acid, malic acid, tartaric acid, citric acid and salicylic acid.
  • Ci ⁇ -C -is-alkyl lactate, and of branched in the 2-position C 12 / i 3 alkanols are under the trademark Cosmacol ® by Nordmann, Rassmann GmbH & Co, Hamburg, to obtain, especially the commercial products Cosmacol ® ESI, Cosmacol® ® EMI and Cosmacol® ® EIT.
  • oil components are selected from the symmetrical, asymmetrical or cyclic esters of carbonic acid with fatty alcohols, eg. As glycerol carbonate, dicaprylyl (Cetiol ® CC) or the esters of DE 197 56 454 A1.
  • Further preferred oil components according to the invention are selected from the esters of dimers of unsaturated C 2 -C 22 -fatty acids (dimer fatty acids) with monovalent linear, branched or cyclic C 2 -C 8 -alkanols or with polyvalent linear or branched C 2 -C 6 -alkanols. It may be extraordinarily preferred according to the invention to use mixtures of the abovementioned oils.
  • oil components preferred according to the invention are selected from silicone oils and hydrocarbon oils.
  • Silicone oils preferred according to the invention are selected from dialkyl and alkylaryl siloxanes, which include, for example, dimethylpolysiloxane and methylphenylpolysiloxane, but also hexamethyldisiloxane, octamethyltrisiloxane and decamethyltetrasiloxane.
  • silicone oils are selected from volatile silicone oils which may be cyclic, such as.
  • volatile silicone oils which may be cyclic, such as.
  • octamethylcyclotetrasiloxane octamethylcyclotetrasiloxane, decamethylcyclopentasiloxane and dodecamethylcyclohexasiloxane and mixtures thereof, as described for. B. in the commercial products DC 244, 245, 344 and 345 of Dow Corning, or linear, z. Hexamethyldisiloxane (L 2 ), Octamethyltrisiloxane (L 3 ), decamethyltetrasiloxane (L 4 ), any two and three mixtures of L 2 , L 3 and / or L 4 , as described for.
  • Dow Corning® 200 0.65 cSt
  • Dow Corning® 200 1.5 cSt
  • silicone oils are selected from non-volatile higher molecular weight linear dimethylpolysiloxanes, commercially available z.
  • preferred natural and synthetic hydrocarbons are selected from paraffinic oils, isohexadecane, isoeicosane, polyisobutenes and polydecenes, the ®, for example, under the designation Emery ® 3004, 3006, 3010 or under the name Ethylflo ® from Albemarle or Nexbase 2004G from Nestle are available, as well as 1 , 3-di- (2-ethylhexyl) -cyclohexane (Cetiol ® S).
  • Particularly preferred deodorant or antiperspirant compositions according to the invention are characterized in that the oil (s) liquid at 20 ° C. in a total amount of 0.1-80% by weight, preferably 2-20% by weight, particularly preferably 3-15% by weight, in each case based on the total weight of the composition, is / are contained.
  • a proportion of the oil components of at least 80 wt .-%, a refractive index n D of 1, 39 - 1, 51 on. It is particularly preferred if 5 - 40 - 50 wt .-%, most preferably 10 - 12 - 25 - 30 wt .-% of the oil components have a refractive index n D of 1, 43 - 1, 58, preferably 1, 44 - 1 , 51, more preferably 1, 45 - 1, 47 - 1, 49, at 20 0 C (measured at ⁇ 589 nm) have.
  • Compositions which are particularly preferred according to the invention furthermore preferably contain at least one skin-cooling active substance.
  • Skin-cooling active ingredients suitable according to the invention are, for example, menthol, isopulegol and menthol derivatives, eg. Menthyl lactate, menthyl glycolate, menthyl pyrrolidone carboxylic acid, menthyl methyl ether, menthoxypropanediol, menthone glycerol acetal (9-methyl-6- (1-methylethyl) -1, 4-dioxaspiro (4.5) decane-2-methanol), monomethyl succinate and 2-hydroxymethyl-3 , 5.5-trimethylcyclohexanol.
  • Preferred skin-cooling active ingredients are menthol, isopulegol, menthyl lactate, menthoxypropanediol and menthylpyrrolidonecarboxylic acid, and mixtures of these substances, in particular mixtures of menthol and menthyl lactate, menthol, menthol glycolate and menthyl lactate, menthol and menthoxypropanediol or menthol and isopulegol.
  • At least one skin-cooling active compound prefferably be present in a total amount of 0.01-1% by weight, more preferably 0.02-0.5% by weight and most preferably 0.05-0.2-0.3% by weight %, in each case based on the total weight of the composition.
  • compositions according to the invention which are formulated as a propellant-driven aerosol, contain at least one propellant.
  • propellants are Propane, propene, n-butane, isobutane, isobutene, n-pentane, pentene, iso-pentane, iso-pentene, methane, ethane, dimethyl ether, nitrogen, air, oxygen, nitrous oxide, 1, 1, 1, 3-tetrafluoroethane, heptafluoro-n-propane, perfluoroethane, monochlorodifluoromethane, 1,1-difluoroethane (INCI: hydrofluorocarbon 152a) both individually and in combination.
  • hydrophilic propellants such as carbon dioxide
  • hydrophilic propellants such as carbon dioxide
  • lipophilic propellant gas eg., Propane / butane
  • propane, n-butane, isobutane and mixtures of these propellants propane, n-butane, isobutane and mixtures of these propellants. It has been found that the use of n-butane as the only propellant gas according to the invention can be particularly preferred.
  • the amount of blowing agent is preferably 20-80-90% by weight, more preferably 30-70-75% by weight and most preferably 40-50% by weight, in each case based on the total weight of the preparation, consisting of the inventive composition Composition and the propellant.
  • compositions of the present invention sprayed with a propellant may either be packaged directly with the propellant or packaged in a multichamber container in which the composition of the present invention is physically separate from the propellant.
  • compositions according to the invention also comprise at least one water-soluble polyhydric C 2 -C 9 -alkanol having 2-6 hydroxyl groups and / or at least one water-soluble polyethylene glycol having 3-20 ethylene oxide units and mixtures thereof.
  • These components are preferably selected from 1,2-propylene glycol, 2-methyl-1,3-propanediol, glycerol, butylene glycols such as 1,2-butylene glycol, 1,3-butylene glycol and 1,4-butylene glycol, pentylene glycols such as 1, 2-pentanediol and 1, 5-pentanediol, hexanediols such as 1,6-hexanediol, hexanetriols such as 1, 2,6-hexanetriol, 1,2-octanediol, 1,8-octanediol, dipropylene glycol, tripropylene glycol, diglycerol, triglycerol, Erythritol, sorbitol and mixtures of the aforementioned substances.
  • Suitable water-soluble polyethylene glycols are selected from PEG-3, PEG-4, PEG-6, PEG-7, PEG-8, PEG-9, PEG-10, PEG-12, PEG-14, PEG-16, PEG-18 and PEG-20 and mixtures thereof, with PEG-3 to PEG-8 being preferred.
  • Preferred deodorant or antiperspirant compositions according to the invention are characterized in that the at least one water-soluble polyvalent C 2 -C 9 -alkanol having 2 to 6 hydroxyl groups and / or at least one water-soluble polyethylene glycol having 3 to 20 ethylene oxide Units selected from 1,2-propylene glycol, 2-methyl-1,3-propanediol, glycerol, butylene glycols such as 1,2-butylene glycol, 1,3-butylene glycol and 1,4-butylene glycol, pentylene glycols such as 1,2-pentanediol and 1, 5-pentanediol, hexanediols such as 1, 6-hexanediol, hexanetriols such as 1, 2,6-hexanetriol, 1, 2-octanediol, 1, 8-octanediol, dipropylene glycol, tripropylene glycol, diglycerol,
  • Particularly preferred deodorant or antiperspirant compositions according to the invention are characterized in that the at least one water-soluble polyhydric C 2 -C 9 -alkanol having 2 to 6 hydroxyl groups and / or at least one water-soluble polyethylene glycol having 3 to 20 ethylene oxide units in total amounts of 3 - 30 wt .-%, preferably 8 - 25 wt .-%, particularly preferably 10-18 wt .-%, each based on the total composition, is included.
  • compositions according to the invention contain water.
  • the proportion of water is preferably 0.1-99 wt .-%, particularly preferably 3 to 80 wt .-%, most preferably 10 to 70 wt .-%, further preferably 15 - 60 wt .-%, 20 - 50 wt .-%, 30- 40 wt .-%, each based on the total composition.
  • deodorant or antiperspirant compositions are characterized in that at least one wax component with a melting point in the range of 25 - ⁇ 50 0 C, selected from Kokosfett Textreglycerin- mono-, di- and tri-esters, Butyrospermum Parkii (Shea butter) and esters of saturated, monohydric C 8 -C 8 -alcohols with saturated Ci 2 -Ci 8 monocarboxylic acids and mixtures of these substances.
  • wax component with a melting point in the range of 25 - ⁇ 50 0 C, selected from Kokosfettklasted Acid- mono-, di- and tri-esters, Butyrospermum Parkii (Shea butter) and esters of saturated, monohydric C 8 -C 8 -alcohols with saturated Ci 2 -Ci 8 monocarboxylic acids and mixtures of these substances.
  • These lower melting wax components allow consistency optimization of sticky or creamy products and minimization of visible skin residue.
  • coco glycerides in particular the commercial products Novata ® (ex Cognis), particularly preferably Novata AB ®, a mixture of C 12 -C 18 mono-, di- and triglycerides, which in the range of 30-32 ° C, as well as the products of the Softisan series (Sasol Germany GmbH) with the INCI name Hydrogenated Cocoglycerides, in particular Softisan 100, 133, 134, 138, 142.
  • Further preferred esters of saturated, monovalent C 12 -C 18 alcohols with saturated C 12 -C 18 monocarboxylic acids are stearic ryllaurat, cetearyl (z. B.
  • Thallamol ® CSS Crodamol ® CSS
  • cetyl palmitate z. B. Cutina ® CP
  • myristyl myristate z. B. Cetiol ® MM
  • DEsetzun- gene in particular those in stick form, are characterized in that the at least one wax component with a melting point in the range of 25 - ⁇ 50 0 C in amounts of 0.01 to 20 weight %, preferably 3 - 20 wt .-%, particularly preferably 5 - 18 wt .-% and most preferably 6 - 15 wt .-%, based on the total composition, is included.
  • Particularly preferred deodorant or antiperspirant compositions according to the invention are characterized in that they further contain at least one solid, water-insoluble particulate filler for improving the pen consistency and the sensory properties.
  • this filler is selected from optionally modified starches (for. Example, of corn, rice, potatoes) and starch derivatives, which are, if desired, pregelatinized, in particular starch derivatives, such as Aluminum Starch Octenylsuccinate (z. B. DRY FLO ®) Sodium Starch Octenyl succinates, cellulose and cellulose derivatives, silica, silicas, e.g.
  • Aerosil ® types spherical Polyalkylsesquisiloxan particles (especially Aerosil ® R972 and Aerosil ® 200V from Degussa), silica gels, talc, kaolin, clays, z. Bentonites, magnesium aluminum silicates, boron nitride, lactoglobulin derivatives, e.g. B. Sodium-C 8 -i 6 -sloalkylsuccinyllacto- globulinsulfonat, available from Brooks Industries as a commercial product Biopol ® OE, glass powders, polymer powders, in particular from polyolefins, polycarbonates, polyurethanes, polyamides, eg. As nylon, polyesters, polystyrenes, polyacrylates, (meth) acrylate or (meth) acrylate-vinylidene copolymers, which may be crosslinked, or silicones, and mixtures of these substances.
  • Polymer powder based on a polymethacrylate copolymer are z. B. as a commercial product Polytrap ® 6603 (Dow Corning) available.
  • Other polymer powders e.g. Example based on polyamides, obtainable under the name Orgasol ® 1002 (polyamide-6) and Orgasol ® 2002 (polyamide-12) from Elf Atochem.
  • Other polymer powders which are suitable for the purpose according to the invention are, for. B.
  • Particularly preferred deodorant or antiperspirant compositions according to the invention are characterized in that they contain at least one solid, water-insoluble particulate filler in a total amount of 0.01 to 30% by weight, preferably 5 to 20% by weight, more preferably 8 to 15 Wt .-%, each based on the total composition included.
  • perfume component perfumes perfume oils or perfume oil ingredients can be used.
  • perfume oils or fragrances can according to the invention individual fragrance compounds, eg. As the synthetic products of the ester type, ethers, aldehydes, ketones, alcohols and hydrocarbons.
  • Fragrance compounds of the ester type are, for example, benzyl acetate, phenoxyethyl isobutyrate, p-tert-butylcyclohexyl acetate, linalyl acetate, dimethylbenzylcarbinyl acetate (DMBCA), phenylethyl acetate, benzyl acetate, ethylmethylphenylglycinate, allylcyclohexylpropionate, styrallylpropionate, benzylsalicylate, cyclohexylsalicylate, floramate, melusate and jasmecyclate.
  • DMBCA dimethylbenzylcarbinyl acetate
  • the ethers include, for example, benzyl ethyl ether and ambroxane, to the aldehydes, for example, the linear alkanals with 8 - 18 carbon atoms, citral, citronellal, citronellyloxy-acetaldehyde, cyclamen aldehyde, lilial and bourgeonal, to the ketones such as the Jonone, alpha-lsomethylionon and Methylcedrylketon , the alcohols include anethole, citronellol, eugenol, geraniol, linalool, phenylethyl alcohol and terpineol, the hydrocarbons mainly include the terpenes such as limonene and pinene.
  • fragrance oils may also contain natural fragrance mixtures as are available from vegetable sources, eg pine, citrus, jasmine, patchouly, rose or ylang-ylang oil.
  • perfume oils may also contain natural fragrance mixtures as are available from vegetable sources, eg pine, citrus, jasmine, patchouly, rose or ylang-ylang oil.
  • oils may also contain natural fragrance mixtures as are available from vegetable sources, eg pine, citrus, jasmine, patchouly, rose or ylang-ylang oil.
  • oils may also contain natural fragrance mixtures as are available from vegetable sources, eg pine, citrus, jasmine, patchouly, rose or ylang-ylang oil.
  • oils may also contain natural fragrance mixtures as are available from vegetable sources, eg pine, citrus, jasmine, patchouly, rose or ylang-ylang oil.
  • oils may also contain natural fragrance mixtures as are available from vegetable sources, eg pine, citrus, jasmine, patchouly, rose or ylang-ylang oil.
  • a fragrance In order to be perceptible, a fragrance must be volatile, whereby besides the nature of the functional groups and the structure of the chemical compound, the molecular weight also plays an important role. For example, most odorants have molecular weights up to about 200 daltons, while molecular weights of 300 daltons and above are more of an exception.
  • fragrances Due to the different volatility of fragrances, the smell of a perfume or fragrance composed of several fragrances changes during evaporation, whereby the odor impressions in "top note", “middle note or body” As the smell perception is based to a large extent on the odor intensity, the top note of a perfume or fragrance consists not only of volatile compounds, while the base note for the most part from less volatile In the composition of perfumes, for example, volatile fragrances can be bound to certain fixatives, which prevents them from evaporating too quickly the smell impression and on whether the corre sponding is perceived as the head or middle note, nothing said.
  • Adhesive-resistant fragrances which can be used in the context of the present invention are, for example, the essential oils such as angelica root oil, aniseed oil, arnica blossom oil, basil oil, bay oil, bergamot oil, Champacablütenöl, Edeltannenöl, Edeltannenzapfen oil, Elemiöl, eucalyptus oil, fennel oil, spruce needle oil, galbanum oil, geranium oil, Ginger Grass Oil, Guaiac Wood Oil, Gurjun Balm Oil, Helichrysum Oil, Ho Oil, Ginger oil, iris oil, cajeput oil, calamus oil, chamomile oil, camphor oil, kanaga oil, cardamom oil, cassia oil, pine oil, copa ⁇ vabalsam oil, coriander oil, spearmint oil, caraway oil, cumin oil, lavender oil, lemongrass oil, lime oil, tangerine oil, lemon balm oil, musk kernel oil, myrrh oil,
  • fragrances can be used in the context of the present invention as adherent fragrances or fragrance mixtures, ie fragrances.
  • These compounds include the following compounds and mixtures thereof: ambrettolide, ⁇ -amylcinnamaldehyde, anethole, anisaldehyde, anisalcohol, anisole, methyl anthranilate, acetophenone, benzylacetone, benzaldehyde, benzoic acid ethyl ester, benzophenone, benzyl alcohol, benzyl acetate, benzyl benzoate, benzyl formate, benzyl valeria nat, borneol, bornyl acetate, ⁇ -bromostyrene, n-decyl aldehyde, n-dodecyl aldehyde, eugenol, eugenol methyl ether, euca
  • the more volatile fragrances include in particular the lower-boiling fragrances of natural or synthetic origin, which can be used alone or in mixtures.
  • Examples of more readily volatile fragrances are alkyl isothiocyanates (alkyl mustard oils), butanedione, limonene, linalool, linayl acetate and propionate, menthol, menthone, methyl-n-heptenone, phellandrene, phenylacetaldehyde, terpinyl acetate, citral, citronellal.
  • Particularly preferred deodorant or antiperspirant compositions according to the invention are characterized in that at least one perfume component is contained in a total amount of 0.00001 to 4 wt .-%, preferably 0.5 to 2 wt .-%, each based on the total composition
  • Further inventively preferred cosmetic or dermatological compositions are characterized in that in addition to the combination of two of a) at least one deodorant or antiperspirant active ingredient and b) at least one active ingredient selected from at least one yoghurt protein and / or at least one hydrolyzate of a yoghurt -Proteins and / or at least one NC 2 -C 24 acyl derivative and / or at least one C 2 -C 24 ester and / or at least one physiologically acceptable salt of these protein drugs, as well as mixtures of these protein drugs, at least one further skin-soothing Active ingredient included.
  • Skin-soothing active ingredients preferred according to the invention are selected from allantoin, ⁇ -bisabolol, ⁇ -lipoic acid, extracts from Centella asiatica, for example obtainable under the name Madecassicoside from DSM, glycyrrethic acid, which is particularly preferably encapsulated in liposomes and in this form z.
  • Mentha piperita extracts which are particularly preferred according to the invention, in particular from the leaves of Mentha piperita, are described, for example, in the commercial products Calmiskin OP (ex Silab, INCI: Water (and) Mentha piperita (Peppermint Leaf Extract) and Caomint (ex Solabia, INCI: Propylene Glycol, Water, Mentha piperita (Peppermint) leaf extract, Theobroma cacao (Cocoa) extract).
  • Extremely preferred according to the invention is allantoin; Extremely preferred compositions according to the invention contain at least one deodorant or antiperspirant active, at least one yoghurt protein and / or at least one hydrolyzate of a yoghurt protein and / or at least one NC 2 -C 24 acyl derivative and / or at least one C 2 -C 24 -ester and / or at least one physiologically acceptable salt of these P red in-active substances, and allantoin.
  • compositions according to the invention comprise at least one hair growth inhibiting substance.
  • Preferred substances which inhibit hair growth are, in particular, selected from eflornithine, active ingredient combinations of soybean hydrolyzate, urea, menthol, salicylic acid and extracts of hypericum perforatum, hamamelis virginiana, arnica montana and the bark of Salix alba, as described, for example and preferably in US Pat Raw material Pilinhib ® Veg LS 9109 from Laboratoires Serobiiquess is included with the INCI declaration "Propylene Glycol, Hydrolyzed Soy Protein, Hypericum Perforatum Extract, Hamamelis Virginiana Extract, Arnica Montana Flower Extract, Urea, Salix Alba Bark Extract, Menthol, Salicylic acid” Farther Active ingredient combinations of extracts of Epilobium angustifolium, the seeds of Cucurbita pepo (pumpkin, zucchini) and the fruits of Serenoa serrulata, as for example
  • Further preferred hair growth inhibiting active substances are selected from substances which inhibit the protein tyrosine kinase, in particular from lavendustin A, erbstatin, tyrphostin, piceatannol, 4-hydroxybenxylidene-malononitrile, 3,5-di-tert-butyl-4-hydroxybenzylidenemalononitrile, ⁇ - Cyano- (3,4-dihydroxy) -cinnamonitrile, ⁇ -cyano- (3,4,5-trihydroxy) cinnamonitrile, ⁇ -cyano- (3,4-dihydroxy) cinnamide, ⁇ -cyano- (3,4-dihydroxy ) thiocinnamide, 2-amino-4- (4'-hydroxyphenyl) -1, 1, 3-tricyanobuta-1,3-diene, 2-amino-4- (3,4,5'-trihydroxyphenyl) -1, 1 , 3-tricyanobuta-1,3-diene, 2-amino-4
  • agonists of the farnesoid X receptor preferably selected from bile acids, in particular lithocholic acid, cholic acid, deoxycholic acid, chenodeoxycholic acid, ursodeoxycholic acid and 6 -alpha-ethylchenodeoxycholic acid, further from farnesoids, in particular farnesol (3,7,11-trimethyl-2,6,10-dodecatrien-1-ol), farnesal, farnesyl acetate, 3,7,11- Trimethyl 2, 6, 10-dodecatriene-1-carboxylic acid, methyl farnesyl ether, methyl farnesoate, ethyl farnesyl ether, ethyl farnesoate, furthermore from methyl 7-methyl-9- (3,3-dimethyloxivanyl) -3-methyl-2,6-nonadienoate ( Juvenile hormone IM
  • compositions according to the invention contain at least one hair growth inhibiting substance in a total amount of 0.0001-5 wt.%, Preferably 0.001-2 wt.%, Particularly preferably 0.01-1 wt.%, And most preferably 0, 1 to 0.5% by weight, in each case based on the weight of active substance of hair growth inhibiting active substance (s) and the total weight of the composition according to the invention.
  • Antiperspirant sticks according to the invention based on an oil-in-water emulsion (amounts in% by weight)
  • the emulsion according to Example 8 had the first day after the preparation has a viscosity of 2200 mPas, measured with a Brookfield viscometer, spindle RV 4, 20 s-1 without Helipath, at 20 0 C ambient temperature and 20 0 C sample temperature; she was filled into a roll-on applicator.
  • Example 9 Antiperspirant Emulsion (O / W) According to the Invention
  • the emulsion according to Example 9 had the first day after the preparation has a viscosity of 1700 mPas, measured with a Brookfield viscometer, spindle RV 4, 20 s-1 without Helipath, at 20 0 C ambient temperature and 20 0 C sample temperature; she was filled into a roll-on applicator.
  • Anhydrous surfactant-containing antiperspirant sticks (in% by weight)
  • Anhydrous surfactant-containing antiperspirant sticks (in% by weight)
  • Anhydrous antiperspirant wax pencils without cyclomethicones (in% by weight)
  • the above-mentioned sprayable antiperspirant microemulsions can be metered with either a propellant-free pump sprayer or a propellant or applied to a substrate such as a nonwoven or cellulose cloth and thus used as an antiperspirant cloth.
  • Soap-containing pens (in% by weight)
  • Soap-containing deodorant sticks (in% by weight)
  • Anhydrous deodorant spray (in% by weight)
  • Antiperspirant roll-on (in% by weight)
  • Suspension type antiperspirant spray (in% by weight) available from spray-dried yoghurt Antiperspirant Wipes (Examples Nos. 17.1 - 17.4)
  • a single-layer substrate made of 100% rayon with a basis weight of 50 g / m 2 with 75 g of the example emulsions 11.1 and 11.2 or 2.3 per square meter or with 75 g of the sample solutions 13.1 and 13.2, cut into cloths of suitable size and packed in sachets.
  • Example Composition 19.1 contains an antiperspirant emulsion according to the invention with 9.9% by weight aluminum chlorohydrate, based on the weight of the propellant-free emulsion. With a spray rate of 0.35 g / s, 0.035 g of the antiperspirant active ingredient aluminum chlorohydrate are sprayed onto the skin surface every second.
  • Example Composition 19.2 contains an antiperspirant emulsion according to the invention with 17.49% by weight aluminum chlorohydrate, based on the weight of the propellant-free emulsion. At a spray rate of 0.2 g / s, 0.035 g of the antiperspirant active ingredient aluminum chlorohydrate is sprayed onto the skin surface every second. Deodorant pump spray / impregnation solution for deodorant wipes
  • the refractive index of the water phase must be adapted to the refractive index of the oil phase.
  • Water or propylene glycol serve as a variable.
  • the thickener (carbomer) should be adjusted to the desired pH with a suitable neutralizing agent (TEA, AMP, NaOH, LiOH).
  • a suitable neutralizing agent TEA, AMP, NaOH, LiOH.
  • Antiperspirant cream based on an oil-in-water emulsion
  • compositions according to the invention are applied to the skin, in particular the underarm skin.
  • Another object of the present application is a method for non-therapeutic treatment of the skin, which is characterized in that a composition according to any one of claims 1-10 on the skin, in particular the armpits, is applied. Particularly preferred is the application to the skin after a shave.
  • the compositions of the invention are characterized by a high, compared to the prior art improved skin compatibility.

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Birds (AREA)
  • Zoology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Dermatology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Cosmetics (AREA)

Abstract

The present application relates to cosmetic and dermatological antiperspirant and deodorant compositions which have an improved care effect and comprise at least one yoghurt protein and/or at least one hydrolysate of a yoghurt protein and/or at least one N-C2-C24-acyl derivative and/or at least one C2-C24 ester and/or at least one physiologically tolerated salt of these substances.

Description

Antitranspirant- und Deodorant-Zusammensetzungen mit verbesserter Pflegewirkung Antiperspirant and deodorant compositions with improved care properties
Beschreibungdescription
Die vorliegende Anmeldung betrifft kosmetische und dermatologische Antitranspirant- und Deodorant- Zusammensetzungen, die eine verbesserte Pflegewirkung und/oder ein verringertes Reizpotenzial aufweisen.The present application relates to cosmetic and dermatological antiperspirant and deodorant compositions which have an improved care effect and / or a reduced irritation potential.
Stand der TechnikState of the art
Handelsübliche schweißhemmende Zusammensetzungen, im Folgenden auch als Antitranspirantien bezeichnet, enthalten als Antitranspirant-Wirkstoff mindestens ein wasserlösliches adstringierendes anorganisches und organisches Salzen des Aluminiums, Zinks oder ausgewählte Aluminium-Zirkonium-Mischsalze. Handelsübliche Deodorant-Zusammensetzungen, im Folgenden auch als Deodoran- tien bezeichnet, enthalten als Deodorant-Wirkstoff häufig mindestens einen antibakteriellen Wirkstoff. Die Antitranspirant-Wirkstoffe haben keinen direkten Einfluss auf die Tätigkeit der Schweißdrüsen, sondern minimieren durch Verengung der Ausflusskanäle die Schweißsekretion. Die AI-Salze bewirken dabei an den behandelten Hautflächen eine Schweißhemmung durch oberflächliche Verstopfung der Schweißdrüsenkanäle infolge von Al-Mucopolysaccharid-Niederschlägen.Commercially available antiperspirant compositions, hereinafter also referred to as antiperspirants, contain as antiperspirant active ingredient at least one water-soluble astringent inorganic and organic salts of aluminum, zinc or selected aluminum-zirconium mixed salts. Commercially available deodorant compositions, also referred to below as deodorants, frequently contain at least one antibacterial active substance as the deodorant active ingredient. The antiperspirant active ingredients have no direct influence on the activity of the sweat glands, but minimize the narrowing of the discharge channels sweat secretion. The AI salts cause thereby on the treated skin surfaces a sweat inhibition by superficial blockage of the sweat gland ducts as a result of Al-Mucopolysaccharid precipitation.
Antitranspirant- und Deodorant-Zusammensetzungen werden üblicherweise im Bereich der Achselhöhlen appliziert und angewendet.Antiperspirant and deodorant compositions are usually applied and applied in the armpit area.
Die Achselhaut weist aufgrund ihrer Lage und Funktion eine schwache Barrierefunktion auf. Die Haut im Achselbereich ist also empfindlicher als die restliche Haut des Körpers, häufig mindestens genau so empfindlich wie die Haut des Gesichtes. Viele Verbraucher betrachten eine unbehaarte Achselhaut als ästhetischer und der Hygiene zuträglicher, denn der Haarwuchs vergrößert die schweißtragende Oberfläche im Achselbereich und trägt damit zu einer verstärkten Körpergeruchsentwicklung bei. Dementsprechend gehört eine regelmäßige Rasur der Achselbehaarung für viele Verbraucher zur Hygieneroutine dazu. Durch die Achselrasur wird die Haut mechanisch gereizt und die Barrierefunktion zusätzlich geschwächt. Nach der Rasur wird auf die Achselhaut üblicherweise ein schweißhemmendes und/ oder deodorierendes Kosmetikum, beispielsweise als Deospray oder Deostift, appliziert. Die schweißhemmenden und/oder deodorierenden Wirkstoffe weisen, beispielsweise aufgrund ihres sauren pH- Wertes, meistens ein beträchtliches Reizpotenzial auf, was auf der - mechanisch gereizten - Achselhaut Hautrötungen, ein unangenehmes Brennen, Spannungsgefühl und/oder Jucken hervorrufen kann. Es besteht daher ein ständiger Bedarf an besonders hautverträglichen Formulierungen, die als Träger für kosmetische und dermatologische Antitranspirant- und Deodorant-Zusammensetzungen geeignet sind. Weiterhin besteht ein Bedarf an besonders hautverträglichen Formulierungen, die als Träger für kosmetische und dermatologische Antitranspirant- und Deodorant-Zusammensetzungen in der Lage sein können, die bei regelmäßigem Gebrauch und/oder bei Gebrauch auf mechanisch oder chemisch gereizter Haut gelegentlich hautreizend wirkenden Antitranspirant- und Deodorant-Wirkstoffe hautverträglicher zu machen beziehungsweise deren irritative Wirkung zu mildern.The armpit skin has a weak barrier function due to its location and function. The skin in the underarm area is therefore more sensitive than the rest of the skin, often at least as sensitive as the skin of the face. Many consumers consider a hairless armpit skin to be more aesthetically pleasing and hygienic, as hair growth increases the sweat-bearing surface in the armpit area and thus contributes to an increased body odor development. Accordingly, a regular shave of underarm hair is part of the routine of hygiene for many consumers. The underarm shave mechanically irritates the skin and additionally weakens the barrier function. After shaving, a sweat-inhibiting and / or deodorizing cosmetic, for example as a deodorant spray or deodorant stick, is usually applied to the underarm skin. The antiperspirant and / or deodorant active ingredients have, for example, due to their acidic pH, usually a considerable irritation potential, which can cause reddening of the skin on the - mechanically irritated - armpit skin, an unpleasant burning, feeling of tension and / or itching. There is therefore a constant need for particularly skin-compatible formulations which are suitable as carriers for cosmetic and dermatological antiperspirant and deodorant compositions. Furthermore, there is a need for particularly skin-compatible formulations which may be able to act as a carrier for cosmetic and dermatological antiperspirant and deodorant compositions which, on regular use and / or on use on mechanically or chemically irritated skin, sometimes have antiperspirant and deodorant which irritates the skin - To make active ingredients skin-friendly or to mitigate their irritative effect.
Aufgabenstellungtask
Aufgabe der vorliegenden Erfindung war es, Wirkstoffe und/oder Träger für kosmetische und dermatologische Antitranspirant- und Deodorant-Zusammensetzungen mit besonders hoher Hautverträglichkeit zu finden. Eine weitere Aufgabe der vorliegenden Erfindung war es, Wirkstoffe und/oder Träger für kosmetische und dermatologische Antitranspirant- und Deodorant-Zusammensetzungen mit besonders hoher Hautverträglichkeit insbesondere für mechanisch gereizte Haut zu finden. Eine weitere Aufgabe der vorliegenden Erfindung war es, Wirkstoffe und/oder Träger für kosmetische und dermatologische Antitranspirant- und Deodorant-Zusammensetzungen zu finden, die die hautreizend wirkenden Antitranspirant- und Deodorant-Wirkstoffe hautverträglicher machen können beziehungsweise deren irritative Wirkung mildern können. Eine weitere Aufgabe der vorliegenden Erfindung war es, Wirkstoffe und/ oder Träger für kosmetische und dermatologische Antitranspirant- und Deodorant-Zusammensetzungen zu finden, die das Brennen und/oder Jucken der Haut bei Applikation reduzieren.The object of the present invention was to find active substances and / or carriers for cosmetic and dermatological antiperspirant and deodorant compositions with particularly high skin tolerance. A further object of the present invention was to find active substances and / or carriers for cosmetic and dermatological antiperspirant and deodorant compositions with particularly high skin compatibility, in particular for mechanically irritated skin. A further object of the present invention was to find active substances and / or carriers for cosmetic and dermatological antiperspirant and deodorant compositions which can make the skin-irritant antiperspirant and deodorant active ingredients more skin-friendly or can alleviate their irritative effect. A further object of the present invention was to find active substances and / or carriers for cosmetic and dermatological antiperspirant and deodorant compositions which reduce the burning and / or itching of the skin when applied.
Überraschend wurde gefunden, dass Wirkstoffe, ausgewählt aus Yoghurt-Proteinen, Yoghurt-Protein- Hydrolysaten, N-C2-C24-Acylderivaten und C2-C24-Estern von Yoghurt-Proteinen und Yoghurt-Protein- Hydrolysaten sowie den physiologisch verträglichen Salzen dieser Protein-Wirkstoffe die gestellten Aufgaben lösen.Surprisingly, it has been found that active ingredients selected from yoghurt proteins, yoghurt protein hydrolysates, NC 2 -C 24 acyl derivatives and C 2 -C 24 esters of yoghurt proteins and yoghurt protein hydrolysates and the physiologically tolerated salts thereof Protein-active ingredients solve the tasks.
Ein Gegenstand der vorliegenden Anmeldung ist daher eine kosmetische oder dermatologische Deodorant- oder Antitranspirant-Zusammensetzung, enthaltend in einem kosmetisch oder dermatologisch verträglichen Träger mindestens einen Deodorant- oder Antitranspirant-Wirkstoff, mindestens ein Yoghurt-Protein und/oder mindestens ein Hydrolysat eines Yoghurt-Proteins und/oder mindestens ein N-C2-C24-Acylderivat und/oder mindestens einen C2-C24-Ester und/oder mindestens ein physiologisch verträgliches Salz dieser P rote in- Wirkstoffe, sowie Mischungen dieser P rote in- Wirkstoffe.An object of the present application is therefore a cosmetic or dermatological deodorant or antiperspirant composition comprising, in a cosmetically or dermatologically acceptable carrier, at least one deodorant or antiperspirant active, at least one yoghurt protein and / or at least one hydrolyzate of a yoghurt protein and / or at least one NC 2 -C 24 acyl derivative and / or at least one C 2 -C 24 ester and / or at least one physiologically acceptable salt of these P red in-active substances, and mixtures of these P red in-active substances.
Ein weiterer Gegenstand der vorliegenden Anmeldung ist die Verwendung von mindestens einem Yoghurt-Protein und/oder mindestens einem Hydrolysat eines Yoghurt-Proteins und/oder mindestens einem N-C2-C24-Acylderivat und/oder mindestens einem C2-C24-Ester und/oder mindestens einem physiologisch verträglichen Salz dieser Substanzen, sowie Mischungen dieser P rote in- Wirkstoffe, in einem kosmetisch oder dermatologisch verträglichen Träger, enthaltend mindestens einen Deodorantoder Antitranspirant-Wirkstoff, zur Verbesserung der Hautverträglichkeit und/oder der Pflegewirkung der Zusammensetzung und/oder zur Verringerung oder Vermeidung von Hautbrennen, einem Spannungsgefühl, Juckreiz und/oder sichtbaren Irritationen, wie Hautrötungen, das/die durch Kontakt der Haut mit der Zusammensetzung hervorgerufen wird/werden.Another object of the present application is the use of at least one yoghurt protein and / or at least one hydrolyzate of a yoghurt protein and / or at least one NC 2 -C 24 acyl derivative and / or at least one C 2 -C 24 ester and / or at least one physiologically acceptable salt of these substances, as well as mixtures of these P red in-active substances, in a cosmetically or dermatologically acceptable carrier containing at least one deodorant or antiperspirant active, for improving the skin compatibility and / or the conditioning effect of the composition and / or for reducing or preventing skin burning, a feeling of tightness, itching and / or visible irritations, such as skin redness, the / caused by contact of the skin with the composition.
Ein weiterer Gegenstand der vorliegenden Anmeldung ist die Verwendung von mindestens einem Yoghurt-Protein und/oder mindestens einem Hydrolysat eines Yoghurt-Proteins und/oder mindestens einem N-C2-C24-Acylderivat und/oder mindestens einem C2-C24-Ester und/oder mindestens einem physiologisch verträglichen Salz dieser Substanzen, sowie Mischungen dieser Protein-Wirkstoffe, in Kombination mit mindestens einem weiteren Wirkstoff, ausgewählt aus Monosacchariden mit 5 oder 6 Kohlenstoffatomen und Disacchariden, in einem kosmetisch oder dermatologisch verträglichen Träger, enthaltend mindestens einen Deodorant- oder Antitranspirant-Wirkstoff, zur Verbesserung der Hautverträglichkeit und/oder der Pflegewirkung der Zusammensetzung und/oder zur Verringerung oder Vermeidung von Hautbrennen, einem Spannungsgefühl, Juckreiz und/oder sichtbaren Irritationen, wie Hautrötungen, das/die durch Kontakt der Haut mit der Zusammensetzung hervorgerufen wird/werden.Another object of the present application is the use of at least one yoghurt protein and / or at least one hydrolyzate of a yoghurt protein and / or at least one NC 2 -C 24 acyl derivative and / or at least one C 2 -C 24 ester and or at least one physiologically acceptable salt of these substances, and mixtures of these protein active ingredients, in combination with at least one further active ingredient selected from monosaccharides having 5 or 6 carbon atoms and disaccharides, in a cosmetically or dermatologically acceptable carrier, containing at least one deodorant or Antiperspirant active, to improve the skin compatibility and / or the care effect of the composition and / or to reduce or avoid burning skin, a feeling of tightness, itching and / or visible irritations, such as skin redness, which is caused by contact of the skin with the composition /become.
Eine bevorzugte Ausführungsform der Erfindung ist dadurch gekennzeichnet, dass das mindestens eine Yoghurt-Protein, mindestens eine Hydrolysat eines Yoghurt-Proteins und/oder das mindestens eine N-C2-C24-Acylderivat und/oder der mindestens eine C2-C24-Ester und/oder das mindestens eine physiologisch verträgliche Salz dieser Substanzen in Form von Yoghurt enthalten ist.A preferred embodiment of the invention is characterized in that the at least one yoghurt protein, at least one hydrolyzate of a yoghurt protein and / or the at least one NC 2 -C 24 acyl derivative and / or the at least one C 2 -C 24 ester and / or the at least one physiologically acceptable salt of these substances is contained in the form of yoghurt.
Eine weitere bevorzugte Ausführungsform der Erfindung ist dadurch gekennzeichnet, dass das mindestens eine Yoghurt-Protein, mindestens eine Hydrolysat eines Yoghurt-Proteins und/oder das mindestens eine N-C2-C24-Acylderivat und/oder der mindestens eine C2-C24-Ester und/oder das mindestens eine physiologisch verträgliche Salz dieser Substanzen in Form von getrocknetem Yoghurt, insbesondere in Form von sprühgetrocknetem Yoghurt, gefriergetrocknetem Yoghurt oder lyophilisiertem Yoghurt enthalten ist. Ebenso ist es erfindungsgemäß bevorzugt, wenn das enthaltene Yoghurt auf andere Art, als vorstehend aufgeführt, getrocknet ist.A further preferred embodiment of the invention is characterized in that the at least one yoghurt protein, at least one hydrolyzate of a yoghurt protein and / or the at least one NC 2 -C 24 -acyl derivative and / or the at least one C 2 -C 24 - Ester and / or the at least one physiologically acceptable salt of these substances in the form of dried yogurt, especially in the form of spray-dried yogurt, freeze-dried yogurt or lyophilized yogurt is included. Likewise, it is preferred according to the invention if the yoghurt contained is dried in a manner other than that stated above.
Unter einem Hydrolysat eines Yoghurt-Proteins wird erfindungsgemäß ein Oligopeptid aus mindestens drei Aminosäuren, bevorzugt aus mindestens 5 Peptiden, besonders bevorzugt aus mindestens 8 Peptiden verstanden, dass durch Hydrolyse von nativem Yoghurt-Protein erhältlich ist.According to the invention, a hydrolyzate of a yoghurt protein means an oligopeptide of at least three amino acids, preferably of at least 5 peptides, more preferably of at least 8 peptides, which is obtainable by hydrolysis of native yoghurt protein.
Eine weitere bevorzugte Ausführungsform der Erfindung ist dadurch gekennzeichnet, dass ein N-C2-C24-Acylderivat eines Yoghurt-Proteins oder eines Yoghurt-Protein-Hydrolysats enthalten ist. Der C2 - C24-Acylrest, mit dem das mindestens eine Yoghurt-Protein oder mindestens eine Yoghurt- Protein-Hydrolysat an mindestens einer Aminogruppe derivatisiert ist, ist bevorzugt ausgewählt aus einem Acetyl-, Propanoyl-, Butanoyl-, Pentanoyl-, Hexanoyl-, Heptanoyl-, Octanoyl-, Nonanoyl-, Decanoyl-, Undecanoyl-, Lauroyl-, Tridecanoyl-, Myristoyl-, Pentadecanoyl-, Cetoyl-, Palmitoyl-, Stearoyl-, Elaidoyl-, Arachidoyl- oder Behenoyl-Rest. Mischungen von C8-C18-Acylresten werden auch als Cocoyl-Rest bezeichnet und sind ebenfalls bevorzugte Substituenten. Besonders bevorzugt ist es, wenn eine terminale Aminogruppe mit einem C2 - C24-Acylrest substituiert ist.A further preferred embodiment of the invention is characterized in that an NC 2 -C 24 acyl derivative of a yoghurt protein or a yoghurt protein hydrolyzate is contained. The C 2 -C 24 -acyl radical with which the at least one yoghurt protein or at least one yoghurt protein Protein hydrolyzate is derivatized on at least one amino group, is preferably selected from an acetyl, propanoyl, butanoyl, pentanoyl, hexanoyl, heptanoyl, octanoyl, nonanoyl, decanoyl, undecanoyl, lauroyl, tridecanoyl , Myristoyl, pentadecanoyl, cetoyl, palmitoyl, stearoyl, elaidoyl, arachidoyl or behenoyl residue. Mixtures of C 8 -C 18 acyl radicals are also referred to as cocoyl radical and are likewise preferred substituents. It is particularly preferred if a terminal amino group is substituted by a C 2 -C 24 -acyl radical.
Eine weitere bevorzugte Ausführungsform der Erfindung ist dadurch gekennzeichnet, dass das mindestens eine Yoghurt-Protein oder mindestens eine Yoghurt-Protein-Hydrolysat an denjenigen Aminosäuren, die eine Hydroxylgruppe tragen, mit den vorgenannten C2 - C24-Acylresten an mindestens einer dieser Hydroxylgruppe über eine Esterbindung verknüpft ist.A further preferred embodiment of the invention is characterized in that the at least one yoghurt protein or at least one yoghurt protein hydrolyzate at those amino acids which carry a hydroxyl group with the aforementioned C 2 - C 24 -acyl radicals on at least one of these hydroxyl group an ester bond is linked.
Eine weitere bevorzugte Ausführungsform der Erfindung ist dadurch gekennzeichnet, dass das mindestens eine Yoghurt-Protein oder mindestens eine Yoghurt-Protein-Hydrolysat, deren N-C2-C24- Acylderivat oder deren C2-C24-Ester in Form mindestens eines physiologisch verträglichen Salzes vorliegt. Erfindungsgemäß bevorzugte physiologisch verträgliche Salze der Protein-Wirkstoffe sind ausgewählt aus den Ammonium-, Alkalimetall-, Magnesium-, Calcium-, Aluminium-, Zink- und Mangan- Salzen. Erfindungsgemäß besonders bevorzugt sind die Natrium-, Kalium-, Magnesium-, Aluminium-, Zink- und Mangan-Salze.A further preferred embodiment of the invention is characterized in that the at least one yoghurt protein or at least one yoghurt protein hydrolyzate, its NC 2 -C 24 acyl derivative or its C 2 -C 24 ester in the form of at least one physiologically acceptable salt is present. Physiologically acceptable salts of the protein active ingredients which are preferred according to the invention are selected from the ammonium, alkali metal, magnesium, calcium, aluminum, zinc and manganese salts. Particularly preferred according to the invention are the sodium, potassium, magnesium, aluminum, zinc and manganese salts.
Überraschend wurde festgestellt, dass das mit den vorgenannten C2 - C24-Acylresten substituierte Yoghurt-Protein oder Yoghurt-Protein-Hydrolysat eine weitere Verbesserung der anti-irritativen Wirkung gegenüber dem unsubstituierten Yoghurt-Protein oder Yoghurt-Protein-Hydrolysat aufweisen kann.Surprisingly, it has been found that the yoghurt protein or yoghurt protein hydrolyzate substituted with the abovementioned C 2 -C 24 -acyl radicals can have a further improvement in the anti-irritative action against the unsubstituted yoghurt protein or yoghurt-protein hydrolyzate.
Eine weitere bevorzugte Ausführungsform der Erfindung ist dadurch gekennzeichnet, dass das Yoghurt-Protein, das Yoghurt-Proteinhydrolysat, das N-C2-C24-Acylderivat, das C2-C24-Esterderivat und/oder deren physiologisch verträgliches Salz in einer Gesamtmenge von 0,001 bis 0,1 Gew.-%, bevorzugt 0,005 - 0,07 Gew.-%, besonders bevorzugt 0,01 - 0,05 Gew.-% und außerordentlich bevorzugt 0,02 - 0,04 Gew.-%, jeweils bezogen auf die gesamte Zusammensetzung, enthalten ist. Ebenso können auch Gesamtmengen an Yoghurt-Protein-Wirkstoffen von mehr als 0,1 bis 1 Gew.-% erfindungsgemäß bevorzugt sein. Gesamtmengen an Yoghurt-Protein-Wirkstoffen von mehr als 0,1 bis 1 Gew.-% können erfindungsgemäß insbesondere dann bevorzugt sein, wenn die Zusammensetzung kein Aluminiumsalz enthält.A further preferred embodiment of the invention is characterized in that the yoghurt protein, the yoghurt protein hydrolyzate, the NC 2 -C 24 acyl derivative, the C 2 -C 24 ester derivative and / or their physiologically acceptable salt in a total amount of 0.001 to 0.1 wt .-%, preferably 0.005 - 0.07 wt .-%, particularly preferably 0.01 - 0.05 wt .-% and exceptionally preferably 0.02 - 0.04 wt .-%, each based on the entire composition, is included. Likewise, total amounts of yoghurt protein active ingredients of more than 0.1 to 1 wt .-% may be preferred according to the invention. Total quantities of yoghurt protein active substances of more than 0.1 to 1% by weight may be preferred according to the invention in particular if the composition contains no aluminum salt.
Ein erfindungsgemäß besonders bevorzugter Yoghurt-Protein-Rohstoff ist unter der Handelsbezeichnung „Yoghurt Protein GBU" von der Firma Cosmetochem erhältlich. Antitranspirant-WirkstoffeA yoghurt protein raw material particularly preferred according to the invention is available under the trade name "Yoghurt Protein GBU" from Cosmetochem. Antiperspirant components
Erfindungsgemäß bevorzugte Antitranspirant-Wirkstoffe sind ausgewählt aus den Aluminiumchlorhydraten, insbesondere den Aluminiumchlorhydraten mit der allgemeinen Formel [AI2(OH)5CI ■ 2-3 H2O]n, die in nicht-aktivierter oder in aktivierter (depolymerisierter) Form vorliegen können, weiterhin Aluminiumsesquichlorhydrat, Aluminiumchlorhydrex-Propylenglycol (PG) oder -Polyethylenglycol (PEG), Aluminiumsesquichlorhydrex-PG oder -PEG, Aluminium-PG-dichlorhydrex oder Aluminium- PEG-dichlorhydrex, Aluminiumhydroxid, weiterhin ausgewählt aus den Aluminiumzirconiumchlorhydra- ten, wie Aluminiumzirconiumtrichlorhydrat, Aluminiumzirconiumtetrachlorhydrat, Aluminiumzirconium- pentachlorhydrat, Aluminiumzirconiumoctachlorhydrat, den Aluminium-Zirkonium-Chlorohydrat-Glycin- Komplexen wie Aluminiumzirconiumtrichlorhydrexglycin, Aluminiumzirconiumtetrachlorhydrexglycin, Aluminiumzirconiumpentachlorhydrexglycin, Aluminiumzirconiumoctachlorhydrexglycin, Kaliumaluminiumsulfat (KAI(SO4)2 ■ 12 H2O, Alaun), Aluminiumundecylenoylkollagenaminosäure, Natriumalumi- niumlactat + Aluminiumsulfat, Natriumaluminiumchlorhydroxylactat, Aluminiumbromhydrat, Aluminiumchlorid, den Komplexen von Zink- und Natriumsalzen, den Komplexe von Lanthan und Cer, den Aluminiumsalzen von Lipoaminosäuren, Aluminiumsulfat, Aluminiumlactat, Aluminiumchlorhydroxyallantoi- nat, Natrium-Aluminium-Chlorhydroxylactat, Zinkchlorid, Zinksulfocarbolat, Zinksulfat und Zirkonium- chlorohydrat. Erfindungsgemäß wird unter Wasserlöslichkeit eine Löslichkeit von wenigstens 5 Gew.-% bei 20 0C verstanden, das heißt, dass Mengen von wenigstens 5 g des Antitranspirant-Wirkstoffs in 95 g Wasser bei 20 0C löslich sind. Die Antitranspirant-Wirkstoffe können als wässrige Lösungen eingesetzt werden.According to the invention preferred antiperspirant active substances are selected from aluminum chlorohydrates, especially aluminum chlorohydrates having the general formula [Al 2 (OH) 5 CI 2-3 ■ H 2 O] n, which may be present in non-activated or activated in (depolymerized) Form , furthermore aluminum sesquichlorohydrate, aluminum chlorohydrex-propylene glycol (PG) or polyethylene glycol (PEG), aluminum sesquichlorohydrex PG or PEG, aluminum PG-dichlorhydrex or aluminum PEG-dichlorhydrex, aluminum hydroxide, furthermore selected from the aluminum zirconium chlorohydrates, such as aluminum zirconium trichlorohydrate, aluminum zirconium tetrachlorohydrate , Aluminum zirconium pentachlorohydrate, aluminum zirconium octachlorohydrate, aluminum zirconium chlorohydrate glycine complexes such as aluminum zirconium trichlorohydrex glycine, aluminum zirconium tetrachlorohydrex glycine, aluminum zirconium pentachlorohydrex glycine, aluminum zirconium octachlorohydrex glycine, potassium aluminum sulfate (KAl (SO 4 ) 2 ■ 12H 2 O, alum), aluminum undecylenoyl collagen amino acid, sodium aluminum lactate + aluminum sulfate, sodium aluminum chlorhydroxactate, aluminum bromohydrate, aluminum chloride, the complexes of zinc and sodium salts, the complexes of lanthanum and cerium, the aluminum salts of lipoamino acids, aluminum sulfate, aluminum lactate, aluminum chlorohydroxyallantoate , Sodium aluminum chlorhydroxylactate, zinc chloride, zinc sulfocarbolate, zinc sulfate and zirconium chlorohydrate. A solubility of at least 5 wt .-% at 20 0 C is understood according to the invention, solubility in water, that is, amounts of at least 5 g of the antiperspirant active ingredient in 95 g of water are soluble at 20 0 C. The antiperspirant active ingredients can be used as aqueous solutions.
Besonders bevorzugte erfindungsgemäße Deodorant- oder Antitranspirant-Zusammensetzungen sind dadurch gekennzeichnet, dass der mindestens eine Antitranspirant-Wirkstoff in einer Gesamtmenge von 3 - 25 Gew.-%, vorzugsweise 5 - 22 Gew.-% und insbesondere 10 - 20 Gew.-%, enthalten ist, bezogen auf das Gesamtgewicht der Aktivsubstanz in der Gesamtzusammensetzung. Die in der vorliegenden Patentanmeldung in Gew.-% angegebene Menge an schweißhemmendem/n Salze/n ist nach der Methode der US Pharmacopoeia (USP) zu berechnen, nach der gebundenes Kristallwasser und andere Liganden, z. B. Glycin, ausgeschlossen sind.Particularly preferred deodorant or antiperspirant compositions according to the invention are characterized in that the at least one antiperspirant active ingredient is present in a total amount of 3 to 25 wt.%, Preferably 5 to 22 wt.% And in particular 10 to 20 wt. contained, based on the total weight of the active substance in the overall composition. The amount of antiperspirant salt (s) indicated in the instant application is to be calculated according to the method of US Pharmacopoeia (USP), after which bound water of crystallization and other ligands, e.g. As glycine, are excluded.
In einer besonders bevorzugten Ausführungsform enthält die Zusammensetzung ein adstringierendes Aluminiumsalz, insbesondere Aluminiumchlorohydrat, das beispielsweise pulverförmig als Micro Dry® Ultrafine oder Micro Dry® SUF von Reheis, in Form einer wässrigen Lösung als Locron® L von Clariant, als Chlorhydrol® sowie in aktivierter Form als Reach® 103 oder Reach® 501 von Reheis vertrieben wird. Unter der Bezeichnung Reach® 301 wird ein Aluminiumsesquichlorohydrat von Reheis angeboten, das ebenfalls besonders bevorzugt ist. Auch die Verwendung von Aluminium-Zirkonium- Tetrachlorohydrex-Glycin-Komplexen, die beispielsweise von Reheis unter der Bezeichnung Rezal® 36G oder Reach® 908 im Handel sind, kann erfindungsgemäß besonders bevorzugt sein. Die erfindungsgemäßen Zusammensetzungen können in einer weiteren besonders bevorzugten Ausführungsform sowohl mindestens einen Deodorant- als auch mindestens einen Antitranspirant-Wirk- stoff enthalten.In a particularly preferred embodiment, the composition comprises an astringent aluminum salt, especially aluminum chlorohydrate, for example, in powder form as Micro Dry ® Ultrafine or Micro Dry ® SUF from Reheis, in the form of an aqueous solution as Locron ® L from Clariant, as Chlorhydrol ® as well as in activated form sold as Reach® 103 or Reach® 501 from Reheis. Under the name Reach® 301 an aluminum sesquichlorohydrate from Reheis is offered, which is likewise particularly preferred. The use of aluminum-zirconium Tetrachlorohydrex glycine complexes, which are, for example, by Reheis under the name Rezal ® 36G or Reach ® 908 commercially, may be particularly preferred according to the invention. In a further particularly preferred embodiment, the compositions according to the invention may contain both at least one deodorant and at least one antiperspirant active.
Deodorant-WirkstoffeDeodorant actives
Erfindungsgemäß bevorzugte Deodorant-Wirkstoffe sind Geruchsabsorber, desodorierend wirkende Ionenaustauscher, keimhemmende Mittel, präbiotisch wirksame Komponenten sowie Enzyminhibitoren oder, besonders bevorzugt, Kombinationen der genannten Wirkstoffe.Deodorant active ingredients which are preferred according to the invention are odor absorbers, deodorizing ion exchangers, germ-inhibiting agents, prebiotic active components and also enzyme inhibitors or, particularly preferred, combinations of said active substances.
Silicate dienen als Geruchsabsorber, die auch gleichzeitig die rheologischen Eigenschaften der erfindungsgemäßen Zusammensetzung vorteilhaft unterstützen. Zu den erfindungsgemäß besonders bevorzugten Silicaten zählen vor allem Schichtsilicate und unter diesen insbesondere Montmorillonit, Kaolinit, Mit, Beidellit, Nontronit, Saponit, Hectorit, Bentonit, Smectit und Talkum. Weitere bevorzugte Geruchsabsorber sind beispielsweise Zeolithe, Zinkricinoleat, Cyclodextrine, bestimmte Metalloxide, wie z. B. Aluminiumoxid, sowie Chlorophyll. Sie werden bevorzugt in einer Menge von 0,1 - 10 Gew.- %, besonders bevorzugt 0,5 - 7 Gew.-% und außerordentlich bevorzugt 1 - 5 Gew.-%, jeweils bezogen auf die Gesamtzusammensetzung, eingesetzt.Silicates serve as odor absorbers, which at the same time advantageously support the rheological properties of the composition according to the invention. Among the silicates particularly preferred according to the invention are, in particular, phyllosilicates and, among these, in particular montmorillonite, kaolinite, mit, beidellite, nontronite, saponite, hectorite, bentonite, smectite and talcum. Other preferred odor absorbers are, for example, zeolites, Zinkricinoleat, cyclodextrins, certain metal oxides, such as. As alumina, and chlorophyll. They are preferably used in an amount of 0.1-10% by weight, more preferably 0.5-7% by weight and most preferably 1-5% by weight, based in each case on the overall composition.
Unter keimhemmenden oder antimikrobiellen Wirkstoffen werden erfindungsgemäß solche Wirkstoffe verstanden, die die Zahl der an der Geruchsbildung beteiligten Hautkeime reduzieren bzw. deren Wachstum hemmen. Zu diesen Keimen zählen unter anderem verschiedene Spezies aus der Gruppe der Staphylokokken, der Gruppe der Corynebakterien, Anaerokokken und Mikrokokken. Als keimhemmende oder antimikrobielle Wirkstoffe erfindungsgemäß bevorzugt sind insbesondere Organohalogenverbindungen sowie -halogenide, quartäre Ammoniumverbindungen, eine Reihe von Pflanzenextrakten und Zinkverbindungen. Hierzu zählen u. a. Triclosan, Chlorhexidin und Chlorhexi- dingluconat, 3,4,4'-Trichlorcarbanilid, Bromchlorophen, Dichlorophen, Chlorothymol, Chloroxylenol, Hexachlorophen, Dichloro-m-xylenol, Dequaliniumchlorid, Domiphenbromid, Ammoniumphenolsulfo- nat, Benzalkoniumhalogenide, Benzalkoniumcetylphosphat, Benzalkoniumsaccharinate, Benzethoni- umchlorid, Cetylpyridiniumchlorid, Laurylpyridiniumchlorid, Laurylisoquinoliniumbromid, Methylbenz- ethoniumchlorid. Weiterhin sind Phenol, Phenoxyethanol, Dinatriumdihydroxyethylsulfosuccinylunde- cylenat, Natriumbicarbonat, Zinklactat, Natriumphenolsulfonat und Zinkphenolsulfonat, Ketoglutar- säure, Terpenalkohole wie z. B. Farnesol, Chlorophyllin-Kupfer-Komplexe, α-Monoalkylglycerinether mit einem verzweigten oder linearen gesättigten oder ungesättigten, gegebenenfalls hydroxylierten C6 - C22-Alkylrest, besonders bevorzugt α-(2-Ethylhexyl)glycerinether, im Handel erhältlich als Sen- siva® SC 50 (ex Schülke & Mayr), Carbonsäureester des Mono-, Di- und Triglycerins (z. B. Glycerin- monolaurat, Diglycerinmonocaprinat), Lantibiotika sowie Pflanzenextrakte (z. B. grüner Tee und Bestandteile des Lindenblütenöls) einsetzbar.According to the invention, germ-inhibiting or antimicrobial active ingredients are understood as meaning those active substances which reduce the number of skin germs participating in the formation of the odor or inhibit their growth. These organisms include, among others, various species from the group of staphylococci, the group of Corynebacteria, anaerococci and micrococci. Preferred antimicrobial or antimicrobial agents according to the invention are in particular organohalogen compounds and halides, quaternary ammonium compounds, a number of plant extracts and zinc compounds. These include triclosan, chlorhexidine and chlorohexadione gluconate, 3,4,4'-trichlorocarbanilide, bromochlorophene, dichlorophen, chlorothymol, chloroxylenol, hexachlorophene, dichloro-m-xylenol, dequalinium chloride, domiphenbromide, ammonium phenolsulfonate, benzalkonium halides, benzalkonium cetyl phosphate, benzalkonium saccharinates, Benzethonium chloride, cetylpyridinium chloride, laurylpyridinium chloride, laurylisoquinolinium bromide, methylbenzethonium chloride. Furthermore, phenol, phenoxyethanol, disodium dihydroxyethylsulfosuccinyl-cylindonate, sodium bicarbonate, zinc lactate, sodium phenolsulfonate and zinc phenolsulfonate, ketoglutaric acid, terpene alcohols such as. As farnesol, chlorophyllin copper complexes, α-monoalkyl glycerol ether with a branched or linear saturated or unsaturated, optionally hydroxylated C 6 - C 22 alkyl, particularly preferably α- (2-ethylhexyl) glycerol, commercially available as Sen- siva ® SC 50 (ex Schülke & Mayr), carboxylic esters of mono-, di- and triglycerol (eg glycerol) monolaurate, diglycerol monocaprinate), lantibiotics and plant extracts (eg green tea and components of lime blossom oil).
Weitere bevorzugte Deodorant-Wirkstoffe sind ausgewählt aus sogenannten präbiotisch wirksamen Komponenten, worunter erfindungsgemäß solche Komponenten zu verstehen sind, die nur oder zumindest überwiegend die geruchsbildenden Keime der Hautmikroflora hemmen, nicht aber die erwünschten, das heißt, die nicht-geruchsbildenden Keime, die zu einer gesunden Hautmikroflora gehören. Explizit sind hier die Wirkstoffe, die in den Offenlegungsschriften DE 10333245 und DE 10 2004 011 968 als präbiotisch wirksam offenbart sind, mit einbezogen; dazu gehören Nadelbaumextrakte, insbesondere aus der Gruppe der Pinaceae, und Pflanzen extra kte aus der Gruppe der Sapindaceae, Araliaceae, Lamiaceae und Saxifragaceae, insbesondere Extrakte aus Picea spp., Paullinia sp., Panax sp., Lamium album oder Ribes nigrum sowie Mischungen dieser Substanzen. Weitere bevorzugte Deodorant-Wirkstoffe sind ausgewählt aus den keimhemmend wirkenden Parfümölen und den Deosafe®-Parfümölen, die von der Firma Symrise, vormals Haarmann und Reimer, erhältlich sind.Further preferred deodorant active substances are selected from so-called prebiotically active components, which according to the invention are to be understood as meaning those components which inhibit only or at least predominantly the odor-causing germs of the skin microflora, but not the desired ones, that is, the non-odor-forming germs that lead to a include healthy skin microflora. Explicitly included here are the active substances which are disclosed in the published patent applications DE 10333245 and DE 10 2004 011 968 as being prebiotically effective; These include conifer extracts, in particular from the group of Pinaceae, and plants extra kte from the group of Sapindaceae, Araliaceae, Lamiaceae and Saxifragaceae, in particular extracts of Picea spp., Paullinia sp., Panax sp., Lamium album or Ribes nigrum and mixtures thereof substances. Further preferred deodorant active ingredients are selected from the germ-inhibiting active perfume oils and Deosafe ® -Parfümölen that, Haarmann and Reimer, by the company Symrise previously available.
Zu den Enzyminhibitoren gehören Stoffe, die die für die Schweißzersetzung verantwortlichen Enzyme, insbesondere die Arylsulfatase, ß-Glucuronidase, Aminoacylase, Esterasen, Lipasen und/oder Lipoxi- genase, hemmen, z. B. Trialkylcitronensäureester, insbesondere Triethylcitrat, oder Zinkglycinat. Bevorzugte erfindungsgemäße Deodorant- oder Antitranspirant-Zusammensetzungen sind dadurch gekennzeichnet, dass der mindestens eine Deodorant-Wirkstoff ausgewählt ist aus Arylsulfatase-Inhi- bitoren, ß-Glucuronidase-lnhibitoren, Aminoacylase-Inhibitoren, Esterase-Inhibitoren, Lipase-Inhibito- ren und Lipoxigenase-Inhibitoren, α-Monoalkylglycerinethern mit einem verzweigten oder linearen gesättigten oder ungesättigten, gegebenenfalls hydroxylierten C6 - C22-Alkylrest, insbesondere α-(2- Ethylhexyl)glycerinether, Phenoxyethanol, keimhemmend wirkenden Parfümölen, Deosafe®-Parfüm- ölen (Deosafe® ist ein eingetragenes Warenzeichen der Firma Symrise, vormals Haarmann & Reimer), präbiotisch wirksamen Komponenten, Trialkylcitronensäureestern, insbesondere Triethylcitrat, Wirkstoffen, die die Zahl der an der Geruchsbildung beteiligten Hautkeime aus der Gruppe der Staphylokokken, Corynebakterien, Anaerokokken und Mikrokokken reduzieren bzw. deren Wachstum hemmen, Zinkverbindungen, insbesondere Zinkphenolsulfonat und Zinkricinoleat, Organohalogenverbindungen, insbesondere Triclosan, Chlorhexidin, Chlorhexidingluconat und Benzalkoniumhalogeniden, quartären Ammoniumverbindungen, insbesondere Cetylpyridiniumchlorid, Geruchsabsorbern, insbesondere Silikaten und Zeolithen, Natriumbicarbonat, Lantibiotika, sowie Mischungen der vorgenannten Substanzen.The enzyme inhibitors include substances which inhibit the enzymes responsible for the sweat decomposition, in particular the arylsulfatase, .beta.-glucuronidase, aminoacylase, esterases, lipases and / or lipoxygenase, eg. B. trialkylcitric acid, in particular triethyl citrate, or zinc glycinate. Preferred deodorant or antiperspirant compositions according to the invention are characterized in that the at least one deodorant active ingredient is selected from arylsulfatase inhibitors, β-glucuronidase inhibitors, aminoacylase inhibitors, esterase inhibitors, lipase inhibitors and lipoxigenase inhibitors. Inhibitors, α-Monoalkylglycerinethern with a branched or linear saturated or unsaturated, optionally hydroxylated C 6 - C 22 alkyl, especially α- (2-ethylhexyl) glycerol ether, phenoxyethanol, germ-inhibiting perfume oils, Deosafe ® -Pparfüm- oils (Deosafe ® a registered trademark of the company Symrise, formerly Haarmann & Reimer), prebiotic active components, trialkylcitric acid esters, in particular triethyl citrate, active substances which reduce or inhibit the growth of the number of skin microorganisms from the group of staphylococci, corynebacteria, anaerococci and micrococci , Zinc compound compounds, in particular zinc phenolsulfonate and zinc ricinoleate, organohalogen compounds, in particular triclosan, chlorhexidine, chlorhexidine gluconate and benzalkonium halides, quaternary ammonium compounds, in particular cetylpyridinium chloride, odor absorbers, in particular silicates and zeolites, sodium bicarbonate, lantibiotics, and mixtures of the abovementioned substances.
Weitere bevorzugte erfindungsgemäße Deodorant- oder Antitranspirant-Zusammensetzungen sind dadurch gekennzeichnet, dass der mindestens eine Deodorant-Wirkstoff in einer Gesamtmenge von 0,1 - 10 Gew.-%, bevorzugt 0,2 - 7 Gew.-%, besonders bevorzugt 0,3 - 5 Gew.-% und außerordentlich bevorzugt 0,4 - 1 ,0 Gew.-%, jeweils bezogen auf das Gesamtgewicht der Aktivsubstanz des Deodorant-Wirkstoffs oder der Deodorant-Wirkstoffe in der Gesamtzusammensetzung, enthalten ist.Further preferred deodorant or antiperspirant compositions according to the invention are characterized in that the at least one deodorant active ingredient is present in a total amount of 0.1-10% by weight, preferably 0.2-7% by weight, particularly preferably 0.3 5% by weight and extraordinarily preferably 0.4 to 1.0% by weight, in each case based on the total weight of the active substance of the deodorant active ingredient or of the deodorant active ingredients in the overall composition.
Die erfindungsgemäßen Zusammensetzungen können in einer weiteren besonders bevorzugten Ausführungsform sowohl mindestens einen Deodorant- als auch mindestens einen Antitranspirant- Wirkstoff enthalten.In a further particularly preferred embodiment, the compositions according to the invention can contain both at least one deodorant and at least one antiperspirant active ingredient.
Eine weitere bevorzugte Ausführungsform der Erfindung ist dadurch gekennzeichnet, dass die erfindungsgemäße oder erfindungsgemäß verwendete Zusammensetzung mindestens ein Monosaccharid mit 5 oder 6 Kohlenstoffatomen und/oder mindestens ein Disaccharid enthält.A further preferred embodiment of the invention is characterized in that the composition according to the invention or used according to the invention contains at least one monosaccharide having 5 or 6 carbon atoms and / or at least one disaccharide.
Überraschend wurde festgestellt, dass die Kombination von Yoghurt-Protein und/oder mindestens einem Hydrolysat eines Yoghurt-Proteins und/oder mindestens einem N-C2-C24-Acylderivat und/oder mindestens einem C2-C24-Ester und/oder mindestens ein physiologisch verträgliches Salz dieser Substanzen, sowie Mischungen dieser Protein-Wirkstoffe, mit mindestens einem Monosaccharid mit 5 oder 6 Kohlenstoffatomen und/oder mindestens einem Disaccharid eine weitere Verbesserung der anti- irritativen Wirkung gegenüber dem unsubstituierten Yoghurt-Protein oder Yoghurt-Protein-Hydrolysat aufweisen kann.Surprisingly, it has been found that the combination of yoghurt protein and / or at least one hydrolyzate of a yoghurt protein and / or at least one NC 2 -C 24 acyl derivative and / or at least one C 2 -C 24 ester and / or at least one physiologically acceptable salt of these substances, as well as mixtures of these protein agents, with at least one monosaccharide having 5 or 6 carbon atoms and / or at least one disaccharide, a further improvement of the anti-irritant effect against the unsubstituted yoghurt protein or yoghurt protein hydrolyzate ,
Eine besonders bevorzugte Ausführungsform der Erfindung ist dadurch gekennzeichnet, dass das Monosaccharid mit 5 oder 6 Kohlenstoffatomen ausgewählt ist aus Glucose, Fructose, Galactose, Arabinose, Ribose, Xylose, Lyxose, Allose, Altrose, Mannose, Gulose, Idose, Talose, Fucose und Rhamnose. Außerordentlich bevorzugt hiervon sind Glucose, Galactose, Fructose, Fucose und Rhamnose, insbesondere Glucose und Galactose.A particularly preferred embodiment of the invention is characterized in that the monosaccharide having 5 or 6 carbon atoms is selected from glucose, fructose, galactose, arabinose, ribose, xylose, lyxose, allose, altrose, mannose, gulose, idose, talose, fucose and rhamnose , Exceptionally preferred are glucose, galactose, fructose, fucose and rhamnose, in particular glucose and galactose.
Eine weitere besonders bevorzugte Ausführungsform der Erfindung ist dadurch gekennzeichnet, dass das Disaccharid mit 5 oder 6 Kohlenstoffatomen ausgewählt ist aus Saccharose, Lactose und Trehalose. Außerordentlich bevorzugt hiervon sind Saccharose und Lactose, insbesondere Lactose.Another particularly preferred embodiment of the invention is characterized in that the disaccharide having 5 or 6 carbon atoms is selected from sucrose, lactose and trehalose. Exceptionally preferred are sucrose and lactose, especially lactose.
Eine weitere besonders bevorzugte Ausführungsform der Erfindung ist dadurch gekennzeichnet, dass mindestens ein Monosaccharid mit 5 oder 6 Kohlenstoffatomen und/oder mindestens ein Disaccharid in einer Gesamtmenge von 0,001 bis 2,0 Gew.-%, bevorzugt 0,005 - 1 ,0 Gew.-%, besonders bevorzugt 0,01 - 0,5 Gew.-% und außerordentlich bevorzugt 0,03 - 0,1 Gew.-%, jeweils bezogen auf die gesamte Zusammensetzung, enthalten ist.A further particularly preferred embodiment of the invention is characterized in that at least one monosaccharide having 5 or 6 carbon atoms and / or at least one disaccharide in a total amount of 0.001 to 2.0 wt .-%, preferably 0.005 - 1, 0 wt .-% , Particularly preferably 0.01 to 0.5 wt .-% and most preferably 0.03 to 0.1 wt .-%, each based on the total composition is included.
Eine weitere besonders bevorzugte Ausführungsform der Erfindung ist durch eine Wirkstoffkombination aus Yoghurt-Protein und Lactose gekennzeichnet. Eine weitere besonders bevorzugte Ausführungsform der Erfindung ist durch eine Wirkstoffkombination aus Yoghurt-Protein-Hydrolysat und Lactose gekennzeichnet.Another particularly preferred embodiment of the invention is characterized by an active ingredient combination of yoghurt protein and lactose. Another particularly preferred embodiment of the invention is characterized by an active ingredient combination of yoghurt protein hydrolyzate and lactose.
Eine weitere besonders bevorzugte Ausführungsform der Erfindung ist durch eine Wirkstoffkombination aus Yoghurt-Protein und Galactose gekennzeichnet.Another particularly preferred embodiment of the invention is characterized by an active ingredient combination of yoghurt protein and galactose.
Eine weitere besonders bevorzugte Ausführungsform der Erfindung ist durch eine Wirkstoffkombination aus Yoghurt-Protein-Hydrolysat und Galactose gekennzeichnet.Another particularly preferred embodiment of the invention is characterized by an active ingredient combination of yoghurt protein hydrolyzate and galactose.
Eine weitere besonders bevorzugte Ausführungsform der Erfindung ist durch eine Wirkstoffkombination aus Yoghurt-Protein und Glucose gekennzeichnet.Another particularly preferred embodiment of the invention is characterized by an active ingredient combination of yoghurt protein and glucose.
Eine weitere besonders bevorzugte Ausführungsform der Erfindung ist durch eine Wirkstoffkombination aus Yoghurt-Protein-Hydrolysat und Glucose gekennzeichnet.Another particularly preferred embodiment of the invention is characterized by an active ingredient combination of yoghurt protein hydrolyzate and glucose.
Weitere bevorzugte Ausführungsformen der Erfindung sind dadurch gekennzeichnet, dass der kosmetisch oder dermatologisch verträgliche Träger als Puder, in Stiftform, als Aerosolspray, Pumpspray, flüssige oder gelförmige Roll-on-Applikation, Creme, Lotion, Lösung, Gel oder auf einem Substrat aufgebracht vorliegt.Further preferred embodiments of the invention are characterized in that the cosmetically or dermatologically acceptable carrier is present as powder, in stick form, as aerosol spray, pump spray, liquid or gel roll-on application, cream, lotion, solution, gel or on a substrate.
Deodorant- oder Antitranspirant-Stifte können in gelierter Form, auf wasserfreier Basis, auf Basis einer W/O-Emulsion, auf Basis einer O/W-Emulsion, auf Basis einer Wasser-Öl-Mehrfach-Emulsion, auf Basis einer Nanoemulsion und auf Basis einer Mikroemulsion vorliegen, wobei die Ölphase mindestens eine Siliconkomponente enthalten oder aus mindestens einer Siliconkomponente bestehen kann. Weiterhin können die erfindungsgemäßen Zusammensetzungen, die als Deodorant- oder Antitranspirant-Stifte formuliert sind, auf wasserfreier Fettbasis, auf Basis einer Polyol-in-ÖI-Emulsion, auf Basis einer ÖI-in-Polyol-Emulsion, auf Basis einer Polyol-Öl-Mehrfach-Emulsion, auf Basis einer Nanoemulsion und auf Basis einer Mikroemulsion vorliegen, wobei die Polyolphase wasserfrei sein oder nur einen geringen Wassergehalt (z. B. 0,5 - 3 Gew.-%, bezogen auf die gesamte Zusammensetzung) aufweisen kann. Gelstifte können auf der Basis von Fettsäureseifen, Alditolen, insbesondere Dibenzyli- densorbitol, N-Acylaminosäureamiden, 12-Hydroxystearinsäure, Polyamiden, Polyamidderivaten, Polysacchariden wie Xanthan, Polyglucomannanen, Guar, Konjak, Cellulosen oder Stärken, PoIy- acrylaten, Polyacrylatderivaten und anderen Gelbildnern formuliert werden.Deodorant or antiperspirant sticks can be in gelled, anhydrous, based on a W / O emulsion, based on an O / W emulsion, based on a water-oil multiple emulsion, based on a nanoemulsion and on Basis of a microemulsion, wherein the oil phase contain at least one silicone component or may consist of at least one silicone component. Furthermore, the compositions according to the invention, which are formulated as deodorant or antiperspirant sticks, may be based on an oil-in-oil emulsion based on a polyol-oil-based emulsion based on a polyol-in-oil emulsion based on an oil-in-oil emulsion. Multiple emulsion, based on a nanoemulsion and based on a microemulsion, wherein the polyol phase may be anhydrous or only a low water content (eg., 0.5 - 3 wt .-%, based on the total composition) may have. Gel sticks can be formulated on the basis of fatty acid soaps, alditols, in particular dibenzylidene sorbitol, N-acylamino acid amides, 12-hydroxystearic acid, polyamides, polyamide derivatives, polysaccharides such as xanthan, polyglucomannans, guar, konjac, celluloses or starches, polyacrylates, polyacrylate derivatives and other gel formers become.
Aerosolsprays, Pumpsprays, Roll-on-Applikationen und Cremes können als Wasser-in-ÖI-Emulsion, Wasser-in-Siliconöl-Emulsionen, ÖI-in-Wasser-Emulsion, Siliconöl-in-Wasser-Emulsion, Wasser-in-ÖI- Mikroemulsion, ÖI-in-Wasser-Mikroemulsion, Siliconöl-in-Wasser-Mikroemulsion, Polyol-in-ÖI-Emulsion, ÖI-in-Polyol-Emulsion, Polyol-Öl-Mehrfach-Emulsion, wasserfreie Suspension, bevorzugt wasserfreie ölbasierte Suspension, alkoholische Lösung, insbesondere ethanolische Lösung, hydroalkoholi- sche Lösung, insbesondere Lösungen mit mehr als 50 Gew.-% eines Wasser-Ethanol-Gemisches, gly- colische Lösung, insbesondere als Lösung in Propylenglycol, Glycerin, Dipropylenglycol und (unter Normalbedingungen) flüssigen Polyethylenglycolen, hydroglycolische Lösung, Polyol-Lösung, Wasser- Polyol-Lösung, wässriges Gel, Lipogel und als Öl vorliegen. Alle genannten Zusammensetzungen können verdickt sein, beispielsweise auf der Basis von Fettsäureseifen, Dibenzylidensorbitol, N-Acyl- aminosäureamiden, 12-Hydroxystearinsäure, Polyacrylaten vom Carbomer- und Carbopol-Typ, Polyacrylamiden und Polysacchariden, die chemisch und/oder physikalisch modifiziert sein können. Die Zusammensetzungen können transparent, translucent oder opak sein.Aerosol sprays, pump sprays, roll-on applications and creams may be in the form of a water-in-oil emulsion, water-in-silicone oil emulsions, oil-in-water emulsion, silicone oil-in-water emulsion, water-in-oil Microemulsion, oil-in-water microemulsion, silicone oil-in-water microemulsion, polyol-in-oil emulsion, oil-in-polyol emulsion, polyol-oil multiple emulsion, anhydrous suspension, preferably anhydrous oil-based suspension , alcoholic solution, in particular ethanolic solution, hydroalcoholic solution, in particular solutions with more than 50 wt .-% of a water-ethanol mixture, glycole solution, especially as a solution in propylene glycol, glycerol, dipropylene glycol and (under normal conditions) liquid Polyethylene glycols, hydroglycolic solution, polyol solution, water Polyol solution, aqueous gel, lipogel and as an oil. All said compositions may be thickened, for example based on fatty acid soaps, dibenzylidenesorbitol, N-acylamino acid amides, 12-hydroxystearic acid, carbomer and Carbopol type polyacrylates, polyacrylamides and polysaccharides, which may be chemically and / or physically modified. The compositions may be transparent, translucent or opaque.
Sofern die erfindungsgemäßen Zusammensetzungen in Form eines Stiftes vorliegen, enthalten sie bevorzugt eine Wachsmatrix, umfassend mindestens eine Wachskomponente mit einem Schmelzpunkt > 500C.If the compositions according to the invention be in the form of a pin, they contain a wax matrix preferably comprising at least one wax component with a melting point of> 50 0 C.
Generell sind Wachse von fester bis brüchig harter Konsistenz, grob bis feinkristallin, durchscheinend bis opak, jedoch nicht glasartig, und schmelzen oberhalb von 50 0C ohne Zersetzung. Sie sind schon wenig oberhalb des Schmelzpunktes niedrigviskos und zeigen eine stark temperaturabhängige Konsistenz und Löslichkeit.In general, waxes of solid to brittle hard consistency, coarse to fine crystalline, translucent to opaque, but not glassy, and melt above 50 0 C without decomposition. They are already slightly above the melting point low viscosity and show a strong temperature-dependent consistency and solubility.
Erfindungsgemäß bevorzugt sind beispielsweise natürliche pflanzliche Wachse, z. B. Candelillawachs, Carnaubawachs, Japanwachs, Zuckerrohrwachs, Ouricourywachs, Korkwachs, Sonnenblumenwachs, Fruchtwachse wie Orangenwachse, Zitronenwachse, Grapefruitwachs, und tierische Wachse, z. B. Bienenwachs, Schellackwachs und Walrat. Im Sinne der Erfindung kann es besonders bevorzugt sein, hydrierte oder gehärtete Wachse einzusetzen. Als Wachskomponente sind auch chemisch modifizierte Wachse, insbesondere die Hartwachse, wie z. B. Montanesterwachse, hydrierte Jojobawachse und Sasolwachse, einsetzbar. Zu den synthetischen Wachsen, die ebenfalls erfindungsgemäß bevorzugt sind, zählen beispielsweise Polyalkylenwachse und Polyethylenglycolwachse, C2o-C4o-Dialkylester von Dimersäuren, C30-50-Alkylbienenwachs sowie Alkyl- und Alkylarylester von Dimerfettsäuren.Preference according to the invention, for example, natural vegetable waxes, z. Candelilla wax, carnauba wax, Japan wax, sugarcane wax, ouricoury wax, cork wax, sunflower wax, fruit waxes such as orange waxes, lemon waxes, grapefruit wax, and animal waxes, e.g. Beeswax, shellac wax and spermaceti. For the purposes of the invention, it may be particularly preferred to use hydrogenated or hardened waxes. As a wax component and chemically modified waxes, especially the hard waxes, such as. As montan ester waxes, hydrogenated jojoba waxes and Sasol waxes used. Synthetic waxes, which are also preferable in the invention include, for example, polyalkylene waxes and polyethylene glycol waxes, C 2 4 oC o-dialkyl esters of dimer acids, C 30 - 50 alkyl and alkylaryl esters of -Alkylbienenwachs and dimer fatty acids.
Eine besonders bevorzugte Wachskomponente ist ausgewählt aus mindestens einem Ester aus einem gesättigten, einwertigen C16-C6o-Alkohol und einer gesättigten Cs-Csβ-Monocarbonsäure. Erfindungsgemäß zählen hierzu auch Lactide, die cyclischen Doppelester von α-Hydroxycarbonsäuren der entsprechenden Kettenlänge. Ester aus Fettsäuren und langkettigen Alkoholen haben sich für die erfindungsgemäße Zusammensetzung als besonders vorteilhaft erwiesen, weil sie der Antitranspirant- zubereitung ausgezeichnete sensorische Eigenschaften und Stiften eine hohe Stabilität verleihen. Die Ester setzen sich aus gesättigten verzweigten oder unverzweigten Monocarbonsäuren und gesättigten verzweigten oder unverzweigten einwertigen Alkoholen zusammen. Auch Ester aus aromatischen Carbonsäuren bzw. Hydroxycarbonsäuren (z. B. 12-Hydroxystearinsäure) und gesättigten verzweigten oder unverzweigten Alkoholen sind erfindungsgemäß einsetzbar, sofern die Wachskomponente einen Schmelzpunkt > 500C hat. Besonders bevorzugt ist, die Wachskomponenten zu wählen aus der Gruppe der Ester aus gesättigten verzweigten oder unverzweigten Alkancarbonsäuren einer Kettenlänge von 12 bis 24 C-Atomen und den gesättigten verzweigten oder unverzweigten Alkoholen einer Kettenlänge von 16 bis 50 C-Atomen, die einen Schmelzpunkt > 50°C haben. Insbesondere können als Wachskomponente C16-36-Alkylstearate und C18.38-Alkylhydroxystearoylstea- rate, C2O-4o-Alkylerucate sowie Cetearylbehenat vorteilhaft sein. Das Wachs oder die Wachskomponenten weisen einen Schmelzpunkt > 500C, bevorzugt > 600C, auf.A particularly preferred wax component is selected from at least one ester of a saturated, monohydric C 16 -C 6 o-alcohol and a saturated Cs-Csβ monocarboxylic acid. According to the invention, lactides, the cyclic double esters of α-hydroxycarboxylic acids of the corresponding chain length, also belong thereto. Esters of fatty acids and long-chain alcohols have proved to be particularly advantageous for the composition according to the invention because they give the antiperspirant preparation excellent sensory properties and pins a high stability. The esters are composed of saturated branched or unbranched monocarboxylic acids and saturated branched or unbranched monohydric alcohols. Also, esters of aromatic carboxylic acids and hydroxycarboxylic acids (eg., 12-hydroxystearic acid) and saturated branched or unbranched alcohols are used according to the invention, provided that the wax component has a melting point of> 50 0 C. It is particularly preferred to choose the wax components from the group of esters of saturated branched or unbranched alkanecarboxylic acids having a chain length of 12 to 24 carbon atoms and the saturated branched or unbranched alcohols having a chain length of 16 to 50 carbon atoms and having a melting point> 50 ° C have. In particular, as the wax component C 16-36 alkyl stearates and C eighteenth 38 Alkylhydroxystearoylstea- rate, C 2O - 4 o-alkyl erucate and Cetearylbehenat be advantageous. The wax or the wax components have a melting point> 50 0 C, preferably> 60 0 C, on.
Eine besonders bevorzugte erfindungsgemäße Ausführung in Stiftform enthält als Wachskomponente ein C2o-C4O-Alkylstearat. Dieser Ester ist unter den Namen Kesterwachs® K82H oder Kesterwachs® K80H bekannt und wird von Koster Keunen Inc. vertrieben. Es handelt sich um die synthetische Nachahmung der Monoesterfraktion des Bienenwachses und zeichnet sich durch seine Härte, seine Ölgelierfähigkeit und seine breite Kompatibiltät mit Lipidkomponenten aus. Dieses Wachs kann als Stabilisator und Konsistenzregulator für W/O- und O/W-Emulsionen verwendet werden. Kesterwachs bietet den Vorteil, dass es auch bei geringen Konzentrationen eine exzellente Ölgelierfähigkeit aufweist und so die Stiftmasse nicht zu schwer macht und einen samtigen Abrieb ermöglicht. Eine weitere besonders bevorzugte erfindungsgemäße Ausführung in Stiftform enthält als Wachskomponente Cetearylbehenat, d. h. Mischungen aus Cetylbehenat und Stearylbehenat. Dieser Ester ist unter dem Namen Kesterwachs® K62 bekannt und wird von Koster Keunen Inc. vertrieben.A particularly preferred embodiment of the invention in stick form contains as wax component a C 2 oC 4O alkyl stearate. This ester is known under the name Kester ® ® K82H or Kesterwachs K80H, sold by Koster Keunen Inc.. It is the synthetic imitation of the monoester fraction of beeswax and is characterized by its hardness, oil gelability and broad compatibility with lipid components. This wax can be used as a stabilizer and consistency regulator for W / O and O / W emulsions. Kester wax has the advantage that it has an excellent oil gelability even at low concentrations and so does not make the pencil mass too heavy and allows a velvety abrasion. Another particularly preferred embodiment of the invention in stick form contains as wax component cetearyl behenate, ie mixtures of cetyl behenate and stearyl behenate. This ester is known under the name Kester ® K62 and is sold by Koster Keunen Inc..
Weitere bevorzugte Wachskomponenten mit einem Schmelzpunkt > 500C sind die Triglyceride gesättigter und gegebenenfalls hydroxylierter C12-3o-Fettsäuren, wie gehärtete Triglyceridfette (hydriertes Palmöl, hydriertes Kokosöl, hydriertes Rizinusöl), Glyceryltribehenat (Tribehenin) oder Glyceryltri-12- hydroxystearat, weiterhin synthetische Vollester aus Fettsäuren und Glycolen oder Polyolen mit 2 - 6 Kohlenstoffatomen, solange sie einen Schmelzpunkt oberhalb von 50 °C aufweisen, beispielsweise bevorzugt C18 - C36 Acid Triglyceride (Syncrowax® HGL-C). Erfindungsgemäß ist als Wachskomponente hydriertes Rizinusöl, erhältlich z.B. als Handelsprodukt Cutina® HR, besonders bevorzugt. Weitere bevorzugte Wachskomponenten mit einem Schmelzpunkt > 500C sind die gesättigten linearen C14 - C36-Ca rbonsä u ren, insbesondere Myristinsäure, Palmitinsäure, Stearinsäure und Behensäure sowie Mischungen dieser Verbindungen, z. B. Syncrowax® AW 1 C (C18 - C36-Fettsäuren) oder Cutina® FS 45 (Palmitin- und Stearinsäure).More preferred wax components with a melting point of> 50 0 C are the triglycerides of saturated and optionally hydroxylated C 12 - 3 o-fatty acids such as hydrogenated triglyceride fats (hydrogenated palm oil, hydrogenated coconut oil, hydrogenated castor oil), glyceryl tribehenate (tribehenin), or glyceryl tri-12-hydroxystearate, further synthetic Vollester of fatty acids and glycols or polyols containing 2 - 6 carbon atoms as long as they have a melting point above 50 ° C, for example, preferably C 18 - C 36 acid triglyceride (Syncrowax HGL-C ®). According to the hydrogenated castor oil as a wax component, available for example as a commercial product Cutina ® HR, is particularly preferred. More preferred wax components with a melting point of> 50 0 C, the saturated linear C 14 - C 36 -Ca rbonsä u reindeer, in particular myristic acid, palmitic acid, stearic acid and behenic acid, and mixtures of these compounds, for example. B. Syncrowax ® AW 1 C (C 18 - C 36 fatty acids) or Cutina ® FS 45 (palmitic and stearic acid).
Bevorzugte erfindungsgemäße Deodorant- oder Antitranspirant-Zusammensetungen, insbesondere Stifte, sind dadurch gekennzeichnet, dass die Wachskomponente ausgewählt ist aus Estern aus einem gesättigten, einwertigen C16-C60-Alkanol und einer gesättigten C8-C36-Monocarbonsäure, insbesondere Cetylbehenat, Stearylbehenat und C2o-C4o-Alkylstearat, Glycerintriestern von gesättigten linearen C12 - C30-Carbonsäuren, die hydroxyliert sein können, Candelillawachs, Carnaubawachs, Bienenwachs, gesättigten linearen C14 - C36-Carbonsäuren sowie Mischungen der vorgenannten Substanzen. Besonders bevorzugte Wachskomponenten-Mischungen sind ausgewählt aus Mischungen von Cetylbehenat, Stearylbehenat, gehärtetem Rizinusöl, Palmitinsäure und Stearinsäure. Weitere besonders bevorzugte Wachskomponenten-Mischungen sind ausgewählt aus Mischungen von C2O-C40-AIkVl- stearat, gehärtetem Rizinusöl, Palmitinsäure und Stearinsäure.Preferred deodorant or antiperspirant compositions according to the invention, in particular sticks, are characterized in that the wax component is selected from esters of a saturated, monohydric C 16 -C 60 -alkanol and a saturated C 8 -C 36 -monocarboxylic acid, in particular cetyl behenate, stearyl behenate and C 2 oC 4 o-alkyl stearate, glycerol triesters of saturated linear C 12 -C 30 -carboxylic acids which may be hydroxylated, candelilla wax, carnauba wax, beeswax, saturated linear C 14 -C 36 -carboxylic acids and mixtures of the abovementioned substances. Particularly preferred wax component blends are selected from mixtures of cetyl behenate, stearyl behenate, hardened castor oil, palmitic acid and stearic acid. More special Preferred wax component mixtures are selected from mixtures of C 2O- C 40 -alkyl stearate, hardened castor oil, palmitic acid and stearic acid.
Bevorzugte erfindungsgemäße Deodorant- oder Antitranspirant-Stifte auf Basis einer Öl-in-Wasser- Emulsion sind dadurch gekennzeichnet, dass die Wachskomponente/n insgesamt in Mengen von 4 - 20 Gew.-%, bevorzugt 8 - 15 Gew.-%, bezogen auf die Gesamtzusammensetzung, enthalten ist. In einer besonders bevorzugten Ausführungsform ist/sind der/die Ester aus einem gesättigten, einwertigen Ci6-C6o-Alkohol und einer gesättigten C8-C36-Monocarbonsäure, der/die Wachskomponente/n darstellt/ darstellen, in Mengen von insgesamt 2 - 10 Gew.-%, bevorzugt 2 - 6 Gew.-%, bezogen auf die Gesamtzusammensetzung, enthalten.Preferred deodorant or antiperspirant sticks according to the invention based on an oil-in-water emulsion are characterized in that the wax component (s) is generally taken in amounts of 4 to 20% by weight, preferably 8 to 15% by weight, based on the total composition is included. In a particularly preferred embodiment, the ester (s) of a saturated monohydric C 6 -C 6 o-alcohol and a saturated C 8 -C 36 monocarboxylic acid representing the wax component (s) are / are in total amounts 2 - 10 wt .-%, preferably 2 - 6 wt .-%, based on the total composition.
ÖI-in-Wasser-EmulgatorenOil-in-water emulsifiers
Die erfindungsgemäßen Zusammensetzungen, die als Emulsion, insbesondere als ÖI-in-Wasser-Emul- sion oder Polyol-in-Wasser-Emulsion, formuliert sind, enthalten bevorzugt mindestens einen nichtionischen ÖI-in-Wasser-Emulgator mit einem HLB-Wert von mehr als 7. Hierbei handelt es sich um dem Fachmann allgemein bekannte Emulgatoren, wie sie beispielsweise in Kirk-Othmer, "Encyclopedia of Chemical Technology", 3. Aufl., 1979, Band 8, Seite 913-916, aufgelistet sind. Für ethoxylierte Produkte wird der HLB-Wert nach der Formel HLB = (100 - L) : 5 berechnet, wobei L der Gewichtsanteil der lipophilen Gruppen, das heißt der Fettalkyl- oder Fettacylgruppen, in den Ethylenoxidaddukten, ausgedrückt in Gewichtsprozent, ist.The compositions according to the invention, which are formulated as an emulsion, in particular as an oil-in-water emulsion or a polyol-in-water emulsion, preferably contain at least one nonionic oil-in-water emulsifier having an HLB value of more as 7. These are generally known in the art emulsifiers, as for example in Kirk-Othmer, "Encyclopedia of Chemical Technology", 3rd ed., 1979, Volume 8, page 913-916 listed. For ethoxylated products, the HLB value is calculated according to the formula HLB = (100-L): 5, where L is the weight fraction of the lipophilic groups, that is the fatty alkyl or fatty acyl groups, in the ethylene oxide adducts, expressed in weight percent.
Bei der Auswahl erfindungsgemäß geeigneter nichtionischer ÖI-in-Wasser-Emulgatoren ist es besonders bevorzugt, ein Gemisch von nichtionischen ÖI-in-Wasser-Emulgatoren einzusetzen, um die Stabilität erfindungsgemäßer O/W-Emulsionszusammensetzungen optimal einstellen zu können. Die einzelnen Emulgatorkomponenten liefern dabei einen Anteil zum Gesamt-HLB-Wert oder mittleren HLB-Wert des ÖI-in-Wasser-Emulgatorgemisches gemäß ihrem Mengenanteil an der Gesamtmenge der ÖI-in- Wasser-Emulgatoren. Erfindungsgemäß beträgt der mittlere HLB-Wert des Öl-in-Wasser- Emulgator- gemisches 10 - 19, bevorzugt 12 - 18 und besonders bevorzugt 14 - 17. Um derartige mittlere HLB- Werte zu erzielen, werden bevorzugt ÖI-in-Wasser-Emulgatoren aus den HLB-Wertbereichen 10 - 14, 14 - 16 und gegebenenfalls 16 - 19 miteinander kombiniert. Selbstverständlich können die Öl-in- Wasser-Emulgatorgemische auch nichtionische Emulgatoren mit HLB-Werten im Bereich von > 7 - 10 und 19 - 20 enthalten; derartige Emulgatorgemische können erfindungsgemäß ebenfalls bevorzugt sein. Die erfindungsgemäßen Deodorant- oder Antitranspirant-Zusammensetzungen können aber in einer anderen bevorzugten Ausführungsform auch nur einen einzigen ÖI-in-Wasser-Emulgator mit einem HLB-Wert im Bereich von 10 - 19 enthalten.In selecting nonionic oil-in-water emulsifiers which are suitable according to the invention, it is particularly preferable to use a mixture of nonionic oil-in-water emulsifiers in order to optimally adjust the stability of O / W emulsion compositions according to the invention. The individual emulsifier components deliver a proportion to the total HLB value or mean HLB value of the oil-in-water emulsifier mixture in accordance with their proportion of the total amount of oil-in-water emulsifiers. According to the invention, the average HLB value of the oil-in-water emulsifier mixture is 10-19, preferably 12-18 and particularly preferably 14-17. In order to achieve such average HLB values, preference is given to oil-in-water emulsifiers from the HLB value ranges 10 - 14, 14 - 16 and possibly 16 - 19 combined. Of course, the oil-in-water emulsifier mixtures may also contain nonionic emulsifiers with HLB values in the range of> 7-10 and 19-20; Such emulsifier mixtures may also be preferred according to the invention. However, in another preferred embodiment, the deodorant or antiperspirant compositions of the present invention may also contain only a single oil-in-water emulsifier having an HLB in the range of 10-19.
Bevorzugte erfindungsgemäße Deodorant- oder Antitranspirant-Zusammensetzungen sind dadurch gekennzeichnet, dass die nichtionischen ÖI-in-Wasser-Emulgatoren ausgewählt sind aus ethoxylierten C8-C24-Alkanolen mit durchschnittlich 10 - 100 Mol Ethylenoxid pro Mol, ethoxylierten C8-C24-Carbon- säuren mit durchschnittlich 10 - 100 Mol Ethylenoxid pro Mol, Silicon-Copolyolen mit Ethylenoxid-Ein- heiten oder mit Ethylenoxid- und Propylenoxid-Einheiten, Alkylmono- und -oligoglycosiden mit 8 bis 22 Kohlenstoffatomen im Alkylrest und deren ethoxylierten Analoga, ethoxylierten Sterinen, Partialestern von Polyglycerinen mit 2 bis 10 Glycerineinheiten und mit 1 bis 4 gesättigten oder ungesättigten, linearen oder verzweigten, gegebenenfalls hydroxylierten C8 - C30-Fettsäureresten verestert, sofern sie einen HLB-Wert von mehr als 7 aufweisen, sowie Mischungen der vorgenannten Substanzen. Die ethoxylierten C8-C24-Alkanole haben die Formel R1O(CH2CH2O)nH, wobei R1 steht für einen linearen oder verzweigten Alkyl- und/oder Alkenylrest mit 8 - 24 Kohlenstoffatomen und n, die mittlere Anzahl der Ethylenoxid-Einheiten pro Molekül, für Zahlen von 10 - 100, vorzugsweise 10 - 30 Mol Ethylenoxid an 1 Mol Caprylalkohol, 2-Ethylhexylalkohol, Caprinalkohol, Laurylalkohol, Isotridecylalko- hol, Myristylalkohol, Cetylalkohol, Isocetylalkohol, Palmitoleylalkohol, Stearylalkohol, Isostearylalkohol, Oleylalkohol, Elaidylalkohol, Petroselinylalkohol, Arachylalkohol, Gadoleylalkohol, Behenylalkohol, Erucylalkohol und Brassidylalkohol sowie deren technische Mischungen. Auch Addukte von 10 - 100 Mol Ethylenoxid an technische Fettalkohole mit 12 - 18 Kohlenstoffatomen, wie beispielsweise Kokos-, Palm-, Palmkern- oder Taigfettalkohol, sind geeignet.Preferred deodorant or antiperspirant compositions according to the invention are characterized in that the nonionic oil-in-water emulsifiers are selected from ethoxylated C 8 -C 24 -alkanols with an average of 10 to 100 moles of ethylene oxide per mole of ethoxylated C 8 -C 24 - carbon acids containing on average 10-100 moles of ethylene oxide per mole, silicone copolyols having ethylene oxide units or with ethylene oxide and propylene oxide units, alkyl mono- and oligoglycosides having 8 to 22 carbon atoms in the alkyl radical and their ethoxylated analogs, ethoxylated sterols, partial esters of polyglycerols having 2 to 10 glycerol units and having 1 to 4 saturated or unsaturated, linear or branched, optionally hydroxylated C 8 - C 30 fatty acid residues esterified, provided they have an HLB value of more than 7, and mixtures of the aforementioned substances. The ethoxylated C 8 -C 24 -alkanols have the formula R 1 O (CH 2 CH 2 O) n H, where R 1 is a linear or branched alkyl and / or alkenyl radical having 8-24 carbon atoms and n, the middle one Number of ethylene oxide units per molecule, for numbers from 10 to 100, preferably 10 to 30, moles of ethylene oxide to 1 mole of caprylic alcohol, 2-ethylhexyl alcohol, capric alcohol, lauryl alcohol, isotridecyl alcohol, myristyl alcohol, cetyl alcohol, isocetyl alcohol, palmitoleyl alcohol, stearyl alcohol, isostearyl alcohol, Oleyl alcohol, elaidyl alcohol, petroselinyl alcohol, arachyl alcohol, gadoleyl alcohol, behenyl alcohol, erucyl alcohol and brassidyl alcohol, and technical mixtures thereof. Adducts of 10 to 100 mol of ethylene oxide onto technical fatty alcohols with 12 to 18 carbon atoms, such as, for example, coconut, palm, palm kernel or tallow fatty alcohol, are also suitable.
Die ethoxylierten C8-C24-Carbonsäuren haben die Formel R1(OCH2CH2)nOH, wobei R1 steht für einen linearen oder verzweigten gesättigten oder ungesättigten Acylrest mit 8 -24 Kohlenstoffatomen und n, die mittlere Anzahl der Ethylenoxid-Einheiten pro Molekül, für Zahlen von 10 - 100, vorzugsweise 10 - 30 Mol Ethylenoxid an 1 Mol Caprylsäure, 2-Ethylhexansäure, Caprinsäure, Laurinsäure, Isotridecan- säure, Myristinsäure, Cetylsäure, Palmitoleinsäure, Stearinsäure, Isostearinsäure, Ölsäure, Elaidin- säure, Petroselinsäure, Arachinsäure, Gadoleinsäure, Behensäure, Erucasäure und Brassidinsäure sowie deren technische Mischungen. Auch Addukte von 10 - 100 Mol Ethylenoxid an technische Fettsäuren mit 12 - 18 Kohlenstoffatomen, wie Kokos-, Palm-, Palmkern- oder Taigfettsäure, sind geeignet. Besonders bevorzugt sind PEG-50-monostearat, PEG-100-monostearat, PEG-50-monooleat, PEG- 100-monooleat, PEG-50-monolaurat und PEG-100-monolaurat.The ethoxylated C 8 -C 24 -carboxylic acids have the formula R 1 (OCH 2 CH 2 ) n OH, where R 1 is a linear or branched saturated or unsaturated acyl radical having 8-24 carbon atoms and n, the average number of ethylene oxide Units per molecule, for numbers from 10 to 100, preferably 10 to 30, mol of ethylene oxide to 1 mol of caprylic acid, 2-ethylhexanoic acid, capric acid, lauric acid, isotridecanoic acid, myristic acid, cetylic acid, palmitoleic acid, stearic acid, isostearic acid, oleic acid, elaidic acid, Petroselinic acid, arachidic acid, gadoleic acid, behenic acid, erucic acid and brassidic acid and their technical mixtures. Adducts of 10 to 100 mol of ethylene oxide with technical fatty acids containing 12 to 18 carbon atoms, such as coconut, palm, palm kernel or tallow fatty acid, are also suitable. Particularly preferred are PEG-50 monostearate, PEG-100 monostearate, PEG-50 monooleate, PEG-100 monooleate, PEG-50 monolaurate and PEG-100 monolaurate.
Besonders bevorzugt eingesetzt werden die C-|2-Ci8-Alkanole oder die Ci2-Ci8-Carbonsäuren mit jeweils 10 - 30 Einheiten Ethylenoxid pro Molekül sowie Mischungen dieser Substanzen, insbesondere Ceteth-12, Ceteth-20, Ceteth-30, lsoceteth-20, Steareth-12, Steareth-20, Steareth-30, Ceteareth-12, Ceteareth-20, Ceteareth-30, Laureth-12 und Beheneth-20.Particularly preferably used are the C | 2 -C 8 -alkanols or C 2 -C 8 carboxylic acids each having 10 to 30 units of ethylene oxide per molecule and mixtures of these substances, in particular ceteth-12, ceteth-20, ceteth-30, lsoceteth-20, Steareth-12, Steareth-20, steareth-30, ceteareth-12, ceteareth-20, ceteareth-30, laureth-12 and beheneth-20.
Weiterhin werden vorzugsweise C8 - C22-Alkylmono- und -oligoglycoside eingesetzt. C8 -C22-Alkyl- mono- und -oligoglycoside stellen bekannte, handelsübliche Tenside und Emulgatoren dar. Ihre Herstellung erfolgt insbesondere durch Umsetzung von Glucose oder Oligosacchariden mit primären Alkoholen mit 8 - 22 Kohlenstoffatomen. Bezüglich des Glycosidrestes gilt, dass sowohl Monoglyco- side, bei denen ein cyclischer Zuckerrest glycosidisch an den Fettalkohol gebunden ist, als auch oligomere Glycoside mit einem Oligomerisationsgrad bis etwa 8, vorzugsweise 1 - 2, geeignet sind. Der Oligomerisierungsgrad ist dabei ein statistischer Mittelwert, dem eine für solche technischen Produkte übliche Homologenverteilung zugrunde liegt. Produkte, die unter dem Warenzeichen Planta- care® erhältlich sind, enthalten eine glucosidisch gebundene C8-C16-Alkylgruppe an einem Oligo- glucosidrest, dessen mittlerer Oligomerisationsgrad bei 1 - 2, insbesondere bei 1 ,1 - 1 ,4, liegt. Besonders bevorzugte C8 - C22-Alkylmono- und -oligoglycoside sind ausgewählt aus Octylglucosid, Decylglucosid, Laurylglucosid, Palmitylglucosid, Isostearylglucosid, Stearylglucosid, Arachidylglucosid und Behenylglucosid sowie Mischungen hiervon. Auch die vom Glucamin abgeleiteten Acylglucamide sind als nicht-ionische ÖI-in-Wasser-Emulgatoren geeignet.Furthermore, preference is given to using C 8 -C 22 -alkyl mono- and -oligoglycosides. C 8 -C 22 -alkyl mono- and oligoglycosides are known, commercially available surfactants and emulsifiers. They are prepared in particular by reacting glucose or oligosaccharides with primary alcohols having 8-22 carbon atoms. With regard to the glycoside radical, monoglycosides in which a cyclic sugar residue is glycosidically bound to the fatty alcohol, as well as oligomeric glycosides having a degree of oligomerization of up to about 8, preferably 1-2, are suitable. The degree of oligomerization is a statistical mean, which is based on a homolog distribution typical for such technical products. Products sold under the trademark Planta- care ® , contain a glucosidically bound C 8 -C 16 alkyl group on a Oligo- glucosidrest whose average degree of oligomerization at 1 - 2, in particular 1, 1 - 1, 4, lies. Particularly preferred C 8 -C 22 alkyl mono- and oligoglycosides are selected from octyl glucoside, decyl glucoside, lauryl glucoside, palmityl glucoside, isostearyl glucoside, stearyl glucoside, arachidyl glucoside and behenyl glucoside and mixtures thereof. The glucamine-derived acylglucamides are also suitable as nonionic oil-in-water emulsifiers.
Auch ethoxylierte Sterine, insbesondere ethoxylierte Sojasterine, stellen erfindungsgemäß geeignete ÖI-in-Wasser-Emulgatoren dar. Der Ethoxylierungsgrad muss größer als 5, bevorzugt mindestens 10 sein, um einen HLB-Wert größer 7 aufzuweisen. Geeignete Handelsprodukte sind z. B. PEG-10 Soy Sterol, PEG-16 Soy Sterol und PEG-25 Soy Sterol.Ethoxylated sterols, in particular ethoxylated soy sterols, are also suitable oil-in-water emulsifiers according to the invention. The degree of ethoxylation must be greater than 5, preferably at least 10, in order to have an HLB value greater than 7. Suitable commercial products are, for. PEG-10 Soy Sterol, PEG-16 Soy Sterol and PEG-25 Soy Sterol.
Weiterhin werden vorzugsweise Partialester von Polyglycerinen mit 2 bis 10 Glycerineinheiten und mit 1 bis 4 gesättigten oder ungesättigten, linearen oder verzweigten, gegebenenfalls hydroxylierten C8 - C30-Fettsäureresten verestert, eingesetzt, sofern sie einen HLB-Wert von mehr als 7 aufweisen. Besonders bevorzugt sind Diglycerinmonocaprylat, Diglycerinmonocaprat, Diglycerinmonolaurat, Triglycerinmonocaprylat, Triglycerinmonocaprat, Triglycerinmonolaurat, Tetraglycerinmonocaprylat, Tetraglycerinmonocaprat, Tetraglycerinmonolaurat, Pentaglycerinmonocaprylat, Pentaglycerinmono- caprat, Pentaglycerinmonolaurat, Hexaglycerinmonocaprylat, Hexaglycerinmonocaprat, Hexa glycerin- monolaurat, Hexaglycerinmonomyristat, Hexaglycerinmonostearat, Decaglycerinmonocaprylat, Deca- glycerinmonocaprat, Decaglycerinmonolaurat, Decaglycerinmonomyristat, Decaglycerinmonoisostea- rat, Decaglycerinmonostearat, Decaglycerinmonooleat, Decaglycerinmonohydroxystearat, Decaglyce- rindicaprylat, Decaglycerindicaprat, Decaglycerindilaurat, Decaglycerindimyristat, Decaglycerindiiso- stearat, Decaglycerindistearat, Decaglycerindioleat, Decaglycerindihydroxystearat, Decaglycerintri- caprylat, Decaglycerintricaprat, Decaglycerintrilaurat, Decaglycerintrimyristat, Decaglycerintriisostearat, Decaglycerintristearat, Decaglycerintrioleat und Decaglycerintrihydroxystearat.Furthermore, preferably partial esters of polyglycerols with 2 to 10 glycerol units and with 1 to 4 saturated or unsaturated, linear or branched, optionally hydroxylated C 8 - C 30 fatty acid esters esterified used, if they have an HLB value of more than 7. Particularly preferred Diglycerinmonocaprylat, Diglycerinmonocaprat, diglycerol, Triglycerinmonocaprylat, Triglycerinmonocaprat, triglycerol, Tetraglycerinmonocaprylat, Tetraglycerinmonocaprat, Tetraglycerinmonolaurat, Pentaglycerinmonocaprylat, Pentaglycerinmono- caprate, Pentaglycerinmonolaurat, Hexaglycerinmonocaprylat, Hexaglycerinmonocaprat, hexa glycerol- monolaurate, Hexaglycerinmonomyristat, Hexaglycerinmonostearat, Decaglycerinmonocaprylat, deca are glycerol monocaprate, decaglyceryl monolaurate, decaglyceryl monomyristate, rat Decaglycerinmonoisostea-, decaglycerol monostearate, Decaglycerinmonooleat, Decaglycerinmonohydroxystearat, Decaglyce- rindicaprylat, stearate Decaglycerindicaprat, Decaglycerindilaurat, Decaglycerindimyristat, Decaglycerindiiso-, Decaglycerindistearat, Decaglycerindioleat, Decaglycerindihydroxystearat, Decaglycerintri- caprylate, Decaglycerintricaprat, Decaglycerintrilaurat, Decaglycerintrimyristat, Decaglycerintriisostearat, Decaglycerintristea rat, decaglycerol trioleate and decaglycerol trihydroxystearate.
Besonders bevorzugte erfindungsgemäße Deodorant- oder Antitranspirant-Zusammensetzungen sind dadurch gekennzeichnet, dass der nichtionische ÖI-in-Wasser-Emulgator in einer Gesamtmenge von 0,5 - 10 Gew.-%, besonders bevorzugt 1 - 4 Gew.-% und außerordentlich bevorzugt 1 ,5 - 3 Gew.-%, bezogen auf die Gesamtzusammensetzung, enthalten ist.Particularly preferred deodorant or antiperspirant compositions according to the invention are characterized in that the nonionic oil-in-water emulsifier in a total amount of 0.5 to 10 wt .-%, particularly preferably 1 to 4 wt .-% and most preferably 1 , 5 - 3 wt .-%, based on the total composition is included.
Wasser-in-ÖI-EmulgatorenWater-in-oil emulsifiers
Erfindungsgemäß bevorzugte Zusammensetzungen, die als Emulsion oder Stift formuliert sind, enthalten bevorzugt weiterhin mindestens einen nichtionischen Wasser-in-ÖI-Emulgator mit einem HLB-Wert größer 1 ,0 und kleiner/gleich 7,0, ausgewählt aus den Mono- und Diestern von Ethylenglycol und den Mono-, Di-, Tri- und Tetraestern von Pentaerythrit mit linearen gesättigten Fettsäuren mit 12 - 30, insbesondere 14 - 22 Kohlenstoffatomen, die hydroxyliert sein können, sowie Mischungen hiervon, als Konsistenzgeber und/oder Wasserbinder. Erfindungsgemäß bevorzugt sind die Mono- und Diester. Erfindungsgemäß bevorzugte C-i2-C3o-Fettsäurereste sind ausgewählt aus Laurinsäure-, Myristinsäure- , Palmitinsäure-, Stearinsäure-, Arachinsäure- und Behensäure-Resten; besonders bevorzugt ist der Stearinsäurerest. Erfindungsgemäß besonders bevorzugte nichtionische Wasser-in-ÖI-Emulgatoren mit einem HLB-Wert größer 1 ,0 und kleiner/gleich 7,0 sind ausgewählt aus Pentaerythritylmonostearat, Pentaerythrityldistearat, Pentaerythrityltristearat, Pentaerythrityltetrastearat, Ethylenglycolmonostearat, Ethylenglycoldistearat sowie Mischungen hiervon. Erfindungsgemäß besonders bevorzugte Wasser-in- ÖI-Emulgatoren mit einem HLB-Wert größer 1 ,0 und kleiner/ gleich 7,0 sind zum Beispiel als Handelsprodukte Cutina® PES (INCI: Pentaerythrityl distearate), Cutina® AGS (INCI: Glycol distearate) oder Cutina® EGMS (INCI: Glycol stearate) erhältlich. Diese Handelsprodukte stellen bereits Mischungen aus Mono- und Diestern (bei den Pentaerythritylestern sind auch Tri- und Tetraester enthalten) dar. Erfindungsgemäß kann es bevorzugt sein, nur einen einzigen Wasser-in-ÖI-Emulgator einzusetzen. In einer anderen bevorzugten Ausführungsform enthalten die erfindungsgemäßen Zusammensetzungen Mischungen, insbesondere technische Mischungen, von mindestens zwei Wasser-in-ÖI-Emulgatoren. Unter einer technischen Mischung wird beispielsweise ein Handelsprodukt wie Cutina® PES verstanden.Preferred compositions according to the invention, which are formulated as an emulsion or stick, preferably furthermore comprise at least one nonionic water-in-oil emulsifier having an HLB value greater than 1.0, and less than or equal to 7.0, selected from the mono- and diesters of Ethylene glycol and the mono-, di-, tri- and tetra-esters of pentaerythritol with linear saturated fatty acids having 12-30, in particular 14-22 carbon atoms, which may be hydroxylated, and mixtures thereof, as consistency regulator and / or water binder. According to the invention, the mono- and diesters are preferred. Ci 2 -C 3 o-fatty acid radicals which are preferred according to the invention are selected from lauric acid, myristic acid, palmitic acid, stearic acid, arachic acid and behenic acid radicals; particularly preferred is the stearic acid residue. Particularly preferred nonionic water-in-oil emulsifiers according to the invention having an HLB value greater than 1.0 and less than or equal to 7.0 are selected from pentaerythrityl monostearate, pentaerythrityl distearate, pentaerythrityl tristearate, pentaerythrityl tetrastearate, ethylene glycol monostearate, ethylene glycol distearate and mixtures thereof. According to the invention, particularly preferred water-in-oil emulsifiers having an HLB value greater than 1, 0 and less than / equal to 7.0, for example as commercial products Cutina ® PES (INCI: Pentaerythrityl distearate), Cutina ® AGS (INCI: distearate Glycol) or Cutina ® EGMS (INCI: glycol stearate) available. These commercial products are already mixtures of mono- and diesters (the pentaerythrityl esters also contain tri- and tetraesters). According to the invention, it may be preferable to use only a single water-in-oil emulsifier. In another preferred embodiment, the compositions according to the invention comprise mixtures, in particular technical mixtures, of at least two water-in-oil emulsifiers. A commercial product such as Cutina ® PES is meant, for example, a technical mixture.
Außer den genannten Wasser-in-ÖI-Emulgatoren auf Basis der Ethylenglycol- oder Pentaerythritylester kann in einer bevorzugten Ausführungsform auch noch mindestens ein weiterer nichtionischer Wasser- in-ÖI-Emulgator mit einem HLB-Wert größer 1 ,0 und kleiner/gleich 7,0 enthalten sein, dessen Anteil an dem Gesamtgewicht an nichtionischen Wasser-in-ÖI-Emulgatoren mit einem HLB-Wert größer 1 ,0 und kleiner/gleich 7,0 bevorzugt allerdings nicht größer als 80 % sein sollte. In einer besonders bevorzugten Ausführungsform enthalten die erfindungsgemäßen Zusammensetzungen den mindestens einen zusätzlichen Wasser-in-ÖI-Emulgator mit einem HLB-Wert größer 1 ,0 und kleiner/ gleich 7,0 nur in einem Gewichtsanteil von maximal 10 % beziehungsweise sind frei von zusätzlichen Wasser-in-ÖI- Emulgatoren. Einige dieser zusätzlichen geeigneten Emulgatoren sind beispielsweise in Kirk-Othmer, "Encyclopedia of Chemical Technology", 3. Aufl., 1979, Band 8, Seite 913, aufgelistet. Für ethoxylierte Addukte lässt sich der HLB-Wert, wie bereits erwähnt, auch berechnen.In addition to the stated water-in-oil emulsifiers based on the ethylene glycol or pentaerythrityl esters, in a preferred embodiment, at least one further nonionic water-in-oil emulsifier having an HLB value greater than 1, 0 and less than or equal to 7, 0 should be included, the proportion of the total weight of nonionic water-in-oil emulsifiers with an HLB value greater than 1, 0 and less than or equal to 7.0 preferably, but should not be greater than 80%. In a particularly preferred embodiment, the compositions according to the invention contain the at least one additional water-in-oil emulsifier having an HLB value greater than 1.0, and less than or equal to 7.0 only in a proportion by weight of not more than 10% or are free of additional water in oil emulsifiers. Some of these additional suitable emulsifiers are listed, for example, in Kirk-Othmer, "Encyclopedia of Chemical Technology" 3rd Ed., 1979, Vol. 8, page 913. For ethoxylated adducts, the HLB value, as already mentioned, can also be calculated.
Als Wasser-in-ÖI-Emulgator bevorzugt geeignet sind: lineare gesättigte Alkanole mit 12 - 30 Kohlenstoffatomen, insbesondere mit 16 - 22 Kohlenstoffatomen, insbesondere Cetylalkohol, Stearylalkohol, Arachidylalkohol, Behenylalkohol und Lanolinalkohol oder Gemische dieser Alkohole, wie sie bei der technischen Hydrierung von pflanzlichen und tierischen Fettsäuren erhältlich sind,Suitable water-in-oil emulsifiers are preferably: linear saturated alkanols having 12 to 30 carbon atoms, in particular 16 to 22 carbon atoms, in particular cetyl alcohol, stearyl alcohol, arachidyl alcohol, behenyl alcohol and lanolin alcohol or mixtures of these alcohols, as used in the industrial hydrogenation of vegetable and animal fatty acids are available,
Ester und insbesondere Partialester aus einem Polyol mit 3 - 6 C-Atomen und linearen gesättigten und ungesättigten Fettsäuren mit 12 - 30, insbesondere 14 - 22 C-Atomen, die hydroxyliert sein können. Solche Ester oder Partialester sind z. B. die Mono- und Diester von Glycerin oder die Monoester von Propylenglycol mit linearen gesättigten und ungesättigten C12 - C30-Carbonsäuren, die hydroxyliert sein können, insbesondere diejenigen mit Palmitin- und Stearinsäure, die Sorbitan- mono-, -di- oder -triester von linearen gesättigten und ungesättigten C12 - C30-Carbonsäuren, die hydroxyliert sein können, insbesondere diejenigen von Myristinsäure, Palmitinsäure, Stearinsäure oder von Mischungen dieser Fettsäuren und die Methylglucosemono- und -diester von linearen gesättigten und ungesättigten C12 - C30-Carbonsäuren, die hydroxyliert sein können; Sterine, also Steroide, die am C3-Atom des Steroid-Gerüstes eine Hydroxylgruppe tragen und sowohl aus tierischem Gewebe (Zoosterine, z. B. Cholesterin, Lanosterin) wie auch aus Pflanzen (Phytosterine, z. B. Ergosterin, Stigmasterin, Sitosterin) und aus Pilzen und Hefen (Mykosterine) isoliert werden und die niedrig ethoxyliert (1 - 5 EO) sein können;Esters and in particular partial esters of a polyol having 3 to 6 C atoms and linear saturated and unsaturated fatty acids having 12 to 30, in particular 14 to 22, C atoms which may be hydroxylated. Such esters or partial esters are, for. The mono- and diesters of glycerine or the monoesters of propylene glycol with linear saturated and unsaturated C 12 -C 30 carboxylic acids which may be hydroxylated, especially those with palmitic and stearic acid, the sorbitan mono-, di- or triesters of linear saturated and unsaturated C 12 -C 30 -carboxylic acids which may be hydroxylated, in particular those of myristic acid, palmitic acid, stearic acid or of mixtures of these fatty acids and the methylglucosemono- and diesters of linear saturated and unsaturated C 12 -C 30 carboxylic acids which may be hydroxylated; Sterols, ie steroids which carry a hydroxyl group at the C3 atom of the steroid skeleton and both from animal tissue (zoosterols, eg cholesterol, lanosterol) as well as from plants (phytosterols, eg ergosterol, stigmasterol, sitosterol) and from fungi and yeasts (mycosterols) which may be low ethoxylated (1-5 EO);
Alkanole und Carbonsäuren mit jeweils 8 - 24 C-Atomen, insbesondere mit 16 - 22 C-Atomen, in der Alkylgruppe und 1 - 4 Ethylenoxid-Einheiten pro Molekül, die einen HLB-Wert größer 1 ,0 und kleiner/gleich 7,0 aufweisen,Alkanols and carboxylic acids each having 8-24 C atoms, in particular having 16-22 C atoms, in the alkyl group and 1-4 ethylene oxide units per molecule which have an HLB value of greater than 1.0, and less than or equal to 7.0 exhibit,
Glycerinmonoether gesättigter und/oder ungesättigter, verzweigter und/oder unverzweigter Alkohole einer Kettenlänge von 8 - 30, insbesondere 12 - 18 Kohlenstoffatomen.Glycerol monoethers of saturated and / or unsaturated, branched and / or unbranched alcohols of a chain length of 8-30, in particular 12-18 carbon atoms.
Partialester von Polyglycerinen mit n = 2 bis 10 Glycerineinheiten und mit 1 bis 5 gesättigten oder ungesättigten, linearen oder verzweigten, gegebenenfalls hydroxylierten C8 - C30-Fettsäureresten verestert, sofern sie einen HLB-Wert von kleiner/gleich 7 aufweisen, sowie Mischungen der vorgenannten Substanzen.Partial ester of polyglycerols having n = 2 to 10 glycerol units and esterified with 1 to 5 saturated or unsaturated, linear or branched, optionally hydroxylated C 8 - C 30 fatty acid residues, if they have an HLB value of 7 or less, and mixtures of aforementioned substances.
Erfindungsgemäß kann es bevorzugt sein, nur einen einzigen zusätzlichen Wasser-in-ÖI-Emulgator einzusetzen. In einer anderen bevorzugten Ausführungsform enthalten die erfindungsgemäßen Zusammensetzungen Mischungen, insbesondere technische Mischungen, von mindestens zwei zusätzlichen Wasser-in-ÖI-Emulgatoren. Unter einer technischen Mischung wird beispielsweise ein Handelsprodukt wie Cutina® GMS verstanden, das eine Mischung aus Glycerylmonostearat und Glyceryldistearat darstellt.According to the invention, it may be preferable to use only a single additional water-in-oil emulsifier. In another preferred embodiment, the compositions according to the invention comprise mixtures, in particular technical mixtures, of at least two additional water-in-oil emulsifiers. For example, a commercial product such as Cutina GMS ® is understood to be a technical mixture, which is a mixture of glyceryl monostearate and glyceryl distearate.
Besonders vorteilhaft einsetzbare zusätzliche Wasser-in-ÖI-Emulgatoren sind Stearylalkohol, Cetyl- alkohol, Glycerylmonostearat, insbesondere in Form der Handelsprodukte Cutina® GMS und Cutina® MD (ex Cognis), Glyceryldistearat, Glycerylmonocaprinat, Glycerylmonocaprylat, Glycerylmonolaurat, Glycerylmonomyristat, Glycerylmonopalmitat, Glycerylmonohydroxystearat, Glycerylmonooleat, Glyce- rylmonolanolat, Glyceryldimyristat, Glyceryldipalmitat, Glyceryldioleat, Propylenglycolmonostearat, Pro- pylenglycolmonolaurat, Sorbitanmonocaprylat, Sorbitanmonolaurat, Sorbitanmonomyristat, Sorbitan- monopalmitat, Sorbitanmonostearat, Sorbitansesquistearat, Sorbitandistearat, Sorbitandioleat, Sorbi- tansesquioleat, Saccharosedistearat, Arachidylalkohol, Behenylalkohol, Polyethylenglycol(2)stearyl- ether (Steareth-2), Steareth-5, Oleth-2, Diglycerinmonostearat, Diglycerinmonoisostearat, Diglycerin- monooleat, Diglycerindihydroxystearat, Diglycerindistearat, Diglycerindioleat, Triglycerindistearat, Tetraglycerinmonostearat, Tetraglycerindistearat, Tetraglycerintristearat, Decaglycerinpentastearat, Decaglycerinpentahydroxystearat, Decaglycerinpentaisostearat, Decaglycerinpentaoleat, Soy Sterol, PEG-1 Soy Sterol, PEG-5 Soy Sterol, PEG-2-monolaurat und PEG-2-monostearat. Besonders bevorzugte erfindungsgemäße Deodorant- oder Antitranspirant-Zusammensetzungen sind dadurch gekennzeichnet, dass mindestens ein Wasser-in-ÖI-Emulgator in einer Gesamtmenge von 0,1 - 15 Gew.-%, bevorzugt 0,5 - 8,0 Gew.-%, und besonders bevorzugt 1 - 4 Gew.-%, bezogen auf die Gesamtzusammensetzung, enthalten sind. Weiterhin können auch Mengen von 2 - 3 - 3,5 Gew.-%, bezogen auf das Gesamtgewicht der Zusammensetzung, erfindungsgemäß außerordentlich bevorzugt sein.Particularly advantageous additional water-in-oil emulsifiers are stearyl alcohol, cetyl alcohol, glyceryl monostearate, in particular in the form of the commercial products Cutina ® GMS and Cutina ® MD (ex Cognis), glyceryl distearate, glyceryl monocaprinate, glyceryl monocaprylate, glyceryl monolaurate, glyceryl monomyristate, glyceryl monopalmitate, glyceryl monohydroxystearate , glyceryl monooleate, glyceryl rylmonolanolat, Glyceryldimyristat, Glyceryldipalmitat, glyceryl dioleate, propylene glycol monostearate, pro pylenglycolmonolaurat, sorbitan monocaprylate, sorbitan monolaurate, sorbitan monomyristate, sorbitan monopalmitate, sorbitan monostearate, Sorbitansesquistearat, sorbitan distearate, sorbitan dioleate, sorbitan tansesquioleat, sucrose distearate, arachidyl alcohol, behenyl alcohol, polyethylene glycol (2 ) stearyl ether (steareth-2), steareth-5, oleth-2, diglycerol monostearate, diglycerol monoisostearate, diglycerol monooleate, diglycerol dihydroxystearate, diglycerol distearate, diglycerol dioleate, triglycerol disteara tetraglycerol monostearate, tetraglycerol distearate, tetraglycerol tristearate, decaglycerol penta stearate, decaglycerin pentahydroxystearate, decaglycerol pentaisostearate, decaglycerin pentaoleate, soy sterol, PEG-1 soy sterol, PEG-5 soy sterol, PEG-2 monolaurate and PEG-2 monostearate. Particularly preferred deodorant or antiperspirant compositions according to the invention are characterized in that at least one water-in-oil emulsifier is present in a total amount of 0.1-15% by weight, preferably 0.5-8.0% by weight, and particularly preferably 1 to 4 wt .-%, based on the total composition, are included. Furthermore, amounts of 2 - 3 - 3.5 wt .-%, based on the total weight of the composition, according to the invention be extremely preferred.
Weitere erfindungsgemäß bevorzugte W/O-Emulgatoren sind silicon-freie polymere Wasser-in-ÖI- Emulgatoren, insbesondere PEG-30 Dipolyhydroxystearat, erhältlich z. B. unter dem Handelsnamen Arlacel P 135 von Uniqema. Insbesondere mit Hilfe dieses Emulgators lassen sich niedrig-viskose und sogar sprühbare Wasser-in-ÖI-Emulsionen formulieren.Other inventively preferred W / O emulsifiers are silicone-free polymeric water-in-oil emulsifiers, in particular PEG-30 dipolyhydroxystearate, available for. B. under the trade name Arlacel P 135 from Uniqema. In particular, with the help of this emulsifier can be formulated low-viscous and even sprayable water-in-oil emulsions.
Erfindungsgemäß besonders bevorzugte Zusammensetzungen, die als Wasser-in-ÖI-Emulsion konfektioniert sind, enthalten bevorzugt weiterhin mindestens einen Wasser-in-ÖI-Emulgator auf Siliconbasis. Der mindestens eine Wasser-in-ÖI-Emulgator auf Siliconbasis ist bevorzugt in einer Menge von 0,5 - 5 Gew.-%, besonders bevorzugt 1 ,0 - 1 ,5 - 2,5 - 3 -3,5 Gew.-%, jeweils bezogen auf das Gesamtgewicht der Emulsion, enthalten.Compositions which are particularly preferred according to the invention and which are formulated as a water-in-oil emulsion preferably furthermore comprise at least one water-in-oil emulsifier based on silicone. The at least one silicone-based water-in-oil emulsifier is preferably present in an amount of from 0.5 to 5% by weight, more preferably from 0.1 to 1.5 to 2.5 to 3.5% by weight. %, in each case based on the total weight of the emulsion.
Eine erfindungsgemäß besonders bevorzugte Gruppe von Wasser-in-ÖI-Emulgatoren auf Siliconbasis sind die Poly-(C2-C3)alkylenglycol-modifizierten Silicone, deren frühere INCI-Bezeichnung Dimethicone Copolyol lautete, mit den aktuellen INCI-Bezeichnungen PEG-x Dimethicone (mit x = 2 - 20, bevorzugt 3 - 17, besonders bevorzugt 11 - 12), Bis-PEG-y Dimethicone (mit y = 3 - 25, bevorzugt 4 - 20), PEG/PPG a/b Dimethicone (wobei a und b unabhängig voneinander für Zahlen von 2 - 30, bevorzugt 3 - 30 und besonders bevorzugt 12 - 20, insbesondere 14 - 18, stehen), Bis-PEG/PPG-c/d Dimethicone (wobei c und d unabhängig voneinander für Zahlen von 10 - 25, bevorzugt 14 - 20 und besonders bevorzugt 14 - 16, stehen) und Bis-PEG/PPG-e/f PEG/PPG g/h Dimethicone (wobei e, f, g und h unabhängig voneinander für Zahlen von 10 - 20, bevorzugt 14 - 18 und besonders bevorzugt 16, stehen). Besonders bevorzugt sind PEG/PPG-18/18 Dimethicone, das in einer 1 :9-Mischung mit Cyclomethicone als DC 3225 C bzw. DC 5225 C im Handel erhältlich ist, PEG/PPG-4/12 Dimethicone, das unter der Bezeichnung Abil B 8852 erhältlich ist, sowie Bis-PEG/PPG-14/14 Dimethicone, das in einer Mischung mit Cyclomethicone als Abil EM 97 (Goldschmidt) im Handel erhältlich ist, Bis- PEG/PPG-20/20 Dimethicone, das unter der Bezeichnung Abil B 8832 erhältlich ist, PEG/PPG-5/3 Trisiloxane (Silsoft 305), sowie PEG/PPG-20/23 Dimethicone (Silsoft 430 und Silsoft 440). Weitere erfindungsgemäß bevorzugte W/O-Emulgatoren auf Siliconbasis sind Poly-(C2-C3)alkylen- glycol-modifizierte Silicone, die mit C4-C18-Alkylgruppen hydrophob modifiziert sind, besonders bevorzugt Cetyl PEG/PPG-10/1 Dimethicone (früher: Cetyl Dimethicone Copolyol, erhältlich als Abil EM 90 oder in einer Mischung aus Polyglyceryl-4-isostearat, Cetyl PEG/PPG-10/1 Dimethicone und Hexyllaurat unter der Handelsbezeichnung Abil WE 09), weiterhin Alkyl Methicone Copolyole und Alkyl Dimethicone Ethoxy Glucoside.A particularly preferred group of silicone-based water-in-oil emulsifiers according to the invention are the poly (C 2 -C 3 ) alkylene glycol-modified silicones whose earlier INCI name was dimethicone copolyol, with the current INCI names PEG-x dimethicone (with x = 2-20, preferably 3-17, more preferably 11-12), bis-PEG-y dimethicone (with y = 3-25, preferably 4-20), PEG / PPG a / b dimethicone (where a and b independently of one another are numbers from 2 to 30, preferably 3 to 30 and particularly preferably 12 to 20, in particular 14 to 18), bis-PEG / PPG-c / d dimethicones (where c and d independently of one another represent numbers of 10-25, preferably 14-20 and more preferably 14-16) and bis-PEG / PPG-e / f PEG / PPG g / h dimethicones (where e, f, g and h independently of one another represent numbers of 10 - 10). 20, preferably 14-18 and more preferably 16, stand). Particular preference is given to PEG / PPG-18/18 dimethicones, which are commercially available in a 1: 9 mixture with cyclomethicone as DC 3225 C or DC 5225 C, PEG / PPG-4/12 dimethicone, sold under the name Abil B 8852 is available as well as Bis-PEG / PPG-14/14 Dimethicone, which is commercially available in a mixture with Cyclomethicone as Abil EM 97 (Goldschmidt), Bis-PEG / PPG-20/20 Dimethicone, under the name Abil B 8832 is available, PEG / PPG-5/3 trisiloxanes (Silsoft 305), and PEG / PPG-20/23 dimethicones (Silsoft 430 and Silsoft 440). Further silicone-based w / o emulsifiers which are preferred according to the invention are poly (C 2 -C 3 ) -alkylene glycol-modified silicones which are hydrophobically modified with C 4 -C 18 -alkyl groups, particularly preferably cetyl PEG / PPG-10/1 Dimethicone (formerly: Cetyl Dimethicone Copolyol, available as Abil EM 90 or in a mixture of polyglyceryl-4-isostearate, Cetyl PEG / PPG-10/1 dimethicone and Hexyl laurate under the trade name Abil WE 09), further alkyl methicone copolyols and alkyl dimethicone ethoxy glucosides.
In der nachfolgenden Tabelle sind verschiedene ÖI-in-Wasser-Emulgatoren und Wasser-in-ÖI- Emulgatoren und ihre HLB-Werte zusammengestellt. Die HLB-Werte können aber auch nach Griffin berechnet werden, wie es beispielsweise im RÖMPP Chemie Lexikon, insbesondere in der Online- Version von November 2003, und den dort unter dem Stichwort „HLB-System" zitierten Handbüchern von Fiedler, Kirk-Othmer und Janistyn dargestellt beziehungsweise tabelliert ist. Sofern es in der Literatur unterschiedliche Angaben zum HLB-Wert einer Substanz gibt, sollte derjenige HLB-Wert für die erfindungsgemäße Lehre genutzt werden, der dem nach Griffin berechneten Wert am nächsten kommt. Falls sich auf diese Art und Weise kein eindeutiger HLB-Wert ermitteln lässt, ist der HLB-Wert, den der Hersteller des Emulgators angibt, für die erfindungsgemäße Lehre zu nutzen. Falls auch dies nicht möglich ist, ist der HLB-Wert experimentell zu ermitteln.The following table summarizes various oil-in-water emulsifiers and water-in-oil emulsifiers and their HLB values. However, the HLB values can also be calculated according to Griffin, as described, for example, in the RÖMPP Chemie Lexikon, in particular in the online version of November 2003, and the manuals cited by Fiedler, Kirk-Othmer, and "HLB-System" there If there is different information on the HLB value of a substance in the literature, the HLB value for the teaching according to the invention which comes closest to the value calculated according to Griffin should be used If no clear HLB value can be determined, the HLB value given by the manufacturer of the emulsifier must be used for the teaching according to the invention. If this too is not possible, the HLB value must be determined experimentally.
HLB-Wert Chemische BezeichnungHLB value Chemical name
(aus H. Janistyn, Handbuch der Kosmetika und Riechstoffe, Hüthig-Verlag Heidelberg, 3. Auflage, 1978,(from H. Janistyn, Handbuch der Kosmetika und Riechstoffe, Hüthig-Verlag Heidelberg, 3rd edition, 1978,
Band 1 , Seite 470 und Band 3, Seiten 68 - 78))Volume 1, page 470 and volume 3, pages 68-78))
1 Triglyceride gesättigter Fettsauren1 triglycerides of saturated fatty acids
Glyceryltrioleatglyceryl
1 ,5 Ethylenglycoldistearat1, 5 ethylene glycol distearate
1 ,6 Pur-Cellinöl1, 6 pure celline oil
1 ,8 Sorbitantrioleat1, 8 sorbitan trioleate
Glycerindioleatdioleate
2,1 Sorbitantristearat2.1 sorbitan tristearate
2,4 Propylenglycollactostearat2,4 propylene glycol lactostearate
2,7 Glycerinmonooleat2.7 glycerol monooleate
SorbitdioleatSorbitdioleat
2,8 Glycerinmonostearat2.8 glycerol monostearate
Propylenglycolmono-/distearat, nicht selbstemulgierendPropylene glycol mono- / distearate, not self-emulsifying
2,9 Ethylenglycolmonostearat2.9 ethylene glycol monostearate
3,0 Decaglycerindecaoleat3.0 decaglycerol decaoleate
DecaglycerindecastearatDecaglycerindecastearat
General 122 (Rapeseed Sterols)General 122 (Rapeseed Sterols)
Sucrosedistearatsucrose distearate
3,1 Decaglycerindecaoleat3.1 decaglycerine deca oleate
Glycerylmonoricinoleatglyceryl
Pentaerythritylmonostearat PentaerythritylsesquioleatPentaerythritylmonostearat Pentaerythritylsesquioleat
3.2 Ethylenglycolmonodistearat, nicht selbstemulgierend Glycolstearat3.2 Ethylene glycol monodistearate, non-self-emulsifying glycol stearate
3.3 Glycerinmonolaurat3.3 glycerol monolaurate
3.4 Propylenglycolmonostearat3.4 Propylene glycol monostearate
3.5 Ethylenglycolmonostearat Pentaerythritylmonooleat Polyethylenglycol(100)monooleat3.5 ethylene glycol monostearate pentaerythrityl monooleate polyethylene glycol (100) monooleate
3.6 Glycerinmono-/dioleat, nicht selbstemulgierend Monoethoxylaurylether3.6 glycerol mono- / dioleate, not self-emulsifying monoethoxylauryl ether
3.7 Sorbitansesquioleat (Dehymuls SSO)3.7 sorbitan sesquioleate (Dehymuls SSO)
3.8 Glycerinmonodistearat, nicht selbstemulgierend Polyethylenglycol(100)monostearat Diglycerinsesquioleat N,N-Dimethylcaproamid Pentaerythritmonotallat Propylenglycolmonolaurat3.8 glycerol monodistearate, non-self-emulsifying polyethylene glycol (100) monostearate diglycerol sesquioleate N, N-dimethyl caproamide pentaerythritol monotallate propylene glycol monolaurate
4,0 Decaglycerinoctaoleat4.0 decaglycerol octaoleate
4.3 Sorbitanmonooleat (Dehymuls SMO) Diethylenglycolmonostearat4.3 Sorbitan monooleate (Dehymuls SMO) Diethylene glycol monostearate
4.4 1.2-Propylenglycolmonodistearat, selbstemulgierend4.4 1.2-propylene glycol monodistearate, self-emulsifying
4.5 Glycerinmonostearatpalmitat (90 %), nicht selbstemulgierend Propylenglycolmonolaurat4.5 Glycerol monostearate palmitate (90%), non-self-emulsifying propylene glycol monolaurate
4.7 Sorbitanmonostearat (Dehymuls SMS) Diethylenglycolmonooleat4.7 Sorbitan monostearate (Dehymuls SMS) Diethylene glycol monooleate
4.8 Pentaerythritmonolaurat4.8 Pentaerythritol monolaurate
4.9 Polyoxyethylen(2)oleylalkohol (Polyoxyethylen(2)oleylether) Polyoxyethylen(2)stearylalkohol (Polyoxyethylen(2)stearylether)4.9 polyoxyethylene (2) oleyl alcohol (polyoxyethylene (2) oleyl ether) polyoxyethylene (2) stearyl alcohol (polyoxyethylene (2) stearyl ether)
5,0 Ethylenglycolmonodistearat5.0 ethylene glycol monodistearate
General 122 E 5 (PEG-5 Soy Sterol)General 122 E 5 (PEG-5 Soy Sterol)
Polyethylenglycol(100)monoricinoleatPolyethylene glycol (100) monoricinoleate
Polyethylenglycol(200)distearatPolyethylene glycol (200) distearate
Polyglyceryl-3-isostearate (z. B. Isolan Gl 34 von Tego) 5,9 Polyethylenglycol(200)dilauratPolyglyceryl-3-isostearates (eg Isolan Gl 34 from Tego) 5.9 Polyethylene glycol (200) dilaurate
6,0 Decaglycerintetraoleat6.0 decaglycerine tetraoleate
Polyethylenglycol(100)monolauratPolyethylene glycol (100) monolaurate
Polyethylenglycol(200)dioleat ,1 Diethylenglycolmonolaurat (Diglycollaurat) ,3 Polyethylenglycol(300)dilaurat ,4 GlycerinmonoricinoleatPolyethylene glycol (200) dioleate , 1 diethylene glycol monolaurate (diglycollaurate), 3 polyethylene glycol (300) dilaurate, 4 glycerol monoricinoleate
Glycerinsorbitanmonolaurat ,5 DiethylenglycolmonolauratGlycerol sorbitan monolaurate, 5-diethylene glycol monolaurate
Natriumstearoyl-2-lactylat ,7 Sorbitanmonopalmitat ,8 GlycerinmonococoatSodium stearoyl-2-lactylate, 7 sorbitan monopalmitate, 8 glycerol monococoate
Glycerinmonolaurat ,0 Polyoxyethylen(2)C10-C-i4-fettalkoholether, Laureth-2 (Dehydol LS 2)Glycerol monolaurate, 0 polyoxyethylene (2) C 10 -C 4 fatty alcohol ether, laureth-2 (Dehydol LS 2)
Saccharosedistearat ,2 Polyethylenglycol(400)dioleatSucrose distearate, 2 polyethylene glycol (400) dioleate
Saccharosedioleat ,4 Polyethylenglycol(100)monolauratSucrose dioleate, 4-polyethyleneglycol (100) monolaurate
Saccharosedipalmitat ,5 Saccharosedipalmitat ,6 Glycerinsorbitanlaurat ,8 Polyethylenglycol(400)distearat ,9 Polyethylenglycol(200)monostearatSucrose dipalmitate, 5 sucrose dipalmitate, 6 glycerol sorbitan laurate, 8 polyethylene glycol (400) distearate, 9 polyethylene glycol (200) monostearate
Polyoxyethylen(3)tridecylalkohol -8,2 Polyethylenglycol(400)distearat ,0 Polyoxyethylen(3)Cio-C14-fettalkoholether, Laureth-3 (Dehydol LS 3)Polyoxyethylene (3) tridecyl alcohol -8.2 Polyethylene glycol (400) distearate, 0 Polyoxyethylene (3) Cio-C 14 fatty alcohol ether, Laureth-3 (Dehydol LS 3)
N.N-DimethyllauramidN, N-dimethyl lauramide
Natriumlauroyllactylat, Natriumlauroyl-2-lactylatSodium lauroyl lactylate, sodium lauroyl-2-lactylate
Polyethylenglycol(200)monooleatPolyethylene glycol (200) monooleate
Polyethylenglycol(220)monotallatPolyethylene glycol (220) monotallate
Polyethylenglycol(1500)dioleatPolyethylene glycol (1500) dioleate
Polyoxyethylen(4)oleylalkoholPolyoxyethylene (4) oleyl alcohol
Polyoxyethylen(4)stearylcetylether ,2 Triglycerinmonooleat ,3 Diethylenglycolmonolaurat ,4 Polyoxyethylen(4)cetyletherPolyoxyethylene (4) stearyl cetyl ether, 2 triglycerol monooleate, 3 diethylene glycol monolaurate, 4 polyoxyethylene (4) cetyl ether
Polyoxyethylenglycol(400)dioleat ,5 NatriumcaproyllactylatPolyoxyethylene glycol (400) dioleate, 5 sodium caproyl lactylate
Polyethylenglycol(200)monostearatPolyethylene glycol (200) monostearate
Sorbitanmonooleat ,6 Sorbitanmonolaurat (Dehymuls SML) Polyethylenglycol(200)monolauratSorbitan monooleate, 6 sorbitan monolaurate (Dehymuls SML) Polyethylene glycol (200) monolaurate
8.8 Polyoxyethylen(4)myristylether Polyethylenglycol (400)dioleat8.8 Polyoxyethylene (4) myristyl ether Polyethylene glycol (400) dioleate
8.9 Nonylphenol, polyoxyethyliert mit 4 Mol EO 9,0 Oleth-5 (z. B. Eumulgin O 5)8.9 Nonylphenol, polyoxyethylated with 4 moles EO 9.0 Oleth-5 (eg Eumulgin O 5)
9.2 - 9,7 Polyoxyethylen(4)laurylalkohol (je nach Handelsprodukt, z. B. Brij 30,9.2-9.7 polyoxyethylene (4) lauryl alcohol (depending on the commercial product, eg Brij 30,
Dehydol LS 4)Dehydol LS 4)
9.3 Polyoxyethylen(4)tridecylalkohol9.3 Polyoxyethylene (4) tridecyl alcohol
9,6 Polyoxyethylen(4)sorbitanmonostearat9.6 polyoxyethylene (4) sorbitan monostearate
9,8 Polyethylenglycol (200)monolaurat9.8 Polyethylene glycol (200) monolaurate
10-11 Polyethylenglycol(400)monooleat10-11 polyethyleneglycol (400) monooleate
10,0 Didodecyldimethylammoniumchlorid10.0 didodecyldimethylammonium chloride
10,0 Polyethylenglycol(200)monolaurat10.0 Polyethylene glycol (200) monolaurate
Polyethylenglycol(400)dilauratPolyethylene glycol (400) dilaurate
Polyethylenglycol(600)dioleatPolyethylene glycol (600) dioleate
Polyoxyethylen(4)sorbitanmonostearatPolyoxyethylene (4) sorbitan monostearate
Polyoxyethylen(5)sorbitanmonooleat 10,2 Polyoxyethylen(40)sorbitol hexaoleatPolyoxyethylene (5) sorbitan monooleate 10.2 polyoxyethylene (40) sorbitol hexaoleate
10,4 - 10,6 Polyoxyethylenglycol(600)distearat10.4-10.6 polyoxyethylene glycol (600) distearate
10.5 Polyoxyethylen(20)sorbitantristearat10.5 Polyoxyethylene (20) sorbitan tristearate
10.6 Saccharosemonostearat10.6 sucrose monostearate
10.7 Saccharosemonooleat10.7 sucrose monooleate
11 - 11 ,4 Polyethylenglycol(400)monooleat11-11, 4 polyethylene glycol (400) monooleate
.1 ,0 Polyethylenglycol(350)monostearat Polyethylenglycol(400)monotallat Polyoxyethylenglycol(7)monostearat Polyoxyethylenglycol(8)monooleat Polyoxyethylen(20)sorbitantrioleat Polyoxyethylen(6)tridecylalkohol.1, 0 Polyethylene glycol (350) Monostearate Polyethylene glycol (400) Monotalate Polyoxyethylene glycol (7) Monostearate Polyoxyethylene glycol (8) Mono-oleate Polyoxyethylene (20) sorbitan trioleate Polyoxyethylene (6) tridecyl alcohol
11.1 Polyethylenglycol(400)monostearat11.1 Polyethylene glycol (400) monostearate
.1 ,2 Polyoxyethylen(9)monostearat Saccharosemonooleat Saccharosemonostearat.1, 2 polyoxyethylene (9) monostearate sucrose monooleate sucrose monostearate
11 ,4 Polyoxyethylen(50)sorbitol hexaoleat11, 4 polyoxyethylene (50) sorbitol hexaoleate
SaccharosemonotallatSaccharosemonotallat
Saccharosestearatpalmitat 11 ,6 Polyoxyethylenglycol(400)monoricinoleat 11 ,7 SaccharosemonomyristatSucrose stearate palmitate 11, 6 polyoxyethylene glycol (400) monoricinoleate 11, 7 sucrose monomyristate
Saccharosemonopalmitat 12,0 PEG-10 Soy Sterol (z. B. General 122 E 10)Sucrose monopalmitate 12.0 PEG-10 soy sterol (eg General 122 E 10)
Triethanolaminoleattriethanolamine
12,2-12,3 Nonylphenol, ethoxyliert mit 8 Mol EO 12,2 Saccharosemonomyristat12.2-12.3 nonylphenol ethoxylated with 8 moles of EO 12.2 sucrose monomyristate
12.4 Saccharosemonolaurat12.4 sucrose monolaurate
Polyoxyethylen(10)oleylalkohol, Polyoxyethylen(10)oleylether Polyoxyethylen(10)stearylalkohol, Polyoxyethylen(10)stearyletherPolyoxyethylene (10) oleyl alcohol, polyoxyethylene (10) oleyl ether, polyoxyethylene (10) stearyl alcohol, polyoxyethylene (10) stearyl ether
12.5 Polyoxyethylen(10)stearylcetylether12.5 polyoxyethylene (10) stearyl cetyl ether
12.7 Polyoxyethylen(8)tridecylalkohol12.7 Polyoxyethylene (8) tridecyl alcohol
12.8 Polyoxyethylenglycol(400)monolaurat Saccharosemonococoat12.8 Polyoxyethylene glycol (400) monolaurate sucrose monococoate
12.9 Polyoxyethylen(10)cetylether12.9 Polyoxyethylene (10) cetyl ether
13 Glycerinmonostearat, ethoxyliert (20 Mol EO)13 glycerol monostearate, ethoxylated (20 moles EO)
13,0 Eumulgin O IO13.0 Eumulgin O IO
Eumulgin 286Eumulgin 286
Eumulgin B 1 (Ceteareth-12)Eumulgin B 1 (Ceteareth-12)
13.0 C12-Fettamine, ethoxyliert (5 Mol EO)13.0 C12 fatty amines, ethoxylated (5 moles EO)
13.1 Nonylphenol, ethoxyliert (9,5 Mol EO)13.1 Nonylphenol, ethoxylated (9.5 mol EO)
13.2 Polyethylenglycol(600)monostearat Polyoxyethylen(16)tallöl13.2 Polyethylene glycol (600) monostearate polyoxyethylene (16) tall oil
13.3 Polyoxyethylen(4)sorbitanmonolaurat 13,5 Nonylphenol, ethoxyliert (10,5 Mol EO)13.3 polyoxyethylene (4) sorbitan monolaurate 13.5 nonylphenol, ethoxylated (10.5 mol EO)
Polyethylenglycol(600)monooleat 13,7 Polyoxyethylen(10)tridecylalkoholPolyethylene glycol (600) monooleate 13.7 polyoxyethylene (10) tridecyl alcohol
Polyethylenglycol(660)monotallatPolyethylene glycol (660) monotallate
Polyethylenglycol(1500)monostearatPolyethylene glycol (1500) monostearate
Polyoxyethylenglycol(1500)dioleat 13,9 Polyethylenglycol(400)monococoatPolyoxyethylene glycol (1500) dioleate 13.9 Polyethylene glycol (400) monococoate
Polyoxyethylen(9)monolauratPolyoxyethylene (9) monolaurate
14-16 Eumulgin HRE 40 (Ricinusöl, mit 40 EO ethoxyliert und hydriert) 14,0 Polyoxyethylen(12)laurylether14-16 Eumulgin HRE 40 (castor oil ethoxylated with 40 EO and hydrogenated) 14.0 polyoxyethylene (12) lauryl ether
Polyoxyethylen(12)tridecylalkoholtridecyl alcohol polyoxyethylene (12)
14.2 Polyoxyethylen(15)stearylalkohol14.2 Polyoxyethylene (15) stearyl alcohol
14.3 Polyoxyethylen(15)stearylcetylether14.3 Polyoxyethylene (15) stearyl cetyl ether
14.4 Gemisch aus C12-C15-Fettalkoholen mit 12 Mol EO 14,5 Polyoxyethylen(12)laurylalkohol14.4 Mixture of C12-C15 fatty alcohols with 12 moles EO 14.5 polyoxyethylene (12) lauryl alcohol
14.8 Polyoxyethylenglycol(600)monolaurat14.8 Polyoxyethylene glycol (600) monolaurate
14.9 - 15,2 Sorbitanmonostearat, mit 20 EO ethoxyliert (z. B. Eumulgin SMS 20) 15 - 15,9 Sorbitanmonooleat, mit 20 EO ethoxyliert (z. B. Eumulgin SMO 20) 15,0 PEG-20 Glyceryl stearate (z. B. Cutina E 24)14.9-15.2 sorbitan monostearate, ethoxylated with 20 EO (eg eumulgin SMS 20) 15-15.9 sorbitan monooleate, ethoxylated with 20 EO (eg, Eumulgin SMO 20) 15.0 PEG-20 glyceryl stearate (e.g. B. Cutina E 24)
PEG-40 Castor OiI (z. B. Eumulgin RO 40) Decylglucosid (Oramix NS 10) Dodecylglucosid (Plantaren APG 600) Dodecyltrimethylammoniumchlorid Nonylphenol, ethoxyliert mit 15 Mol EO Polyethylenglycol(1000)monostearat Polyoxyethylen(600)monooleat 15-17 Eumulgin HRE 60 (Ricinusöl, mit 60 EO ethoxyliert und hydriert)PEG-40 Castor OiI (eg Eumulgin RO 40) Decylglucoside (Oramix NS 10) Dodecylglucoside (Plantaren APG 600) Dodecyltrimethylammonium chloride Nonylphenol ethoxylated with 15 moles EO Polyethylene glycol (1000) Monostearate Polyoxyethylene (600) Monooleate 15-17 Eumulgin HRE 60 (Castor oil, ethoxylated with 60 EO and hydrogenated)
15.3 C12-Fettamine, polyoxyethyliert mit 12 Mol EO Polyoxyethylen(20)oleylalkohol, Polyoxyethylen(20)oleylether15.3 C12 fatty amines polyoxyethylated with 12 moles EO polyoxyethylene (20) oleyl alcohol, polyoxyethylene (20) oleyl ether
15.4 Polyoxyethylen(20)stearylcetylether (z. B. Eumulgin B 2 (Ceteareth-20))15.4 polyoxyethylene (20) stearyl cetyl ether (eg eumulgin B 2 (ceteareth-20))
15,5 Polyoxyethylen(20)stearylalkohol15.5% polyoxyethylene (20) stearyl alcohol
15.6 Polyoxyethylenglycol(1000)monostearat Polyoxyethylen(20)sorbitanmonopalmitat15.6 Polyoxyethylene glycol (1000) Monostearate Polyoxyethylene (20) sorbitan monopalmitate
15,7 Polyoxyethylen(20)cetylether15.7 polyoxyethylene (20) cetyl ether
15,9 Dinatriumtriethanolamindistearylheptaglycolethersulfosuccinat15.9 disodium triethanolamine stearylheptaglycol ether sulfosuccinate
16,0 Nonylphenol ethoxyliert mit 20 Mol EO16.0 nonylphenol ethoxylated with 20 moles of EO
Polyoxyethylen(25)propylenglycolstearat 16 - 16,8 Polyoxyethylen(30)monostearat 16,3-16,9 Polyoxyethylen(40)monostearatPolyoxyethylene (25) propylene glycol stearate 16 - 16.8 polyoxyethylene (30) monostearate 16.3-16.9 polyoxyethylene (40) monostearate
16.5 - 16,7 Polyoxyethylen(20)sorbitanmonolaurat (z. B. Eumulgin SML 20)16.5 - 16.7 polyoxyethylene (20) sorbitan monolaurate (eg Eumulgin SML 20)
16.6 Polyoxyethylen(20)sorbit16.6 Polyoxyethylene (20) sorbitol
16.7 C18-Fettamine, polyoxyethyliert mit 5 Mol EO Polyoxyethylen(23)laurylalkohol16.7 C18 fatty amines polyoxyethylated with 5 moles EO polyoxyethylene (23) lauryl alcohol
17.0 Ceteareth-30, z. B. Eumulgin B 3 Octylglucosid (Triton CG 110) Polyoxyethylen(30)glycerylmonolaurat17.0 Ceteareth-30, z. B. Eumulgin B 3 Octylglucoside (Triton CG 110) Polyoxyethylene (30) glyceryl monolaurate
17.1 Nonylphenol, ethoxyliert mit 30 Mol EO 17,4 Polyoxyethylen(40)stearylalkohol17.1 Nonylphenol ethoxylated with 30 moles EO 17.4 polyoxyethylene (40) stearyl alcohol
Weitere bevorzugte erfindungsgemäße Zusammensetzungen sind dadurch gekennzeichnet, dass der Gesamtgehalt an nichtionischen und ionischen Emulgatoren und/oder Tensiden mit einem HLB-Wert über 8 maximal 20 Gew.-%, bevorzugt maximal 15 Gew.-%, besonders bevorzugt maximal 10 Gew.- %, besonders bevorzugt maximal 7 Gew.-%, weiterhin besonders bevorzugt maximal 4 Gew.-% und außerordentlich bevorzugt maximal 3 Gew.-%, jeweils bezogen auf die gesamte erfindungsgemäße Zusammensetzung, beträgt.Further preferred compositions according to the invention are characterized in that the total content of nonionic and ionic emulsifiers and / or surfactants having an HLB value more than 8 not more than 20% by weight, preferably not more than 15% by weight, more preferably not more than 10% by weight, more preferably not more than 7% by weight, still more preferably not more than 4% by weight and exceptionally preferably not more than 3% by weight .-%, in each case based on the total composition of the invention is.
Öleoils
Bevorzugte erfindungsgemäße Zusammensetzungen, die als Emulsion, Suspension oder Stift vorliegen, enthalten bevorzugt weiterhin mindestens ein bei 20 ° C flüssiges Öl, das keine Duftstoffkompo- nente und kein etherisches Öl darstellt. Erfindungsgemäß bevorzugte Öle sind ausgewählt aus verzweigten gesättigten oder ungesättigten Fettalkoholen mit 6 - 30 Kohlenstoffatomen. Diese Alkohole werden häufig auch als Guerbet-Alkohole bezeichnet, da sie nach der Guerbet-Reaktion erhältlich sind. Bevorzugte Alkoholöle sind Hexyldecanol (Eutanol® G 16, Guerbitol® T 16), Octyldodecanol (Eutanol® G, Guerbitol® 20), 2-Ethylhexylalkohol und die Handelsprodukte Guerbitol® 18, Isofol® 12, Isofol® 16, Isofol® 24, Isofol® 36, Isocarb® 12, Isocarb® 16 oder Isocarb® 24. Weitere bevorzugte Öl- komponenten sind Mischungen aus Guerbetalkoholen und Guerbetalkoholestern, z.B. das Handelsprodukt Cetiol® PGL (Hexyldecanol und Hexyldecyllaurat).Preferred compositions according to the invention, which are present as emulsion, suspension or stick, preferably furthermore contain at least one oil which is liquid at 20 ° C. and which does not represent a perfume component and does not represent an essential oil. Oils preferred according to the invention are selected from branched saturated or unsaturated fatty alcohols having 6 to 30 carbon atoms. These alcohols are also often referred to as Guerbet alcohols, as they are obtainable by the Guerbet reaction. Preferred alcohol oils are Hexyldecanol (Eutanol ® G 16, Guerbitol ® T 16) Octyldodecanol (Eutanol ® G, Guerbitol ® 20), 2-ethylhexyl alcohol and the commercial products Guerbitol ® 18, Isofol ® 12, Isofol ® 16, Isofol ® 24, Isofol ® 36, Isocarb 12 ®, ® Isocarb 16 or Isocarb ® 24. Further preferred oil components are mixtures of Guerbet alcohols and Guerbet alcohol esters, for example the commercial product Cetiol ® PGL (hexyldecanol and hexyldecyl laurate).
Weitere erfindungsgemäß bevorzugte Öle sind ausgewählt aus den Triglyceriden von linearen oder verzweigten, gesättigten oder ungesättigten, gegebenenfalls hydroxylierten C8-3o-Fettsäuren. Besonders geeignet kann die Verwendung natürlicher Öle, z.B. Sojaöl, Baumwollsaatöl, Sonnenblumenöl, Palmöl, Palmkernöl, Leinöl, Mandelöl, Rizinusöl, Maisöl, Olivenöl, Rapsöl, Sesamöl, Distelöl, Weizen- keimöl, Pfirsichkernöl und die flüssigen Anteile des Kokosöls und dergleichen sein. Geeignet sind aber auch synthetische Triglyceridöle, insbesondere Capric/Caprylic Triglycerides, z. B. die Handelsprodukte Myritol® 318, Myritol® 331 (Cognis) oder Miglyol® 812 (Hüls) mit unverzweigten Fettsäureresten sowie Glyceryltriisostearin und die Handelsprodukte Estol® GTEH 3609 (Uniqema) oder Myritol® GTEH (Cognis) mit verzweigten Fettsäureresten.Further according to the invention preferred oils are selected from the triglycerides of linear or branched, saturated or unsaturated, optionally hydroxylated C 8 - 3 o-fatty acids. Particularly suitable may be the use of natural oils, for example soybean oil, cottonseed oil, sunflower oil, palm oil, palm kernel oil, linseed oil, almond oil, castor oil, corn oil, olive oil, rapeseed oil, sesame oil, thistle oil, wheat germ oil, peach kernel oil and the liquid portions of coconut oil and the like. But are also synthetic triglyceride oils, in particular Capric / Caprylic triglycerides, z. As the commercial products Myritol ® 318, Myritol ® 331 (Cognis) or Miglyol ® 812 (Hüls) with unbranched fatty acid residues and glyceryl triisostearin and the commercial products Estol ® GTEH 3609 (Uniqema) or Myritol ® GTEH (Cognis) with branched fatty acid residues.
Weitere erfindungsgemäß besonders bevorzugte Öle sind ausgewählt aus den Dicarbonsäureestern von linearen oder verzweigten C2-Ci0-Alkanolen, insbesondere Diisopropyladipat, Di-n-butyladipat, Di- (2-ethylhexyl)adipat, Dioctyladipat, Diethyl-/Di-n-butyl/Dioctylsebacat, Diisopropylsebacat, Dioctylmalat, Dioctylmaleat, Dicaprylylmaleat, Diisooctylsuccinat, Di-2-ethylhexylsuccinat und Di-(2-hexyldecyl)- succinat.Further according to the invention particularly preferred oils are selected from the dicarboxylic acid esters of linear or branched C 2 -C 0 alkanols, especially diisopropyl adipate, di-n-butyl adipate, di- (2-ethylhexyl) adipate, dioctyl adipate, diethyl / di-n-butyl / Dioctyl sebacate, diisopropyl sebacate, dioctyl malate, dioctyl maleate, dicaprylyl maleate, diisooctyl succinate, di-2-ethylhexyl succinate and di (2-hexyldecyl) succinate.
Weitere erfindungsgemäß besonders bevorzugte Öle sind ausgewählt aus den Anlagerungsprodukten von 1 bis 5 Propylenoxid-Einheiten an ein- oder mehrwertige C8-22-Alkanole wie Octanol, Decanol, Decandiol, Laurylalkohol, Myristylalkohol und Stearylalkohol, z. B. PPG-2-Myristylether und PPG-3- Myristylether (Witconol® APM).Further according to the invention particularly preferred oils are selected from the addition products of from 1 to 5 propylene oxide units onto mono- or polyhydric C 8-22 alkanols, such as octanol, decanol, decanediol, lauryl alcohol, myristyl alcohol and stearyl alcohol, eg. B. PPG-2 myristyl ether and PPG-3-myristyl ether (Witconol APM ®).
Weitere erfindungsgemäß bevorzugte Ölkomponenten sind ausgewählt aus den Estern der linearen oder verzweigten gesättigten oder ungesättigten Fettalkohole mit 2 - 30 Kohlenstoffatomen mit linearen oder verzweigten gesättigten oder ungesättigten Fettsäuren mit 2 - 30 Kohlenstoffatomen, die hydroxy- liert sein können. Dazu zählen Hexyldecylstearat (Eutanol G 16 S), Hexyldecyllaurat, Isodecylneopen- tanoat, Isononylisononanoat, 2-Ethylhexylpalmitat (Cegesoft® C 24) und 2-Ethylhexylstearat (Cetiol® 868). Ebenfalls bedingt geeignet sind Isopropylmyristat, Isopropylpalmitat, Isopropylstearat, Isopropyl- isostearat, Isopropyloleat, Isooctylstearat, Isononylstearat, Isocetylstearat, Isononylisononanoat, Isotri- decylisononanoat, Cetearylisononanoat, 2-Ethylhexyllaurat, 2-Ethylhexylisostearat, 2-Ethylhexylcocoat, 2-Octyldodecylpalmitat, Butyloctansäure-2-butyloctanoat, Diisotridecylacetat, n-Butylstearat, n-Hexyl- laurat, n-Decyloleat, Oleyloleat, Oleylerucat, Erucyloleat, Erucylerucat, Ethylenglycoldioleat und -dipal- mitat.Further oil components which are preferred according to the invention are selected from the esters of linear or branched saturated or unsaturated fatty alcohols having 2 to 30 carbon atoms with linear or branched saturated or unsaturated fatty acids having 2 to 30 carbon atoms, which are hydroxylated. can be liert. These include, hexyldecyl stearate (Eutanol G 16 S), hexyldecyl, Isodecylneopen- tanoat, isononyl isononanoate, 2-ethylhexyl palmitate (Cegesoft ® C 24) and 2-ethylhexyl stearate (Cetiol ® 868). Also suitably suitable are isopropyl myristate, isopropyl palmitate, isopropyl stearate, isopropyl isostearate, isopropyl oleate, isooctyl stearate, isononyl stearate, isocetyl stearate, isononyl isononanoate, isotridecyl isononanoate, cetearyl isononanoate, 2-ethylhexyl laurate, 2-ethylhexyl isostearate, 2-ethylhexyl cocoate, 2-octyldodecyl palmitate, butyloctanoic acid-2 butyl octanoate, diisotridecyl acetate, n-butyl stearate, n-hexyl laurate, n-decyl oleate, oleyl oleate, oleyl erucate, erucyl oleate, erucyl erucate, ethylene glycol dioleate and dipalmitate.
Weitere erfindungsgemäß bevorzugte Ölkomponenten sind ausgewählt aus den Anlagerungsprodukten von mindestens 6 Ethylenoxid und/oder Propylenoxid-Einheiten an ein- oder mehrwertige C3.22- Alkanole wie Butanol, Butandiol, Myristylalkohol und Stearylalkohol, z. B. PPG-14-Butylether (Ucon Fluid® AP), PPG-9-Butylether (Breox® B25), PPG-10-Butandiol (Macol® 57) und PPG-15-Stearylether (Arlamol® E).Further according to the invention preferred oil components are selected from the addition products of at least 6 ethylene oxide and / or propylene oxide units onto mono- or polyhydric C. 3 22 - alkanols such as butanol, butanediol, myristyl alcohol and stearyl alcohol, e.g. As PPG-14 butyl ether (Ucon Fluid ® AP), PPG-9-butyl ether (Breox B25 ®), PPG-10 butanediol (Macol ® 57) and PPG-15 stearyl ether (Arlamol ® E).
Weitere erfindungsgemäß bevorzugte Ölkomponenten sind ausgewählt aus den C8-C22-Fettalkohol- estern einwertiger oder mehrwertiger C2-C7-Hydroxycarbonsäuren, insbesondere die Ester der Glycol- säure, Milchsäure, Äpfelsäure, Weinsäure, Citronensäure und Salicylsäure. Solche Ester auf Basis von linearen C14/-i5-Alkanolen, z. B. C-i∑-C-is-Alkyllactat, und von in 2-Position verzweigten C12/i3-Alkanolen sind unter dem Warenzeichen Cosmacol® von der Firma Nordmann, Rassmann GmbH & Co, Hamburg, zu beziehen, insbesondere die Handelsprodukte Cosmacol® ESI, Cosmacol® EMI und Cosmacol® ETI.Further oil components preferred according to the invention are selected from the C 8 -C 22 -fatty alcohol esters of monohydric or polyhydric C 2 -C 7 -hydroxycarboxylic acids, in particular the esters of glycolic acid, lactic acid, malic acid, tartaric acid, citric acid and salicylic acid. Such esters based on linear C 14 / -i 5 alkanols, eg. B. Ci Σ -C -is-alkyl lactate, and of branched in the 2-position C 12 / i 3 alkanols are under the trademark Cosmacol ® by Nordmann, Rassmann GmbH & Co, Hamburg, to obtain, especially the commercial products Cosmacol ® ESI, Cosmacol® ® EMI and Cosmacol® ® EIT.
Weitere erfindungsgemäß bevorzugte Ölkomponenten sind ausgewählt aus den symmetrischen, unsymmetrischen oder cyclischen Estern der Kohlensäure mit Fettalkoholen, z. B. Glycerincarbonat, Dicaprylylcarbonat (Cetiol® CC) oder die Ester der DE 197 56 454 A1.Further inventively preferred oil components are selected from the symmetrical, asymmetrical or cyclic esters of carbonic acid with fatty alcohols, eg. As glycerol carbonate, dicaprylyl (Cetiol ® CC) or the esters of DE 197 56 454 A1.
Weitere erfindungsgemäß bevorzugte Ölkomponenten sind ausgewählt aus den Estern von Dimeren ungesättigter Ci2-C22-Fettsäuren (Dimerfettsäuren) mit einwertigen linearen, verzweigten oder cyclischen C2-Ci8-Alkanolen oder mit mehrwertigen linearen oder verzweigten C2-C6-Alkanolen. Es kann erfindungsgemäß außerordentlich bevorzugt sein, Mischungen der vorgenannten Öle einzusetzen.Further preferred oil components according to the invention are selected from the esters of dimers of unsaturated C 2 -C 22 -fatty acids (dimer fatty acids) with monovalent linear, branched or cyclic C 2 -C 8 -alkanols or with polyvalent linear or branched C 2 -C 6 -alkanols. It may be extraordinarily preferred according to the invention to use mixtures of the abovementioned oils.
Weitere erfindungsgemäß bevorzugte Ölkomponenten sind ausgewählt aus Siliconölen und Kohlenwasserstoffölen.Further oil components preferred according to the invention are selected from silicone oils and hydrocarbon oils.
Erfindungsgemäß bevorzugte Siliconöle sind ausgewählt aus Dialkyl- und Alkylarylsiloxanen, zu denen beispielsweise Dimethylpolysiloxan und Methylphenylpolysiloxan, aber auch Hexamethyldisiloxan, Octamethyltrisiloxan und Decamethyltetrasiloxan zählen.Silicone oils preferred according to the invention are selected from dialkyl and alkylaryl siloxanes, which include, for example, dimethylpolysiloxane and methylphenylpolysiloxane, but also hexamethyldisiloxane, octamethyltrisiloxane and decamethyltetrasiloxane.
Weitere erfindungsgemäß bevorzugte Siliconöle sind ausgewählt aus flüchtigen Siliconölen, die cyclisch sein können, wie z. B. Octamethylcyclotetrasiloxan, Decamethylcyclopentasiloxan und Dodecamethylcyclohexasiloxan sowie Mischungen hiervon, wie sie z. B. in den Handelsprodukten DC 244, 245, 344 und 345 von Dow Corning enthalten sind, oder linear, z. B. Hexamethyldisiloxan (L2), Octamethyltrisiloxan (L3), Decamethyltetrasiloxan (L4), beliebige Zweier- und Dreiermischungen aus L2, L3 und/oder L4, wie sie z. B. in den Handelsprodukten DC 2-1 184, Dow Corning® 200 (0, 65 cSt) und Dow Corning® 200 (1 ,5 cSt) von Dow Corning enthalten sind.Further inventively preferred silicone oils are selected from volatile silicone oils which may be cyclic, such as. For example, octamethylcyclotetrasiloxane, decamethylcyclopentasiloxane and dodecamethylcyclohexasiloxane and mixtures thereof, as described for. B. in the commercial products DC 244, 245, 344 and 345 of Dow Corning, or linear, z. Hexamethyldisiloxane (L 2 ), Octamethyltrisiloxane (L 3 ), decamethyltetrasiloxane (L 4 ), any two and three mixtures of L 2 , L 3 and / or L 4 , as described for. In the commercial products DC 2-1 184, Dow Corning® 200 (0.65 cSt) and Dow Corning® 200 (1.5 cSt) from Dow Corning.
Weitere erfindungsgemäß bevorzugte Siliconöle sind ausgewählt aus nichtflüchtigen höhermolekularen linearen Dimethylpolysiloxanen, im Handel erhältlich z. B. unter der Bezeichnung Dow Corning® 190, Dow Corning® 200 Fluid mit Viskositäten im Bereich von 5 - 100 cSt, bevorzugt 5 - 50 cSt oder auch 5 - 10 cSt, und Baysilon® 350 M.Further inventively preferred silicone oils are selected from non-volatile higher molecular weight linear dimethylpolysiloxanes, commercially available z. Example under the name Dow Corning ® 190, Dow Corning ® 200 fluid with viscosities ranging from 5 to 100 cSt, preferably of 5 - 50 cSt or 5 - 10 cSt, and Baysilon ® 350 M.
Erfindungsgemäß bevorzugte natürliche und synthetische Kohlenwasserstoffe sind ausgewählt aus Paraffinölen, Isohexadecan, Isoeicosan, Polyisobutenen und Polydecenen, die beispielsweise unter der Bezeichnung Emery® 3004, 3006, 3010 oder unter der Bezeichnung Ethylflo® von Albemarle oder Nexbase® 2004G von Nestle erhältlich sind, sowie 1 ,3-Di-(2-ethylhexyl)-cyclohexan (Cetiol®S). Besonders bevorzugte erfindungsgemäße Deodorant- oder Antitranspirant-Zusammensetzungen sind dadurch gekennzeichnet, dass das/die bei 20 0C flüssige/n Öl/e in einer Gesamtmenge von 0,1 - 80 Gew.-%, bevorzugt 2 - 20 Gew.-%, besonders bevorzugt 3 - 15 Gew.-%, jeweils bezogen auf das Gesamtgewicht der Zusammensetzung, enthalten ist/sind.According to the invention preferred natural and synthetic hydrocarbons are selected from paraffinic oils, isohexadecane, isoeicosane, polyisobutenes and polydecenes, the ®, for example, under the designation Emery ® 3004, 3006, 3010 or under the name Ethylflo ® from Albemarle or Nexbase 2004G from Nestle are available, as well as 1 , 3-di- (2-ethylhexyl) -cyclohexane (Cetiol ® S). Particularly preferred deodorant or antiperspirant compositions according to the invention are characterized in that the oil (s) liquid at 20 ° C. in a total amount of 0.1-80% by weight, preferably 2-20% by weight, particularly preferably 3-15% by weight, in each case based on the total weight of the composition, is / are contained.
In einer weiteren bevorzugten Ausführungsform der Erfindung weist ein Anteil der Ölkomponenten von mindestens 80 Gew.-% einen Brechungsindex nD von 1 ,39 - 1 ,51 auf. Besonders bevorzugt ist es, wenn 5 - 40 - 50 Gew.-%, außerordentlich bevorzugt 10 - 12 - 25 - 30 Gew.-% der Ölkomponenten einen Brechungsindex nD von 1 ,43 - 1 ,58, bevorzugt 1 ,44 - 1 ,51 , besonders bevorzugt 1 ,45 - 1 ,47 - 1 ,49, bei 20 0C (gemessen bei λ = 589 nm) aufweisen.In a further preferred embodiment of the invention, a proportion of the oil components of at least 80 wt .-%, a refractive index n D of 1, 39 - 1, 51 on. It is particularly preferred if 5 - 40 - 50 wt .-%, most preferably 10 - 12 - 25 - 30 wt .-% of the oil components have a refractive index n D of 1, 43 - 1, 58, preferably 1, 44 - 1 , 51, more preferably 1, 45 - 1, 47 - 1, 49, at 20 0 C (measured at λ = 589 nm) have.
Erfindungsgemäß besonders bevorzugte Zusammensetzungen enthalten weiterhin bevorzugt mindestens einen hautkühlenden Wirkstoff enthalten. Erfindungsgemäß geeignete hautkühlende Wirkstoffe sind beispielsweise Menthol, Isopulegol sowie Mentholderivate, z. B. Menthyllactat, Menthylglycolat, Menthylpyrrolidoncarbonsäure, Menthylmethylether, Menthoxypropandiol, Menthonglycerinacetal (9- Methyl-6-(1-methylethyl)-1 ,4- dioxaspiro (4.5)decan-2-methanol), Monomenthylsuccinat und 2-Hydro- xymethyl-3,5,5-trimethylcyclohexanol. Als hautkühlende Wirkstoffe bevorzugt sind Menthol, Isopulegol, Menthyllactat, Menthoxypropandiol und Menthylpyrrolidoncarbonsäure sowie Mischungen dieser Substanzen, insbesondere Mischungen von Menthol und Menthyllactat, Menthol, Mentholglycolat und Menthyllactat, Menthol und Menthoxypropandiol oder Menthol und Isopulegol.Compositions which are particularly preferred according to the invention furthermore preferably contain at least one skin-cooling active substance. Skin-cooling active ingredients suitable according to the invention are, for example, menthol, isopulegol and menthol derivatives, eg. Menthyl lactate, menthyl glycolate, menthyl pyrrolidone carboxylic acid, menthyl methyl ether, menthoxypropanediol, menthone glycerol acetal (9-methyl-6- (1-methylethyl) -1, 4-dioxaspiro (4.5) decane-2-methanol), monomethyl succinate and 2-hydroxymethyl-3 , 5.5-trimethylcyclohexanol. Preferred skin-cooling active ingredients are menthol, isopulegol, menthyl lactate, menthoxypropanediol and menthylpyrrolidonecarboxylic acid, and mixtures of these substances, in particular mixtures of menthol and menthyl lactate, menthol, menthol glycolate and menthyl lactate, menthol and menthoxypropanediol or menthol and isopulegol.
Erfindungsgemäß besonders bevorzugt ist, dass mindestens ein hautkühlender Wirkstoff in einer Gesamtmenge von 0,01 - 1 Gew.%, besonders bevorzugt 0,02 - 0,5 Gew.% und außerordentlich bevorzugt 0,05 - 0,2 - 0,3 Gew.%, jeweils bezogen auf das Gesamtgewicht der Zusammensetzung, enthalten ist.It is particularly preferred according to the invention for at least one skin-cooling active compound to be present in a total amount of 0.01-1% by weight, more preferably 0.02-0.5% by weight and most preferably 0.05-0.2-0.3% by weight %, in each case based on the total weight of the composition.
Erfindungsgemäß besonders bevorzugte Zusammensetzungen, die als treibgasgetriebenes Aerosol konfektioniert sind, enthalten mindestens ein Treibmittel. Bevorzugte Treibmittel (Treibgase) sind Propan, Propen, n-Butan, iso-Butan, iso-Buten, n-Pentan, Penten, iso-Pentan, iso-Penten, Methan, Ethan, Dimethylether, Stickstoff, Luft, Sauerstoff, Lachgas, 1 ,1 ,1 ,3-Tetrafluorethan, Heptafluoro-n-pro- pan, Perfluorethan, Monochlordifluormethan, 1 ,1-Difluorethan (INCI: Hydrofluorocarbon 152a), und zwar sowohl einzeln als auch in Kombination. Auch hydrophile Treibgase, wie z. B. Kohlendioxid, können vorteilhaft im Sinne der vorliegenden Erfindung eingesetzt werden, wenn der Anteil an hydrophilen Gasen gering gewählt wird und lipophiles Treibgas (z. B. Propan/Butan) im Überschuss vorliegt. Besonders bevorzugt sind Propan, n-Butan, iso-Butan sowie Mischungen dieser Treibgase. Es hat sich gezeigt, dass der Einsatz von n-Butan als einzigem Treibgas erfindungsgemäß besonders bevorzugt sein kann.Particularly preferred compositions according to the invention, which are formulated as a propellant-driven aerosol, contain at least one propellant. Preferred propellants (propellant gases) are Propane, propene, n-butane, isobutane, isobutene, n-pentane, pentene, iso-pentane, iso-pentene, methane, ethane, dimethyl ether, nitrogen, air, oxygen, nitrous oxide, 1, 1, 1, 3-tetrafluoroethane, heptafluoro-n-propane, perfluoroethane, monochlorodifluoromethane, 1,1-difluoroethane (INCI: hydrofluorocarbon 152a) both individually and in combination. Also hydrophilic propellants, such. As carbon dioxide, can be used advantageously in the context of the present invention, when the proportion of hydrophilic gases is selected low and lipophilic propellant gas (eg., Propane / butane) is present in excess. Particularly preferred are propane, n-butane, isobutane and mixtures of these propellants. It has been found that the use of n-butane as the only propellant gas according to the invention can be particularly preferred.
Die Menge der Treibmittel beträgt bevorzugt 20 - 80 - 90 Gew.-%, besonders bevorzugt 30 - 70 - 75 Gew.-% und außerordentlich bevorzugt 40 - 50 Gew.-%, jeweils bezogen auf das Gesamtgewicht der Zubereitung, bestehend aus der erfindungsgemäßen Zusammensetzung und dem Treibmittel.The amount of blowing agent is preferably 20-80-90% by weight, more preferably 30-70-75% by weight and most preferably 40-50% by weight, in each case based on the total weight of the preparation, consisting of the inventive composition Composition and the propellant.
Als Druckgasbehälter kommen Gefäße aus Metall (Aluminium, Weißblech, Zinn), geschütztem bzw. nicht-splitterndem Kunststoff oder aus Glas, das außen mit Kunststoff beschichtet ist, in Frage, bei deren Auswahl Druck- und Bruchfestigkeit, Korrosionsbeständigkeit, leichte Füllbarkeit wie auch ästhetische Gesichtspunkte, Handlichkeit, Bedruckbarkeit etc. eine Rolle spielen. Spezielle Innenschutz- lacke gewährleisten die Korrosionsbeständigkeit gegenüber der erfindungsgemäßen Zusammensetzung. Die erfindungsgemäßen Zusammensetzungen, die mit einem Treibmittel versprüht werden, können entweder direkt mit dem Treibmittel verpackt sein, oder aber in einem Mehrkammer-Behälter verpackt sein, in dem die erfindungsgemäße Zusammensetzung physikalisch getrennt vom Treibmittel vorliegt.As pressure gas container come vessels made of metal (aluminum, tinplate, tin), protected or non-splitterndem plastic or glass, which is coated with plastic outside, in question, in their selection pressure and fracture resistance, corrosion resistance, easy fillability as well as aesthetic Aspects, handiness, printability etc. play a role. Special internal protective lacquers ensure corrosion resistance to the composition according to the invention. The compositions of the present invention sprayed with a propellant may either be packaged directly with the propellant or packaged in a multichamber container in which the composition of the present invention is physically separate from the propellant.
Polyolepolyols
Bevorzugte erfindungsgemäße Zusammensetzungen enthalten weiterhin mindestens ein wasserlösliches mehrwertiges C2 - C9-Alkanol mit 2 - 6 Hydroxylgruppen und/oder mindestens ein wasserlösliches Polyethylenglycol mit 3 - 20 Ethylenoxid-Einheiten sowie Mischungen hiervon. Bevorzugt sind diese Komponenten ausgewählt aus 1 ,2-Propylenglycol, 2-Methyl-1 ,3-propandiol, Glycerin, Butylen- glycolen wie 1 ,2-Butylenglycol, 1 ,3-Butylenglycol und 1 ,4-Butylenglycol, Pentylenglycolen wie 1 ,2-Pen- tandiol und 1 ,5-Pentandiol, Hexandiolen wie 1 ,6-Hexandiol, Hexantriolen wie 1 ,2,6-Hexantriol, 1 ,2- Octandiol, 1 ,8-Octandiol, Dipropylenglycol, Tripropylenglycol, Diglycerin, Triglycerin, Erythrit, Sorbit sowie Mischungen der vorgenannten Substanzen. Geeignete wasserlösliche Polyethylenglycole sind ausgewählt aus PEG-3, PEG-4, PEG-6, PEG-7, PEG-8, PEG-9, PEG-10, PEG-12, PEG-14, PEG-16, PEG-18 und PEG-20 sowie Mischungen hiervon, wobei PEG-3 bis PEG-8 bevorzugt sind. Bevorzugte erfindungsgemäße Deodorant- oder Antitranspirant-Zusammensetzungen sind dadurch gekennzeichnet, dass das mindestens eine wasserlösliche mehrwertige C2 - C9-Alkanol mit 2 - 6 Hydroxylgruppen und/oder mindestens eine wasserlösliche Polyethylenglycol mit 3 - 20 Ethylenoxid- Einheiten ausgewählt ist aus 1 ,2-Propylenglycol, 2-Methyl-1 ,3-propandiol, Glycerin, Butylenglycolen wie 1 ,2-Butylenglycol, 1 ,3-Butylenglycol und 1 ,4-Butylenglycol, Pentylenglycolen wie 1 ,2-Pentandiol und 1 ,5-Pentandiol, Hexandiolen wie 1 ,6-Hexandiol, Hexantriolen wie 1 ,2,6-Hexantriol, 1 ,2-Octandiol, 1 ,8-Octandiol, Dipropylenglycol, Tripropylenglycol, Diglycerin, Triglycerin, Erythrit, Sorbit sowie Mischungen der vorgenannten Substanzen.Preferred compositions according to the invention also comprise at least one water-soluble polyhydric C 2 -C 9 -alkanol having 2-6 hydroxyl groups and / or at least one water-soluble polyethylene glycol having 3-20 ethylene oxide units and mixtures thereof. These components are preferably selected from 1,2-propylene glycol, 2-methyl-1,3-propanediol, glycerol, butylene glycols such as 1,2-butylene glycol, 1,3-butylene glycol and 1,4-butylene glycol, pentylene glycols such as 1, 2-pentanediol and 1, 5-pentanediol, hexanediols such as 1,6-hexanediol, hexanetriols such as 1, 2,6-hexanetriol, 1,2-octanediol, 1,8-octanediol, dipropylene glycol, tripropylene glycol, diglycerol, triglycerol, Erythritol, sorbitol and mixtures of the aforementioned substances. Suitable water-soluble polyethylene glycols are selected from PEG-3, PEG-4, PEG-6, PEG-7, PEG-8, PEG-9, PEG-10, PEG-12, PEG-14, PEG-16, PEG-18 and PEG-20 and mixtures thereof, with PEG-3 to PEG-8 being preferred. Preferred deodorant or antiperspirant compositions according to the invention are characterized in that the at least one water-soluble polyvalent C 2 -C 9 -alkanol having 2 to 6 hydroxyl groups and / or at least one water-soluble polyethylene glycol having 3 to 20 ethylene oxide Units selected from 1,2-propylene glycol, 2-methyl-1,3-propanediol, glycerol, butylene glycols such as 1,2-butylene glycol, 1,3-butylene glycol and 1,4-butylene glycol, pentylene glycols such as 1,2-pentanediol and 1, 5-pentanediol, hexanediols such as 1, 6-hexanediol, hexanetriols such as 1, 2,6-hexanetriol, 1, 2-octanediol, 1, 8-octanediol, dipropylene glycol, tripropylene glycol, diglycerol, triglycerol, erythritol, sorbitol and mixtures of aforementioned substances.
Besonders bevorzugte erfindungsgemäße Deodorant- oder Antitranspirant-Zusammensetzungen sind dadurch gekennzeichnet, dass das mindestens eine wasserlösliche mehrwertige C2 - C9-Alkanol mit 2 - 6 Hydroxylgruppen und/oder mindestens eine wasserlösliche Polyethylenglycol mit 3 - 20 Ethylenoxid-Einheiten insgesamt in Mengen von 3 - 30 Gew.-%, bevorzugt 8 - 25 Gew.-%, besonders bevorzugt 10 - 18 Gew.-%, jeweils bezogen auf die Gesamtzusammensetzung, enthalten ist.Particularly preferred deodorant or antiperspirant compositions according to the invention are characterized in that the at least one water-soluble polyhydric C 2 -C 9 -alkanol having 2 to 6 hydroxyl groups and / or at least one water-soluble polyethylene glycol having 3 to 20 ethylene oxide units in total amounts of 3 - 30 wt .-%, preferably 8 - 25 wt .-%, particularly preferably 10-18 wt .-%, each based on the total composition, is included.
Wasserwater
Bevorzugte erfindungsgemäße Zusammensetzungen enthalten Wasser. Der Anteil des Wassers beträgt bevorzugt 0,1 - 99 Gew.-%, besonders bevorzugt 3 bis 80 Gew.-%, außerordentlich bevorzugt 10 bis 70 Gew.-%, weiterhin bevorzugt 15 - 60 Gew.-%, 20 - 50 Gew.-%, 30 - 40 Gew.-%, jeweils bezogen auf die Gesamtzusammensetzung.Preferred compositions according to the invention contain water. The proportion of water is preferably 0.1-99 wt .-%, particularly preferably 3 to 80 wt .-%, most preferably 10 to 70 wt .-%, further preferably 15 - 60 wt .-%, 20 - 50 wt .-%, 30- 40 wt .-%, each based on the total composition.
Niedrigschmelzende Lipid- oder WachskomponenteLow-melting lipid or wax component
Besonders bevorzugte erfindungsgemäße Deodorant- oder Antitranspirant-Zusammensetzungen, insbesondere solche in Stiftform, sind dadurch gekennzeichnet, dass mindestens eine Wachskomponente mit einem Schmelzpunkt im Bereich von 25 - < 500C, ausgewählt aus Kokosfettsäureglycerin- mono-, -di- und -triestern, Butyrospermum Parkii (Shea Butter) und Estern von gesättigten, einwertigen C8-Ci8-Alkoholen mit gesättigten Ci2-Ci8-Monocarbonsäuren sowie Mischungen dieser Substanzen, enthalten ist. Diese niedriger schmelzenden Wachskomponenten ermöglichen eine Konsistenzoptimierung stiftförmiger oder cremeförmiger Produkte und eine Minimierung der sichtbaren Rückstände auf der Haut. Besonders bevorzugt sind Handelsprodukte mit der INCI-Bezeichnung Coco- glycerides, insbesondere die Handelsprodukte Novata® (ex Cognis), besonders bevorzugt Novata® AB, ein Gemisch aus C12-C18-Mono-, Di- und Triglyceriden, das im Bereich von 30 - 32°C schmilzt, sowie die Produkte der Softisan-Reihe (Sasol Germany GmbH) mit der INCI-Bezeichnung Hydrogena- ted Cocoglycerides, insbesondere Softisan 100, 133, 134, 138, 142. Weitere bevorzugte Ester von gesättigten, einwertigen C12-C18-Alkoholen mit gesättigten C12-C18-Monocarbonsäuren sind Stea- ryllaurat, Cetearylstearat (z. B. Crodamol® CSS), Cetylpalmitat (z. B. Cutina® CP) und Myristylmyristat (z. B. Cetiol® MM). Weitere besonders bevorzugte erfindungsgemäße Deodorant- oder Antitranspirant-Zusammensetzun- gen, insbesondere solche in Stiftform, sind dadurch gekennzeichnet, dass die mindestens eine Wachskomponente mit einem Schmelzpunkt im Bereich von 25 - < 500C in Mengen von 0,01 bis 20 Gew.-%, bevorzugt 3 - 20 Gew.-%, besonders bevorzugt 5 - 18 Gew.-% und außerordentlich bevorzugt 6 - 15 Gew.-%, bezogen auf die Gesamtzusammensetzung, enthalten ist.Particularly preferred according to the invention deodorant or antiperspirant compositions, particularly those in stick form, are characterized in that at least one wax component with a melting point in the range of 25 - <50 0 C, selected from Kokosfettsäureglycerin- mono-, di- and tri-esters, Butyrospermum Parkii (Shea butter) and esters of saturated, monohydric C 8 -C 8 -alcohols with saturated Ci 2 -Ci 8 monocarboxylic acids and mixtures of these substances. These lower melting wax components allow consistency optimization of sticky or creamy products and minimization of visible skin residue. Especially preferred are products sold under the INCI name coco glycerides, in particular the commercial products Novata ® (ex Cognis), particularly preferably Novata AB ®, a mixture of C 12 -C 18 mono-, di- and triglycerides, which in the range of 30-32 ° C, as well as the products of the Softisan series (Sasol Germany GmbH) with the INCI name Hydrogenated Cocoglycerides, in particular Softisan 100, 133, 134, 138, 142. Further preferred esters of saturated, monovalent C 12 -C 18 alcohols with saturated C 12 -C 18 monocarboxylic acids are stearic ryllaurat, cetearyl (z. B. Crodamol ® CSS), cetyl palmitate (z. B. Cutina ® CP) and myristyl myristate (z. B. Cetiol ® MM ). Further particularly preferred deodorant or antiperspirant according to the invention Zusammensetzun- gene, in particular those in stick form, are characterized in that the at least one wax component with a melting point in the range of 25 - <50 0 C in amounts of 0.01 to 20 weight %, preferably 3 - 20 wt .-%, particularly preferably 5 - 18 wt .-% and most preferably 6 - 15 wt .-%, based on the total composition, is included.
Füllstoffefillers
Besonders bevorzugte erfindungsgemäße Deodorant- oder Antitranspirant-Zusammensetzungen sind dadurch gekennzeichnet, dass sie zur Verbesserung der Stiftkonsistenz und der sensorischen Eigenschaften weiterhin mindestens einen festen, wasserunlöslichen teilchenförmigen Füllstoff enthalten. In einer außerordentlich bevorzugten Ausführungsform ist dieser Füllstoff ausgewählt aus gegebenenfalls modifizierten Stärken (z. B. aus Mais, Reis, Kartoffeln) und Stärkederivaten, die gewünschtenfalls vorverkleistert sind, insbesondere Stärkederivaten wie Aluminium Starch Octenylsuccinate (z. B. DRY FLO®) Sodium Starch Octenylsuccinate, Cellulose und Cellulosederivaten, Siliciumdioxid, Kieselsäuren, z. B. Aerosil®-Typen, sphärischen Polyalkylsesquisiloxan-Partikeln (insbesondere Aerosil® R972 und Aerosil® 200V von Degussa), Kieselgelen, Talkum, Kaolin, Tonen, z. B. Bentoniten, Magnesiumaluminiumsilikaten, Bornitrid, Lactoglobulinderivaten, z. B. Natrium-C8-i6-lsoalkylsuccinyllacto- globulinsulfonat, von Brooks Industries erhältlich als Handelsprodukt Biopol® OE, Glaspulvern, Polymerpulvern, insbesondere aus Polyolefinen, Polycarbonaten, Polyurethanen, Polyamiden, z. B. Nylon, Polyestern, Polystyrolen, Polyacrylaten, (Meth)acrylat- oder (Meth)acrylat-Vinyliden-Copolymeren, die vernetzt sein können, oder Siliconen, sowie Mischungen dieser Substanzen.Particularly preferred deodorant or antiperspirant compositions according to the invention are characterized in that they further contain at least one solid, water-insoluble particulate filler for improving the pen consistency and the sensory properties. In a highly preferred embodiment of this filler is selected from optionally modified starches (for. Example, of corn, rice, potatoes) and starch derivatives, which are, if desired, pregelatinized, in particular starch derivatives, such as Aluminum Starch Octenylsuccinate (z. B. DRY FLO ®) Sodium Starch Octenyl succinates, cellulose and cellulose derivatives, silica, silicas, e.g. As Aerosil ® types, spherical Polyalkylsesquisiloxan particles (especially Aerosil ® R972 and Aerosil ® 200V from Degussa), silica gels, talc, kaolin, clays, z. Bentonites, magnesium aluminum silicates, boron nitride, lactoglobulin derivatives, e.g. B. Sodium-C 8 -i 6 -sloalkylsuccinyllacto- globulinsulfonat, available from Brooks Industries as a commercial product Biopol ® OE, glass powders, polymer powders, in particular from polyolefins, polycarbonates, polyurethanes, polyamides, eg. As nylon, polyesters, polystyrenes, polyacrylates, (meth) acrylate or (meth) acrylate-vinylidene copolymers, which may be crosslinked, or silicones, and mixtures of these substances.
Polymerpulver auf Basis eines Polymethacrylat-Copolymers sind z. B. als Handelsprodukt Polytrap® 6603 (Dow Corning) erhältlich. Andere Polymerpulver, z. B. auf Basis von Polyamiden, sind unter der Bezeichnung Orgasol® 1002 (Polyamid-6) und Orgasol® 2002 (Polyamid-12) von Elf Atochem erhältlich. Weitere Polymerpulver, die sich für den erfindungsgemäßen Zweck eignen, sind z. B. Polymeth- acrylate (Micropearl® M von SEPPIC oder Plastic Powder A von NIKKOL), Styrol-Divinylbenzol-Copo- lymeren (Plastic Powder FP von NIKKOL), Polyethylen- und Polypropylen-Pulver (ACCUREL® EP 400 von AKZO) oder auch Siliconpolymere (Silicone Powder X2-1605 von Dow Corning). Besonders bevorzugte erfindungsgemäße Deodorant- oder Antitranspirant-Zusammensetzungen sind dadurch gekennzeichnet, dass sie mindestens einen festen, wasserunlöslichen teilchenförmigen Füllstoff in einer Gesamtmenge von 0,01 bis 30 Gew.-%, bevorzugt 5 - 20 Gew.-%, besonders bevorzugt 8 - 15 Gew.-%, jeweils bezogen auf die Gesamtzusammensetzung, enthalten.Polymer powder based on a polymethacrylate copolymer are z. B. as a commercial product Polytrap ® 6603 (Dow Corning) available. Other polymer powders, e.g. Example based on polyamides, obtainable under the name Orgasol ® 1002 (polyamide-6) and Orgasol ® 2002 (polyamide-12) from Elf Atochem. Other polymer powders which are suitable for the purpose according to the invention are, for. B. polymethacrylic acrylates (Micro Pearl ® M from SEPPIC or Plastic Powder A of NIKKOL), styrene-divinylbenzene Copo- lymeren (Plastic Powder FP of NIKKOL), polyethylene and polypropylene powder (® ACCUREL EP 400 from AKZO) or Silicone polymers (Silicone Powder X2-1605 from Dow Corning). Particularly preferred deodorant or antiperspirant compositions according to the invention are characterized in that they contain at least one solid, water-insoluble particulate filler in a total amount of 0.01 to 30% by weight, preferably 5 to 20% by weight, more preferably 8 to 15 Wt .-%, each based on the total composition included.
Duftstoffefragrances
Besonders bevorzugte erfindungsgemäße Deodorant- oder Antitranspirant-Zusammensetzungen sind dadurch gekennzeichnet, dass weiterhin mindestens eine Duftstoffkomponente enthalten ist. Als Duftstoffkomponente können Parfüme, Parfümöle oder Parfümölbestandteile eingesetzt werden. Parfümöle bzw. Duftstoffe können erfindungsgemäß einzelne Riechstoffverbindungen, z. B. die synthetischen Produkte vom Typ der Ester, Ether, Aldehyde, Ketone, Alkohole und Kohlenwasserstoffe sein. Riechstoffverbindungen vom Typ der Ester sind z.B. Benzylacetat, Phenoxyethylisobutyrat, p-tert.- Butylcyclohexylacetat, Linalylacetat, Dimethylbenzylcarbinylacetat (DMBCA), Phenylethylacetat, Benzylacetat, Ethylmethylphenylglycinat, Allylcyclohexylpropionat, Styrallylpropionat, Benzylsalicylat, Cyclohexylsalicylat, Floramat, Melusat und Jasmecyclat. Zu den Ethern zählen beispielsweise Benzylethylether und Ambroxan , zu den Aldehyden z.B. die linearen Alkanale mit 8 - 18 C-Atomen, Citral, Citronellal, Citronellyloxy-acetaldehyd, Cyclamenaldehyd, Lilial und Bourgeonal, zu den Ketonen z.B. die Jonone, alpha-lsomethylionon und Methylcedrylketon, zu den Alkoholen Anethol, Citronellol, Eugenol, Geraniol, Linalool, Phenylethylalkohol und Terpineol, zu den Kohlenwasserstoffen gehören hauptsächlich die Terpene wie Limonen und Pinen. Bevorzugt werden jedoch Mischungen verschiedener Riechstoffe verwendet, die gemeinsam eine ansprechende Duftnote erzeugen. Solche Parfümöle können auch natürliche Riechstoffgemische enthalten, wie sie aus pflanzlichen Quellen zugänglich sind, z.B. Pine-, Citrus-, Jasmin-, Patchouly-, Rosen- oder Ylang-Ylang-Öl. Ebenfalls geeignet sind Muskateller-Salbeiöl, Kamillenöl, Nelkenöl, Melissenöl, Minzöl, Zimtblätteröl, Lindenblütenöl, Wacholderbeeröl, Vetiveröl, Olibanumöl, Galbanumöl und Labdanumöl sowie Orangenblütenöl, Neroliöl, Orangenschalenöl und Sandelholzöl.Particularly preferred deodorant or antiperspirant compositions according to the invention are characterized in that furthermore at least one perfume component is contained. As perfume component perfumes, perfume oils or perfume oil ingredients can be used. Perfume oils or fragrances can according to the invention individual fragrance compounds, eg. As the synthetic products of the ester type, ethers, aldehydes, ketones, alcohols and hydrocarbons. Fragrance compounds of the ester type are, for example, benzyl acetate, phenoxyethyl isobutyrate, p-tert-butylcyclohexyl acetate, linalyl acetate, dimethylbenzylcarbinyl acetate (DMBCA), phenylethyl acetate, benzyl acetate, ethylmethylphenylglycinate, allylcyclohexylpropionate, styrallylpropionate, benzylsalicylate, cyclohexylsalicylate, floramate, melusate and jasmecyclate. The ethers include, for example, benzyl ethyl ether and ambroxane, to the aldehydes, for example, the linear alkanals with 8 - 18 carbon atoms, citral, citronellal, citronellyloxy-acetaldehyde, cyclamen aldehyde, lilial and bourgeonal, to the ketones such as the Jonone, alpha-lsomethylionon and Methylcedrylketon , the alcohols include anethole, citronellol, eugenol, geraniol, linalool, phenylethyl alcohol and terpineol, the hydrocarbons mainly include the terpenes such as limonene and pinene. Preferably, however, mixtures of different fragrances are used, which together produce an attractive fragrance. Such perfume oils may also contain natural fragrance mixtures as are available from vegetable sources, eg pine, citrus, jasmine, patchouly, rose or ylang-ylang oil. Also suitable are Muskateller sage oil, chamomile oil, clove oil, lemon balm oil, mint oil, cinnamon leaf oil, lime blossom oil, juniper berry oil, vetiver oil, olibanum oil, galbanum oil and labdanum oil and orange blossom oil, neroli oil, orange peel oil and sandalwood oil.
Um wahrnehmbar zu sein, muss ein Riechstoff flüchtig sein, wobei neben der Natur der funktionellen Gruppen und der Struktur der chemischen Verbindung auch die Molmasse eine wichtige Rolle spielt. So besitzen die meisten Riechstoffe Molmassen bis etwa 200 Dalton, während Molmassen von 300 Dalton und darüber eher eine Ausnahme darstellen. Aufgrund der unterschiedlichen Flüchtigkeit von Riechstoffen verändert sich der Geruch eines aus mehreren Riechstoffen zusammengesetzten Parfüms bzw. Duftstoffs während des Verdampfens, wobei man die Geruchseindrücke in „Kopfnote" (top note), „Herz- bzw. Mittelnote" (middle note bzw. body) sowie „Basisnote" (end note bzw. dry out) unterteilt. Da die Geruchswahrnehmung zu einem großen Teil auch auf der Geruchsintensität beruht, besteht die Kopfnote eines Parfüms bzw. Duftstoffs nicht allein aus leichtflüchtigen Verbindungen, während die Basisnote zum größten Teil aus weniger flüchtigen, d.h. haftfesten Riechstoffen besteht. Bei der Komposition von Parfüms können leichter flüchtige Riechstoffe beispielsweise an bestimmte Fixative gebunden werden, wodurch ihr zu schnelles Verdampfen verhindert wird. Bei der nachfolgenden Einteilung der Riechstoffe in „leichter flüchtige" bzw. „haftfeste" Riechstoffe ist also über den Geruchseindruck und darüber, ob der entsprechende Riechstoff als Kopf- oder Herznote wahrgenommen wird, nichts ausgesagt.In order to be perceptible, a fragrance must be volatile, whereby besides the nature of the functional groups and the structure of the chemical compound, the molecular weight also plays an important role. For example, most odorants have molecular weights up to about 200 daltons, while molecular weights of 300 daltons and above are more of an exception. Due to the different volatility of fragrances, the smell of a perfume or fragrance composed of several fragrances changes during evaporation, whereby the odor impressions in "top note", "middle note or body" As the smell perception is based to a large extent on the odor intensity, the top note of a perfume or fragrance consists not only of volatile compounds, while the base note for the most part from less volatile In the composition of perfumes, for example, volatile fragrances can be bound to certain fixatives, which prevents them from evaporating too quickly the smell impression and on whether the corre sponding is perceived as the head or middle note, nothing said.
Haftfeste Riechstoffe, die im Rahmen der vorliegenden Erfindung einsetzbar sind, sind beispielsweise die ätherischen Öle wie Angelikawurzelöl, Anisöl, Arnikablütenöl, Basilikumöl, Bayöl, Bergamottöl, Champacablütenöl, Edeltannenöl, Edeltannenzapfenöl, Elemiöl, Eukalyptusöl, Fenchelöl, Fichten- nadelöl, Galbanumöl, Geraniumöl, Gingergrasöl, Guajakholzöl, Gurjunbalsamöl, Helichrysumöl, Ho-Öl, Ingweröl, Irisöl, Kajeputöl, Kalmusöl, Kamillenöl, Kampferöl, Kanagaöl, Kardamomenöl, Kassiaöl, Kiefernnadelöl, Kopaϊvabalsamöl, Korianderöl, Krauseminzeöl, Kümmelöl, Kuminöl, Lavendelöl, Lemongrasöl, Limetteöl, Mandarinenöl, Melissenöl, Moschuskörneröl, Myrrhenöl, Nelkenöl, Neroliöl, Niaouliöl, Olibanumöl, Orangenöl, Origanumöl, Palmarosaöl, Patschuliöl, Perubalsamöl, Petitgrainöl, Pfefferöl, Pfefferminzöl, Pimentöl, Pine-Öl, Rosenöl, Rosmarinöl, Sandelholzöl, Sellerieöl, Spiköl, Sternanisöl, Terpentinöl, Thujaöl, Thymianöl, Verbenaöl, Vetiveröl, Wacholderbeeröl, Wermutöl, Wintergrünöl, Ylang-Ylang-Öl, Ysop-Öl, Zimtöl, Zimtblätteröl, Zitronellöl, Zitronenöl sowie Zypressenöl. Aber auch die höhersiedenden bzw. festen Riechstoffe natürlichen oder synthetischen Ursprungs können im Rahmen der vorliegenden Erfindung als haftfeste Riechstoffe bzw. Riechstoffgemische, also Duftstoffe, eingesetzt werden. Zu diesen Verbindungen zählen die nachfolgend genannten Verbindungen sowie Mischungen aus diesen: Ambrettolid, α-Amylzimtaldehyd, Anethol, Anisaldehyd, Anisalkohol, Anisol, Anthranilsäuremethylester, Acetophenon, Benzylaceton, Benzaldehyd, Benzoesäure- ethylester, Benzophenon, Benzylakohol, Benzylacetat, Benzylbenzoat, Benzylformiat, Benzylvaleria- nat, Borneol, Bornylacetat, α-Bromstyrol, n-Decylaldehyd, n-Dodecylaldehyd, Eugenol, Eugenolmethyl- ether, Eukalyptol, Farnesol, Fenchon, Fenchylacetat, Geranylacetat, Geranylformiat, Heliotropin, Heptincarbonsäuremethylester, Heptaldehyd, Hydrochinon-Dimethylether, Hydroxyzimtaldehyd, Hydroxyzimtalkohol, Indol, Iron, Isoeugenol, Isoeugenolmethylether, Isosafrol, Jasmon, Kampfer, Karvakrol, Karvon, p-Kresolmethylether, Cumarin, p-Methoxyacetophenon, Methyl-n-amylketon, Methylanthranilsäuremethylester, p-Methylacetophenon, Methylchavikol, p-Methylchinolin, Methyl-ß- naphthylketon, Methyl-n-nonylacetaldehyd, Methyl-n-nonylketon, Muskon, ß-Naphtholethylether, ß- Naphtholmethylether, Nerol, Nitrobenzol, n-Nonylaldehyd, Nonylakohol, n-Octylaldehyd, p-Oxy-Aceto- phenon, Pentadekanolid, ß-Phenylethylakohol, Phenylacetaldehyd-Dimethyacetal, Phenylessigsäure, Pulegon, Safrol, Salicylsäureisoamylester, Salicylsäuremethylester, Salicylsäurehexylester, Salicyl- säurecyclohexylester, Santalol, Skatol, Terpineol, Thymen, Thymol, γ-Undelacton, Vanilin, Veratrumaldehyd, Zimtaldehyd, Zimatalkohol, Zimtsäure, Zimtsäureethylester, Zimtsäurebenzylester. Zu den leichter flüchtigen Riechstoffen zählen insbesondere die niedriger siedenden Riechstoffe natürlichen oder synthetischen Ursprungs, die allein oder in Mischungen eingesetzt werden können. Beispiele für leichter flüchtige Riechstoffe sind Alkylisothiocyanate (Alkylsenföle), Butandion, Limonen, Linalool, Linaylacetat und -propionat, Menthol, Menthon, Methyl-n-heptenon, Phellandren, Phenylacet- aldehyd, Terpinylacetat, Zitral, Zitronellal.Adhesive-resistant fragrances which can be used in the context of the present invention are, for example, the essential oils such as angelica root oil, aniseed oil, arnica blossom oil, basil oil, bay oil, bergamot oil, Champacablütenöl, Edeltannenöl, Edeltannenzapfen oil, Elemiöl, eucalyptus oil, fennel oil, spruce needle oil, galbanum oil, geranium oil, Ginger Grass Oil, Guaiac Wood Oil, Gurjun Balm Oil, Helichrysum Oil, Ho Oil, Ginger oil, iris oil, cajeput oil, calamus oil, chamomile oil, camphor oil, kanaga oil, cardamom oil, cassia oil, pine oil, copaϊvabalsam oil, coriander oil, spearmint oil, caraway oil, cumin oil, lavender oil, lemongrass oil, lime oil, tangerine oil, lemon balm oil, musk kernel oil, myrrh oil, clove oil, neroli oil, niaouli oil, Olibanum Oil, Orange Oil, Origanum Oil, Palmarosa Oil, Patchouli Oil, Peru Balsam Oil, Petitgrain Oil, Pepper Oil, Peppermint Oil, Pimento Oil, Pine Oil, Rose Oil, Rosemary Oil, Sandalwood Oil, Celery Oil, Spik Oil, Star Aniseed Oil, Turpentine Oil, Thuja Oil, Thyme Oil, Verbena Oil, Vetiver Oil, Juniper Berry Oil, Vermouth Oil, Wintergreen oil, ylang-ylang oil, hyssop oil, cinnamon oil, cinnamon oil, lemon oil, lemon oil and cypress oil. But also the higher-boiling or solid fragrances of natural or synthetic origin can be used in the context of the present invention as adherent fragrances or fragrance mixtures, ie fragrances. These compounds include the following compounds and mixtures thereof: ambrettolide, α-amylcinnamaldehyde, anethole, anisaldehyde, anisalcohol, anisole, methyl anthranilate, acetophenone, benzylacetone, benzaldehyde, benzoic acid ethyl ester, benzophenone, benzyl alcohol, benzyl acetate, benzyl benzoate, benzyl formate, benzyl valeria nat, borneol, bornyl acetate, α-bromostyrene, n-decyl aldehyde, n-dodecyl aldehyde, eugenol, eugenol methyl ether, eucalyptol, farnesol, fenchone, fenchyl acetate, geranyl acetate, geranyl formate, heliotropin, heptincarboxylic acid methyl ester, heptaldehyde, hydroquinone dimethyl ether, hydroxycinnamaldehyde, hydroxycinnamyl alcohol , Indole, iron, isoeugenol, isoeugenol methyl ether, isosafrole, jasmone, camphor, karvakrol, karvon, p-cresol methyl ether, coumarin, p-methoxyacetophenone, methyl n-amyl ketone, methyl anthranilate, p-methylacetophenone, methylchavikole, p-methylquinoline, methyl-β naphthyl ketone, methyl n-nonyl acetaldehyde, methyl n-nonyl ketone, Muskon , β-naphtholethyl ether, β-naphthol methyl ether, nerol, nitrobenzene, n-nonyl aldehyde, nonyl alcohol, n-octyl aldehyde, p-oxyacetophenone, pentadecanolide, β-phenylethyl alcohol, phenylacetaldehyde dimethyacetal, phenylacetic acid, pulegone, safrole, salicylic acid isoamyl ester, methyl salicylate , Salicylic acid hexyl ester, cyclohexyl salicylate, santalol, skatole, terpineol, thymes, thymol, γ-undelactone, vanilin, veratrum aldehyde, cinnamaldehyde, cimat alcohol, cinnamic acid, cinnamic acid ethyl ester, cinnamic acid benzyl ester. The more volatile fragrances include in particular the lower-boiling fragrances of natural or synthetic origin, which can be used alone or in mixtures. Examples of more readily volatile fragrances are alkyl isothiocyanates (alkyl mustard oils), butanedione, limonene, linalool, linayl acetate and propionate, menthol, menthone, methyl-n-heptenone, phellandrene, phenylacetaldehyde, terpinyl acetate, citral, citronellal.
Besonders bevorzugte erfindungsgemäße Deodorant- oder Antitranspirant-Zusammensetzungen sind dadurch gekennzeichnet, dass mindestens eine Duftstoffkomponente in einer Gesamtmenge von 0,00001 bis 4 Gew.-%, bevorzugt 0,5 - 2 Gew.-%, jeweils bezogen auf die Gesamtzusammensetzung, enthalten ist. Weitere erfindungsgemäß bevorzugte kosmetische oder dermatologische Zusammensetzungen sind dadurch gekennzeichnet, dass sie zusätzlich zu der Zweierkombination aus a) mindestens einem Deodorant- oder Antitranspirant-Wirkstoff und b) mindestens einem Wirkstoff, ausgewählt aus mindestens einem Yoghurt-Protein und/oder mindestens einem Hydrolysat eines Yoghurt-Proteins und/oder mindestens einem N-C2-C24-Acylderivat und/oder mindestens einem C2-C24-Ester und/oder mindestens einem physiologisch verträglichen Salz dieser Protein-Wirkstoffe, sowie Mischungen dieser Protein- Wirkstoffe, mindestens einen weiteren hautberuhigenden Wirkstoff enthalten.Particularly preferred deodorant or antiperspirant compositions according to the invention are characterized in that at least one perfume component is contained in a total amount of 0.00001 to 4 wt .-%, preferably 0.5 to 2 wt .-%, each based on the total composition , Further inventively preferred cosmetic or dermatological compositions are characterized in that in addition to the combination of two of a) at least one deodorant or antiperspirant active ingredient and b) at least one active ingredient selected from at least one yoghurt protein and / or at least one hydrolyzate of a yoghurt -Proteins and / or at least one NC 2 -C 24 acyl derivative and / or at least one C 2 -C 24 ester and / or at least one physiologically acceptable salt of these protein drugs, as well as mixtures of these protein drugs, at least one further skin-soothing Active ingredient included.
Überraschend wurde festgestellt, dass die hautberuhigende Wirkung bekannter Wirkstoffe durch Yoghurt-Protein(hydrolysat)/e und deren Derivate in unerwartetem Ausmaß gesteigert und verbessert werden konnte.Surprisingly, it was found that the skin-soothing effect of known active ingredients could be increased and improved to an unexpected extent by yoghurt protein (hydrolyzate) / s and its derivatives.
Erfindungsgemäß bevorzugte hautberuhigende Wirkstoffe sind ausgewählt aus Allantoin, α-Bisabolol, α-Liponsäure, Extrakten aus Centella asiatica, beispielsweise erhältlich unter der Bezeichnung Madecassicoside von DSM, Glycyrrethinsäure, die besonders bevorzugt in Liposomen verkapselt vorliegt und in dieser Form z. B. unter dem Handelsnamen Calmsphere von Soliance erhältlich ist, Mischungen aus Getreidewachsen, Extrakten aus Schibutter und Argania Spinosa-Öl mit der INCI- Bezeichnung „Spent grain wax and Butyrospermum Parkii (shea butter) extract and Argania Spinosa Kernel OiI", wie sie z. B. unter der Handelsbezeichnung Stimu-Tex AS von der Firma Pentapharm erhältlich sind, Extrakten aus Vanilla Tahitensis, wie sie z. B. unter der Handelsbezeichnung Vanirea (INCI : Vanilla Tahitensis Fruit Extract) von der Firma Solabia erhältlich sind, Alginhydrolysaten, wie sie z. B. unter der Handelsbezeichnung Phycosaccharide, insbesondere Phycosaccharide AI, von der Firma Codif erhältlich sind, Extrakten aus Bacopa Monniera, wie sie z. B. unter der Handelsbezeichnung Bacocalmine von der Firma Sederma erhältlich sind, Extrakten aus der Rooibos-Pflanze, wie sie z. B. unter dem Handelsnamen Rooibos Herbasec MPE von der Firma Cosmetochem erhältlich sind, Hefeextrakten, besonders bevorzugt das Handelsprodukt Drieline (INCI-Bezeichnung "Sorbitol, Yeast Extract"), erhältlich von der Firma Lanatech, den physiologisch verträglichen Salzen von Sterolsulfaten, wie sie z. B. unter dem Handelsnamen Phytocohesine (INCI: Sodium Beta-Sitosterylsulfate) von der Firma Vincience erhältlich sind, Aminodicarbonsäuren mit einer C-Kettenlänge von 3 - 6 Kohlenstoffatomen sowie deren physiologisch verträglichen Salzen, bevorzugt ausgewählt aus Aminomalon- säure, Aminobernsteinsäure (= Asparaginsäure), Aminoglutarsäure und Aminoadipinsäure sowie deren physiologisch verträglichen Salzen wie Kaliumaspartat und Magnesiumaspartat, Extrakten aus den Samen von Cucurbita pepo (Zucchini), Extrakten aus Mentha piperita, insbesondere aus den Blättern von Mentha piperita, N-acylierten Alkanolaminen, insbesondere N-Palmitoylethanolamin, Hydroly- saten und/oder Extrakten aus der Alge Enteromorpha compressa (Darmtang, eine Grünalge), insbesondere aus dem Vegetationskörper ("Phallus) der Alge, kommerziell erhältlich z. B. unter dem Handelsnamen Enteline 2, weiterhin ausgewählt aus dem Dipeptid Tyr-Arg, dessen Estern und dessen N-Acyl-Derivaten, insbesondere N-Acetyl-Tyr-Arg-hexyldecylester (z. B. Calmosensine von Sederma, sowie beliebigen Mischungen dieser Substanzen. Erfindungsgemäß besonders bevorzugte Extrakte aus den Samen von Cucurbita pepo (Zucchini) sind beispielsweise in den Handelsprodukten Curbilene (ex lndena SpA, INCI: Cucurbita pepo (pumpkin) seed extract), Ocaline (ex Soliance, INCI: Sea Water (and) Water (and) Cucurbita pepo (pumpkin) seed extract), ARP 100 (ex Greentech, INCI: Water, Alcohol, Serenoa Serrulata Fruit Extract, Epilo- bium Angustifolium Extract, Cucurbita Pepo (Pumpkin) Seed Extract), ARP 100 Huileux (ex Greentech, INCI: Caprylic/Capric Triglyceride, Serenoa Serrulata Fruit Extract, Epilobium Angustifolium Flower/ Leaf/Stem Extract, Cucurbita Pepo (Pumpkin) Seed Extract), Cucurbitine (ex Christian Dior Parfüms, INCI: Water (and) Cucurbita pepo (pumpkin) seed extract), Herbasol Extract Pumpkin (ex Cosmeto- chem, INCI: Water (and) Propylene glycol (and) Cucurbita pepo (pumpkin) seed extract) und Pumpkin Extract (ex Draco Natural Products, INCI: Water (and) Cucurbita pepo (pumpkin) seed extract) enthalten.Skin-soothing active ingredients preferred according to the invention are selected from allantoin, α-bisabolol, α-lipoic acid, extracts from Centella asiatica, for example obtainable under the name Madecassicoside from DSM, glycyrrethic acid, which is particularly preferably encapsulated in liposomes and in this form z. B. sold under the trade name Calmsphere by Soliance, mixtures of cereal waxes, extracts of shea butter and Argania Spinosa oil with the INCI name "Spent grain wax and Butyrospermum Parkii (shea butter) extract and Argania Spinosa Kernel OiI", as z B. under the trade name Stimu-Tex AS available from the company Pentapharm, extracts of vanilla Tahitensis, as they are available, for example, under the trade name Vanirea (INCI: Vanilla Tahitensis Fruit Extract) from the company Solabia, Alginhydrolysaten, such they are obtainable, for example, from Codif under the trade name Phycosaccharides, in particular phycosaccharides AI, extracts from Bacopa Monniera, as obtainable, for example, under the trade name Bacocalmine from Sederma, extracts from the Rooibos plant, as obtainable, for example, under the trade name Rooibos Herbasec MPE from the company Cosmetochem, yeast extracts, more preferably the commercial pr Drieline (INCI name "sorbitol, Yeast Extract"), available from Lanatech, the physiologically acceptable salts of sterol sulfates, as described, for. B. under the trade name phytocohesins (INCI: Sodium Beta Sitosterylsulfate) are available from the company Vincience, aminodicarboxylic acids having a C chain length of 3 to 6 carbon atoms and their physiologically acceptable salts, preferably selected from aminomalic acid, aminosuccinic acid (= aspartic acid) , Aminoglutaric and aminoadipic acid and their physiologically acceptable salts such as potassium aspartate and magnesium aspartate, extracts from the seeds of Cucurbita pepo (zucchini), extracts of Mentha piperita, in particular from the leaves of Mentha piperita, N-acylated alkanolamines, in particular N-palmitoylethanolamine, hydrolyzed and / or extracts from the algae Enteromorpha compressa (Darmtang, a green alga), in particular from the vegetation body ( " phallus " ) of the algae, commercially available, for example, under the trade name Enteline 2, furthermore selected from the dipeptide Tyr-Arg, the Esters and its N-acyl derivatives, in particular N-acet yl-Tyr-Arg-hexyldecyl ester (e.g. As calmosensins of Sederma, as well as any mixtures of these substances. Extracts of the seeds of Cucurbita pepo (courgettes) which are particularly preferred according to the invention are described, for example, in the commercial products Curbilene (ex lndena SpA, INCI: Cucurbita pepo (pumpkin seed extract), Ocaline (ex Soliance, INCI: Sea Water (and) Water (and ) Cucurbita pepo (pumpkin seed extract), ARP 100 (ex Greentech, INCI: Water, Alcohol, Serenoa Serrulata Fruit Extract, Epilobium Angustifolium Extract, Cucurbita Pepo (Pumpkin) Seed Extract), ARP 100 Huileux (ex Greentech, INCI : Caprylic / Capric Triglycerides, Serenoa Serrulata Fruit Extract, Epilobium Angustifolium Flower / Leaf / Stem Extract, Cucurbita Pepo (Pumpkin) Seed Extract), Cucurbitine (ex Christian Dior Perfumes, INCI: Water (and) Cucurbita pepo (pumpkin) seed extract) , Herbasol Extract Pumpkin (ex Cosmetochem, INCI: Water (and) Propylene glycol (and) Cucurbita pepo (pumpkin seed extract) and Pumpkin Extract (ex Draco Natural Products, INCI: Water (and) Cucurbita pepo (pumpkin) seed extract).
Erfindungsgemäß besonders bevorzugte Extrakte aus Mentha piperita, insbesondere aus den Blättern von Mentha piperita, sind beispielsweise in den Handelsprodukten Calmiskin OP (ex Silab, INCI: Water (and) Mentha piperita (Peppermint) Leaf Extract) und Caomint (ex Solabia, INCI: Propylene Glycol, Water, Mentha piperita (Peppermint) Leaf Extract, Theobroma Cacao (Cocoa) Extract) enthalten. Erfindungsgemäß außerordentlich bevorzugt ist Allantoin; erfindungsgemäß außerordentlich bevorzugte Zusammensetzungen enthalten mindestens einen Deodorant- oder Antitranspirant-Wirkstoff, mindestens ein Yoghurt-Protein und/oder mindestens ein Hydrolysat eines Yoghurt-Proteins und/oder mindestens ein N-C2-C24-Acylderivat und/oder mindestens einen C2-C24-Ester und/oder mindestens ein physiologisch verträgliches Salz dieser P rote in- Wirkstoffe, und Allantoin.Mentha piperita extracts which are particularly preferred according to the invention, in particular from the leaves of Mentha piperita, are described, for example, in the commercial products Calmiskin OP (ex Silab, INCI: Water (and) Mentha piperita (Peppermint Leaf Extract) and Caomint (ex Solabia, INCI: Propylene Glycol, Water, Mentha piperita (Peppermint) leaf extract, Theobroma cacao (Cocoa) extract). Extremely preferred according to the invention is allantoin; Extremely preferred compositions according to the invention contain at least one deodorant or antiperspirant active, at least one yoghurt protein and / or at least one hydrolyzate of a yoghurt protein and / or at least one NC 2 -C 24 acyl derivative and / or at least one C 2 -C 24 -ester and / or at least one physiologically acceptable salt of these P red in-active substances, and allantoin.
Der (zusätzlich zu dem mindestens einen Wirkstoff, ausgewählt aus mindestens einem Yoghurt- Protein und/oder mindestens einem Hydrolysat eines Yoghurt-Proteins und/oder mindestens einem N-C2-C24-Acylderivat und/oder mindestens einem C2-C24-Ester und/oder mindestens einem physiologisch verträglichen Salz dieser Protein-Wirkstoffe, sowie Mischungen dieser Protein-Wirkstoffe) weitere hautberuhigende Wirkstoff ist bevorzugt in einer Gesamtmenge von 0,001 bis 5 Gew.-%, besonders bevorzugt 0,01 bis 2 Gew.-% und außerordentlich bevorzugt 0,05 bis 1 Gew.-%, jeweils bezogen auf die gesamte Zusammensetzung, enthalten.The (in addition to the at least one active ingredient selected from at least one yoghurt protein and / or at least one hydrolyzate of a yoghurt protein and / or at least one NC 2 -C 24 acyl derivative and / or at least one C 2 -C 24 ester and / or at least one physiologically acceptable salt of these protein active substances, as well as mixtures of these protein active substances) further skin-soothing active substance is prefers in a total amount of 0.001 to 5 Gew. -%, particularly prefers 0.01 to 2 Gew. -% and extraordinarily preferably 0.05 to 1 wt .-%, each based on the total composition.
In einer weiteren bevorzugten Ausführungsform enthalten die erfindungsgemäßen Zusammensetzungen mindestens eine den Haarwuchs inhibierende Substanz. Bevorzugte Substanzen, die den Haarwuchs inhibieren, sind insbesondere ausgewählt aus Eflornithin, Wirkstoffkombinationen aus Sojapro- teinhydrolysat, Harnstoff, Menthol, Salicylsäure und Extrakten aus Hypericum Perforatum, Hamamelis Virginiana, Arnica Montana und der Rinde von Salix Alba, wie sie beispielsweise und bevorzugt in dem Rohstoff Pilinhib® Veg LS 9109 von Laboratoires Serobiologiques mit der INCI-Deklaration „Propylene glycol, Hydrolyzed Soy Protein, Hypericum Perforatum Extract, Hamamelis Virginiana Extract, Arnica Montana Flower Extract, Urea, Salix Alba Bark Extract, Menthol, Salicylic acid" enthalten ist, weiterhin Wirkstoffkombinationen aus Extrakten aus Epilobium Angustifolium, den Samen von Cucurbita pepo (pumpkin, Zucchini) und den Früchten von Serenoa serrulata, wie sie beispielsweise und bevorzugt in den Rohstoffen ARP 100 von Greentech S.A./Rahn mit der INCI-Deklaration „Water, Alcohol, Serenoa Serrulata Fruit Extract, Epilobium Angustifolium Extract, Cucurbita Pepo (Pumpkin) Seed Extract" und ARP 100 Huileux (ex Greentech, INCI: Caprylic/Capric Triglyceride, Serenoa Serrulata Fruit Extract, Epilobium Angustifolium Flower/Leaf/Stem Extract, Cucurbita Pepo (Pumpkin) Seed Extract), enthalten sind, weiterhin Wirkstoffkombinationen aus Xylitol und Extrakten von Citrus Medica Limonum (Lemon) Fruit, Carica Papaya (Papaya) und Olivenblättern, wie sie beispielsweise und bevorzugt in dem Rohstoff Xyleine von Impag / Seporga mit der INCI-Deklaration „Xylitol and Citrus Medica Limonum (Lemon) Fruit Extract and Carica Papaya (Papaya) Fruit Extract and Olea europaea (olive) leaf extract" enthalten sind, weiterhin Wirkstoffkombinationen aus Humulus Lupulus, Viscum Album, Salvia Officinalis, Carica Papaya und Thuya Occidentalis, wie sie beispielsweise und bevorzugt in dem Rohstoff Plantafluid Komplex AH der Firma Plantapharm mit der INCI-Deklaration „Aqua, Propylene Glycol, Humulus Lupulus, Viscum Album, Salvia Officinalis, Carica Papaya, Thuya Occidentalis" enthalten sind, sowie Extrakten aus Larrea divaricata, wie sie beispielsweise und bevorzugt in dem Rohstoff Capislow von Sederma, der Lecithinvesikel mit einem hydroglycolischen Extrakt aus Larrea divaricata enthält, enthalten sind.In a further preferred embodiment, the compositions according to the invention comprise at least one hair growth inhibiting substance. Preferred substances which inhibit hair growth are, in particular, selected from eflornithine, active ingredient combinations of soybean hydrolyzate, urea, menthol, salicylic acid and extracts of hypericum perforatum, hamamelis virginiana, arnica montana and the bark of Salix alba, as described, for example and preferably in US Pat Raw material Pilinhib ® Veg LS 9109 from Laboratoires Serobiologiques is included with the INCI declaration "Propylene Glycol, Hydrolyzed Soy Protein, Hypericum Perforatum Extract, Hamamelis Virginiana Extract, Arnica Montana Flower Extract, Urea, Salix Alba Bark Extract, Menthol, Salicylic acid" Farther Active ingredient combinations of extracts of Epilobium angustifolium, the seeds of Cucurbita pepo (pumpkin, zucchini) and the fruits of Serenoa serrulata, as for example and preferably in the raw materials ARP 100 from Greentech SA / Rahn with the INCI declaration "Water, Alcohol, Serenoa Serrulata Fruit Extract, Epilobium Angustifolium Extract, Cucurbita Pepo (Pumpkin) Seed Extract "and ARP 100 Huileux (ex Greentech, INCI: Caprylic / Capric Triglyceride, Serenoa Serrulata Fruit Extract, Epilobium Angustifolium Flower / Leaf / Stem Extract, Cucurbita Pepo (Pumpkin) Seed Extract), furthermore, active ingredient combinations of xylitol and extracts of Citrus Medica Limonum (Lemon) Fruit, Carica Papaya (papaya) and olive leaves, as for example and preferably in the raw material Xyleine of Impag / Seporga with the INCI declaration "Xylitol and Citrus Medica Limonum (Lemon) Fruit Extract and Carica Papaya (Papaya) Fruit Extract and Olea europaea (olive) leaf extract "included Furthermore, active ingredient combinations of Humulus Lupulus, Viscum Album, Salvia Officinalis, Carica Papaya and Thuya Occidentalis, as for example and preferably in Plantapharm Complex AH Plantapharm with the INCI Declaration "Aqua, Propylene Glycol, Humulus Lupulus, Viscum Album , Salvia officinalis, Carica papaya, Thuya occidentalis ", as well as extracts of Larrea divaricata, as for example and preferably contained in the raw material Capislow of Sederma, which contains lecithin vesicles with a hydroglycolic extract of Larrea divaricata.
Weitere bevorzugte Haarwuchs-inhibierende Wirkstoffe sind ausgewählt aus Substanzen, die die Protein-Tyrosinkinase hemmen, insbesondere aus Lavendustin-A, Erbstatin, Tyrphostin, Piceatannol, 4-Hydroxybenxylidenmalononitril, 3,5-Di-ferf-butyl-4-hydroxybenzylidenmalononitril, α-Cyano-(3,4- dihydroxy)-cinnamonitril, α-Cyano-(3,4,5-trihydroxy)cinnamonitril, α-Cyano-(3,4-dihydroxy)cinnamid, α- Cyano-(3,4-dihydroxy)thiocinnamid, 2- Amino-4-(4'-hydroxyphenyl)-1 ,1 ,3-tricyanobuta-1 ,3-dien, 2- Amino-4-(3,4,5'- trihydroxyphenyl)-1 ,1 ,3-tricyanobuta-1 ,3-dien, 2-Amino-4-(1 H-alpha-indol-5-yl)-1 ,1 ,3- tricyanobuta-1 ,3-dien, 4-Hydroxy-3-methoxy-5-(benzothiazolylthiomethyl)benzylidencyanoacetamid, A- Amino-N-(2,5-dihydroxybenzyl)methylbenzoat, α-Cyano-(3,4-dihydroxy)-cinnamonitril, 4-(3-Chloranili- no)-6,7-dimethoxychinazolin, α-Cyano-(3,4-dihydroxy)-N-benzylcinnamid, (-)-R-N-(a-Methylbenzyl)-3,4- dihydroxybenzylidencyanoacetamid, α-Cyano-(3,4-dihydroxy)-N-(3-phenylpropyl)-cinnamid, α-Cyano- (3,4-dihydroxy)-N-phenylcinnamid, α-Cyano-(+)-(S)-N-(alpha-phenethyl)-(3,4-dihydroxy)cinnamid, α- Cyano-(3,4-dihydroxy)-N-(phenylbutyl)cinnamid, Herbimycin A, Thiazolidindion, Phenazocin, 2,3- Dihydro-2-thioxo-1 H-indol-3-Alkansäuren, 2,2'-Dithiobis-(1 H-indol-3-Alkansäuren), Sulfonylbenzoyl- nitrostyrol, Methylcaffeat, HNMPA(AM)3(hydroxy-2-naphthalenylmethylphosphonsäure-fr/s-acet- oxymethylester) und N-Acetyl-Asp-Tyr-(2-malonyl)-Val-Pro-Met-Leu-NH2.Further preferred hair growth inhibiting active substances are selected from substances which inhibit the protein tyrosine kinase, in particular from lavendustin A, erbstatin, tyrphostin, piceatannol, 4-hydroxybenxylidene-malononitrile, 3,5-di-tert-butyl-4-hydroxybenzylidenemalononitrile, α- Cyano- (3,4-dihydroxy) -cinnamonitrile, α-cyano- (3,4,5-trihydroxy) cinnamonitrile, α-cyano- (3,4-dihydroxy) cinnamide, α-cyano- (3,4-dihydroxy ) thiocinnamide, 2-amino-4- (4'-hydroxyphenyl) -1, 1, 3-tricyanobuta-1,3-diene, 2-amino-4- (3,4,5'-trihydroxyphenyl) -1, 1 , 3-tricyanobuta-1,3-diene, 2-amino-4- (1H-alpha-indol-5-yl) -1, 1, 3-tricyanobuta-1,3-diene, 4-hydroxy-3- methoxy-5- (benzothiazolylthiomethyl) benzylidenecyanoacetamide, A-amino-N- (2,5-dihydroxybenzyl) methylbenzoate, α-cyano- (3,4-dihydroxy) -cinnamonitrile, 4- (3-chloroanilino) -6, 7-dimethoxyquinazoline, α-cyano- (3,4-dihydroxy) -N-benzylcinnamide, (-) - RN- (α-methylbenzyl) -3,4-dihydroxybenzylidenecyanoacetamide, α-cyano- (3,4-dihydroxy) - N- (3-phenylpropyl) cinnamide, α-C yano- (3,4-dihydroxy) -N-phenylcinnamide, α-cyano - (+) - (S) -N- (alpha-phenethyl) - (3,4-dihydroxy) cinnamide, α-cyano- (3, 4-dihydroxy) -N- (phenylbutyl) cinnamide, herbimycin A, thiazolidinedione, phenazocine, 2,3-dihydro-2-thioxo-1H-indole-3-alkanoic acids, 2,2'-dithiobis- (1H-indole 3-alkanoic acids), sulfonylbenzoyl nitrostyrene, methyl caffeate, HNMPA (AM) 3 (hydroxy-2-naphthalenylmethylphosphonic acid fr / s-acetoxymethyl ester) and N-acetyl-Asp-Tyr- (2-malonyl) -Val-Pro -Met-Leu-NH 2 .
Weitere bevorzugte Haarwuchs-inhibierende Wirkstoffe sind ausgewählt aus den Substanzen, die in WO 2006/130330 A2 offenbart sind, nämlich Agonisten des Farnesoid X-Rezeptors, bevorzugt ausgewählt aus Gallensäuren, wie insbesondere Lithocholsäure, Cholsäure, Deoxycholsäure, Chenodeoxy- cholsäure, Ursodeoxycholsäure und 6-alpha-Ethylchenodeoxycholsäure, weiterhin aus Farnesoiden, insbesondere Farnesol (3,7,11-Trimethyl-2,6,10-dodecatrien-1-ol), Farnesal, Farnesylacetat, 3,7,11- Trimethyl-2, 6, 10-dodecatrien-1 -carbonsäure, Methylfarnesylether, Methylfarnesoat, Ethylfarnesylether, Ethylfarnesoat, weiterhin aus 7-Methyl-9-(3,3-dimethyloxivanyl)-3-methyl-2,6-nonadiensäuremethyl- ester (Juvenilhormon IM), 7-Methyl-9-(3,3-dimethyloxivanyl)-3-methyl-2,6-nonadiensäureethylester, 3-alpha,7-alpha-Dihydroxy-6-alpha-ethyl-5p-cholan-24-säure, 7-alpha-Dihydroxy-6-alpha-propyl-5p- cholan-24-säure, 7-alpha-Dihydroxy-6-alpha-allyl-5p-cholan-24-säure, N-(2,2,2-trifluoroethyl)-N-[4- [2,2,2-trifluoro-1-hydroxy-1-(trifluoromethyl)-ethyl]phenyl]-benzolsulfonanilid, 3-[2-[2-Chloro-4-[3-(2,6- dichlorophenyl)-5-(1-methylethyl)-4-isoxazolyl]methoxy]-phenylethenyl]-benzoesäure, [3,5-bis(1 ,1-di- methylethyl)-4-hydroxyphenyl]ethenyliden]bisphosphonsäuretetraethylester, [2-[3,5-bis(1 ,1-dimethyl- ethyl)-4-hydroxyphenyl]ethyliden]bisphosphonsäuretetrakis(1-methylethyl)ester, [2-[3,5-bis(1 ,1-di- methylethyl)-4-hydroxyphenyl]ethyliden]bisphosphonsäuretetraethylester und [3,5-bis(1 ,1-dimethyl- ethyl-4-hydroxyphenyl]ethenyliden]bisphosphonsäuretetrakis(1-methylethyl)ester. Bevorzugte erfindungsgemäße Zusammensetzungen enthalten mindestens eine den Haarwuchs inhibierende Substanz in einer Gesamtmenge von 0,0001 - 5 Gew.-%, bevorzugt 0,001 - 2 Gew.-%, besonders bevorzugt 0,01 - 1 Gew.-%, und außerordentlich bevorzugt 0,1 - 0,5 Gew.-%, jeweils bezogen auf das Gewicht an Aktivsubstanz des/der Haarwuchs inhibierenden Wirkstoffs/e und das Gesamtgewicht der erfindungsgemäßen Zusammensetzung.Further preferred hair growth inhibiting active substances are selected from the substances disclosed in WO 2006/130330 A2, namely agonists of the farnesoid X receptor, preferably selected from bile acids, in particular lithocholic acid, cholic acid, deoxycholic acid, chenodeoxycholic acid, ursodeoxycholic acid and 6 -alpha-ethylchenodeoxycholic acid, further from farnesoids, in particular farnesol (3,7,11-trimethyl-2,6,10-dodecatrien-1-ol), farnesal, farnesyl acetate, 3,7,11- Trimethyl 2, 6, 10-dodecatriene-1-carboxylic acid, methyl farnesyl ether, methyl farnesoate, ethyl farnesyl ether, ethyl farnesoate, furthermore from methyl 7-methyl-9- (3,3-dimethyloxivanyl) -3-methyl-2,6-nonadienoate ( Juvenile hormone IM), ethyl 7-methyl-9- (3,3-dimethyloxivanyl) -3-methyl-2,6-nonadienoate, 3-alpha, 7-alpha-dihydroxy-6-alpha-ethyl-5p-cholan-24 acid, 7-alpha-dihydroxy-6-alpha-propyl-5p-cholan-24-acid, 7-alpha-dihydroxy-6-alpha-allyl-5p-cholan-24-acid, N- (2,2,2 -trifluoroethyl) -N- [4- [2,2,2-trifluoro-1-hydroxy-1- (trifluoromethyl) -ethyl] -phenyl] -benzenesulfonanilide, 3- [2- [2-chloro-4- [3- (2,6-Dichlorophenyl) -5- (1-methylethyl) -4-isoxazolyl] methoxy] phenylethenyl] benzoic acid, [3,5-bis (1,1-dimethylethyl) -4-hydroxyphenyl] ethenylidene] bisphosphonic acid tetraethyl ester, [2- [3,5-bis (1,1-dimethyl-ethyl) -4-hydroxyphenyl] ethylidene] bisphosphonic acid tetrakis (1-methylethyl) ester, [2- [3,5-bis (1,1-di - methylethyl) -4-hydroxyphenyl] ethylidene] bisphosphonic acid tetraethyl ester and [3,5-bi s (1, 1-dimethyl-ethyl-4-hydroxyphenyl) ethenylidene] bisphosphonic acid tetrakis (1-methylethyl) ester. Preferred compositions according to the invention contain at least one hair growth inhibiting substance in a total amount of 0.0001-5 wt.%, Preferably 0.001-2 wt.%, Particularly preferably 0.01-1 wt.%, And most preferably 0, 1 to 0.5% by weight, in each case based on the weight of active substance of hair growth inhibiting active substance (s) and the total weight of the composition according to the invention.
Ausführungsbeispieleembodiments
Die nachfolgenden Formulierungsbeispiele sollen den Gegenstand der Erfindung erläutern, ohne ihn hierauf zu beschränken.The following formulation examples are intended to illustrate the subject matter of the invention without limiting it thereto.
Erfindungsgemäße Antitranspirant-Stifte auf Basis einer ÖI-in-Wasser-Emulsion (Mengenangaben in Gew.-%)Antiperspirant sticks according to the invention based on an oil-in-water emulsion (amounts in% by weight)
aus sprühgetrocknetem Yoghurt erhältlich available from spray-dried yoghurt
Beispiel 8: Erfindungsgemäße Antitranspirant-Emulsion (O/W)Example 8 Antiperspirant Emulsion (O / W) According to the Invention
Die Emulsion gemäß Beispiel 8 wies am ersten Tag nach der Herstellung eine Viskosität von 2200 mPas auf, gemessen mit einem Brookfield-Viskosimeter, Spindel RV 4, 20 s-1 , ohne Helipath, bei 20 0C Umgebungstemperatur und 20 0C Probentemperatur; sie wurde in einen Roll-on-Applikator abgefüllt. Beispiel 9: erfindungsgemäße Antitranspirant-Emulsion (O/W)The emulsion according to Example 8 had the first day after the preparation has a viscosity of 2200 mPas, measured with a Brookfield viscometer, spindle RV 4, 20 s-1 without Helipath, at 20 0 C ambient temperature and 20 0 C sample temperature; she was filled into a roll-on applicator. Example 9 Antiperspirant Emulsion (O / W) According to the Invention
Die Emulsion gemäß Beispiel 9 wies am ersten Tag nach der Herstellung eine Viskosität von 1700 mPas auf, gemessen mit einem Brookfield-Viskosimeter, Spindel RV 4, 20 s-1 , ohne Helipath, bei 20 0C Umgebungstemperatur und 20 0C Probentemperatur; sie wurde in einen Roll-on-Applikator abgefüllt.The emulsion according to Example 9 had the first day after the preparation has a viscosity of 1700 mPas, measured with a Brookfield viscometer, spindle RV 4, 20 s-1 without Helipath, at 20 0 C ambient temperature and 20 0 C sample temperature; she was filled into a roll-on applicator.
aus sprühgetrocknetem Yoghurt erhältlich available from spray-dried yoghurt
Wasserfreie tensidhaltige Antitranspirant-Stifte (Angaben in Gewichts-%)Anhydrous surfactant-containing antiperspirant sticks (in% by weight)
Wasserfreie tensidhaltige Antitranspirant-Stifte (Angaben in Gewichts-%) Anhydrous surfactant-containing antiperspirant sticks (in% by weight)
Wasserfreie Antitranspirant-Wachsstifte ohne Cyclomethicone (Angaben in Gew.-%)Anhydrous antiperspirant wax pencils without cyclomethicones (in% by weight)
10.18 10.19 10.20 10.21 10.22 10.2310.18 10.19 10.20 10.21 10.22 10.23
Stearyl Alcohol 16 18 18 18 18 18Stearyl Alcohol 16 18 18 18 18 18
Behenyl Alcohol - - 0,2 - - -Behenyl Alcohol - - 0.2 - - -
Ceteareth-30 3 3 3 3 3 3Ceteareth-30 3 3 3 3 3 3
PPG-14 Butyl Ether 15 5 10 15 10 7,5PPG-14 butyl ether 15 5 10 15 10 7.5
Hydrogenated Polydecene - - - - 15 15Hydrogenated polydecenes - - - - 15 15
Coco Glycerides 5 4 4 4 4 4Coco Glycerides 5 4 4 4 4 4
Hydrogenated Castor OiI 1 ,5 1 ,5 2 1 ,5 1 ,5 1 ,5Hydrogenated Castor OiI 1, 5 1, 5 2 1, 5 1, 5 1, 5
Aluminum Chlorohydrate 20 20 20 20 20 20Aluminum Chlorohydrate 20 20 20 20 20 20
TaIc 5 3 5 3 3 5TaIc 5 3 5 3 3 5
Yoghurt Protein GBU 0,1 0,08 0,05 0,1 0,06 0,1Yoghurt Protein GBU 0.1 0.08 0.05 0.1 0.06 0.1
Parfüm 1 1 1 1 1 1Perfume 1 1 1 1 1 1
Dimethicone ( 2 cSt ) - - 18,35 23 ad 100 ad 100Dimethicone (2 cSt) - - 18.35 23 ad 100 ad 100
Dimethicone ( 5 cSt ) ad 100 ad 100 18,4 11 ,4 - - aus sprühgetrocknetem Yoghurt erhältlich Dimethicone (5 cSt) ad 100 ad 100 18.4 11, 4 - - available from spray-dried yoghurt
Die oben angeführten sprühfähigen Antitranspirant-Mikroemulsionen können sowohl mit einem treibmittelfreien Pumpsprüher als auch mit einem Treibmittel dosiert werden oder auf ein Substrat, beispielsweise ein Nonwoven oder ein Cellulose-Tuch, aufgetragen und somit als Antitranspirant-Tuch verwendet werden.The above-mentioned sprayable antiperspirant microemulsions can be metered with either a propellant-free pump sprayer or a propellant or applied to a substrate such as a nonwoven or cellulose cloth and thus used as an antiperspirant cloth.
Seifenhaltige Stifte (Angaben in Gew.-%)Soap-containing pens (in% by weight)
aus sprühgetrocknetem Yoghurt erhältlich available from spray-dried yoghurt
Seifenhaltige Deodorant-Stifte (Angaben in Gew.-%)Soap-containing deodorant sticks (in% by weight)
Deodorant-Stifte auf ethanolfreier SeifenbasisDeodorant pens on ethanol-free soap base
Deodorant im Pumpzerstäuber (Angaben in Gew.-%)Deodorant in the pump sprayer (in% by weight)
13.1 13.2 13.3 13.4 13.5 13 .6 13.7 13. 813.1 13.2 13.3 13.4 13.5 13 .6 13.7 13. 8
Ethanol 96 %-ig, (DEP 55,0 55,0 55,0 55,0 55,0 55 ,0 55,0 55, 0 vergällt) Ethanol 96%, (DEP 55.0 55.0 55.0 55.0 55.0 55.0 55, 0 55.0 55, 0 denatured)
aus sprühgetrocknetem Yoghurt erhältlich available from spray-dried yoghurt
Wasserfreies Deodorant-Spray (Angaben in Gew.-%)Anhydrous deodorant spray (in% by weight)
Antitranspirant Roll-on (Angaben in Gew.-%) Antiperspirant roll-on (in% by weight)
Antitranspirant-Spray vom Suspensionstyp (Angaben in Gew.-%) aus sprühgetrocknetem Yoghurt erhältlich Antitranspirant-Tücher (Beispiele Nr. 17.1. - 17.4)Suspension type antiperspirant spray (in% by weight) available from spray-dried yoghurt Antiperspirant Wipes (Examples Nos. 17.1 - 17.4)
Für die erfindungsgemäße Ausführungsform als Antitranspirant-Tuch wurde ein einlagiges Substrat aus 100 % Viskose mit einem Flächengewicht von 50 g/m2 mit jeweils 75 g der Beispielemulsionen 11.1 bzw. 11.2 bzw. 2.3 pro Quadratmeter oder mit jeweils 75 g der Beispiellösungen 13.1 bzw. 13.2 beaufschlagt, in Tücher geeigneter Größe geschnitten und in Sachets verpackt.For the inventive embodiment as antiperspirant cloth a single-layer substrate made of 100% rayon with a basis weight of 50 g / m 2 with 75 g of the example emulsions 11.1 and 11.2 or 2.3 per square meter or with 75 g of the sample solutions 13.1 and 13.2, cut into cloths of suitable size and packed in sachets.
Wasser-in-ÖI-EmulsionsspraysWater-in-oil emulsion spray
Beispielzusammensetzung 19.1 enthält eine erfindungsgemäße Antitranspirant-Emulsion mit 9,9 Gew.- % Aluminiumchlorohydrat, bezogen auf das Gewicht der treibgasfreien Emulsion. Mit einer Sprührate von 0,35 g/s versprüht man in der Sekunde 0,035 g des schweißhemmenden Wirkstoffs Aluminiumchlorohydrat auf die Hautoberfläche.Example Composition 19.1 contains an antiperspirant emulsion according to the invention with 9.9% by weight aluminum chlorohydrate, based on the weight of the propellant-free emulsion. With a spray rate of 0.35 g / s, 0.035 g of the antiperspirant active ingredient aluminum chlorohydrate are sprayed onto the skin surface every second.
Beispielzusammensetzung 19.2 enthält eine erfindungsgemäße Antitranspirant-Emulsion mit 17,49 Gew.-% Aluminiumchlorohydrat, bezogen auf das Gewicht der treibgasfreien Emulsion. Mit einer Sprührate von 0,2 g/s versprüht man in der Sekunde 0,035 g des schweißhemmenden Wirkstoffs Aluminiumchlorohydrat auf die Hautoberfläche. Deodorant-Pumpspray / Tränklösung für Deodorant-TücherExample Composition 19.2 contains an antiperspirant emulsion according to the invention with 17.49% by weight aluminum chlorohydrate, based on the weight of the propellant-free emulsion. At a spray rate of 0.2 g / s, 0.035 g of the antiperspirant active ingredient aluminum chlorohydrate is sprayed onto the skin surface every second. Deodorant pump spray / impregnation solution for deodorant wipes
Wässrig-alkoholische Lösung von solubilisierten Deodorantwirkstoffen und ParfümsAqueous-alcoholic solution of solubilized deodorant ingredients and perfumes
Klare Antitranspirant-GeleClear antiperspirant gels
Um klare Gele zu erzielen, ist der Brechungsindex der Wasserphase dem Brechungsindex der Ölphase anzupassen. Wasser bzw. Propylenglycol dienen als Variable.In order to obtain clear gels, the refractive index of the water phase must be adapted to the refractive index of the oil phase. Water or propylene glycol serve as a variable.
Klare Deodorant-GeleClear deodorant gels
Der Verdicker (Carbomer) ist mit einem geeigneten Neutralisierungsmittel (TEA, AMP, NaOH, LiOH) auf den gewünschten pH Wert einzustellen.The thickener (carbomer) should be adjusted to the desired pH with a suitable neutralizing agent (TEA, AMP, NaOH, LiOH).
Antiperspirant-Creme auf Basis einer ÖI-in-Wasser-EmulsionAntiperspirant cream based on an oil-in-water emulsion
Antiperspirant-Creme wasserfrei (Soft Solid)Antiperspirant Cream Anhydrous (Soft Solid)
Puder (Deodorant / Antitranspirant) Deodorant-SyndetsPowder (deodorant / antiperspirant) Deodorant Syndets
Deodorant-WaschlotionenDeodorant cleansing lotions
Die erfindungsgemäßen Beispielzusammensetzungen werden auf die Haut, insbesondere die Achselhaut, aufgetragen.The example compositions according to the invention are applied to the skin, in particular the underarm skin.
Damit ist ein weiterer Gegenstand der vorliegenden Anmeldung ein Verfahren zur nicht-therapeutischen Behandlung der Haut, dass dadurch gekennzeichnet ist, dass eine Zusammensetzung gemäß einem der Ansprüche 1 - 10 auf die Haut, insbesondere die Achselhaut, aufgetragen wird. Besonders bevorzugt erfolgt die Applikation auf die Haut nach einer Rasur. Die erfindungsgemäßen Zusammensetzungen zeichnen sich durch eine hohe, gegenüber dem Stand der Technik verbesserte Hautverträglichkeit aus.Thus, another object of the present application is a method for non-therapeutic treatment of the skin, which is characterized in that a composition according to any one of claims 1-10 on the skin, in particular the armpits, is applied. Particularly preferred is the application to the skin after a shave. The compositions of the invention are characterized by a high, compared to the prior art improved skin compatibility.
Liste der verwendeten RohstoffeList of raw materials used

Claims

Patentansprüche claims
1. Kosmetische oder dermatologische Deodorant- oder Antitranspirant-Zusammensetzung, enthaltend in einem kosmetisch oder dermatologisch verträglichen Träger a) mindestens einen Deodorant- oder Antitranspirant-Wirkstoff, b) mindestens ein Yoghurt-Protein und/oder mindestens ein Hydrolysat eines Yoghurt- Proteins und/oder mindestens ein N-C2-C24-Acylderivat und/oder mindestens einen C2-C24-Ester und/oder mindestens ein physiologisch verträgliches Salz dieser Protein- Wirkstoffe, sowie Mischungen dieser Protein-Wirkstoffe.1. Cosmetic or dermatological deodorant or antiperspirant composition comprising, in a cosmetically or dermatologically acceptable carrier a) at least one deodorant or antiperspirant active ingredient, b) at least one yoghurt protein and / or at least one hydrolyzate of a yoghurt protein and / or or at least one NC 2 -C 24 -acyl derivative and / or at least one C 2 -C 24 -ester and / or at least one physiologically acceptable salt of these protein-active substances, as well as mixtures of these protein-active substances.
2. Zusammensetzung nach Anspruch 1 , dadurch gekennzeichnet, dass das mindestens eine Yoghurt-Protein, mindestens eine Hydrolysat eines Yoghurt-Proteins und/oder das mindestens eine N-C2-C24-Acylderivat und/oder der mindestens eine C2-C24-Ester und/oder das mindestens eine physiologisch verträgliche Salz dieser Substanzen in Form von Yoghurt oder sprühgetrocknetem Yoghurt oder gefriergetrocknetem Yoghurt oder lyophilisiertem Yoghurt oder einem auf andere Art getrockneten Yoghurt enthalten ist.2. Composition according to claim 1, characterized in that the at least one yoghurt protein, at least one hydrolyzate of a yoghurt protein and / or the at least one NC 2 -C 24 acyl derivative and / or the at least one C 2 -C 24 - Ester and / or the at least one physiologically acceptable salt of these substances in the form of yogurt or spray-dried yogurt or freeze-dried yogurt or lyophilized yogurt or otherwise dried yogurt is included.
3. Zusammensetzung nach Anspruch 1 oder 2, dadurch gekennzeichnet, dass das Yoghurt- Protein, das Yoghurt-Proteinhydrolysat, das N-C2-C24-Acylderivat, das C2-C24-Esterderivat und/oder deren physiologisch verträgliches Salz in einer Gesamtmenge von 0,001 bis 0,1 Gew.-%, bevorzugt 0,005 - 0,07 Gew.-%, besonders bevorzugt 0,01 - 0,05 Gew.-% und außerordentlich bevorzugt 0,02 - 0,04 Gew.-%, jeweils bezogen auf die gesamte Zusammensetzung, enthalten ist.3. Composition according to claim 1 or 2, characterized in that the yoghurt protein, the yoghurt protein hydrolyzate, the NC 2 -C 24 acyl derivative, the C 2 -C 24 ester derivative and / or their physiologically acceptable salt in a total amount from 0.001 to 0.1% by weight, preferably 0.005-0.07% by weight, more preferably 0.01-0.05% by weight and most preferably 0.02-0.04% by weight, each based on the total composition is included.
4. Zusammensetzung nach einem der vorstehenden Ansprüche, dadurch gekennzeichnet, dass der mindestens eine Antitranspirant-Wirkstoff in einer Gesamtmenge in einer Gesamtmenge von 3 - 25 Gew.-%, vorzugsweise 5 - 22 Gew.-% und insbesondere 10 - 20 Gew.-%, enthalten ist, bezogen auf das Gesamtgewicht der Aktivsubstanz in der gesamten Zusammensetzung, enthalten ist.4. Composition according to one of the preceding claims, characterized in that the at least one antiperspirant active ingredient in a total amount in a total amount of 3 - 25 wt .-%, preferably 5 - 22 wt .-% and in particular 10 - 20 wt. %, based on the total weight of the active substance in the whole composition.
5. Zusammensetzung nach einem der vorstehenden Ansprüche, dadurch gekennzeichnet, dass der mindestens eine Deodorant-Wirkstoff in einer Gesamtmenge von 0,1 - 10 Gew.-%, bevorzugt 0,2 - 7 Gew.-%, besonders bevorzugt 0,3 - 5 Gew.-% und außerordentlich bevorzugt 0,4 - 1 ,0 Gew.-%, jeweils bezogen auf das Gesamtgewicht der Aktivsubstanz des Deodorant-Wirkstoffs oder der Deodorant-Wirkstoffe in der Gesamtzusammensetzung, enthalten ist. 5. Composition according to one of the preceding claims, characterized in that the at least one deodorant active ingredient in a total amount of 0.1 to 10 wt .-%, preferably 0.2 to 7 wt .-%, particularly preferably 0.3 - 5 wt .-% and most preferably 0.4 to 1, 0 wt .-%, each based on the total weight of the active substance of the deodorant active ingredient or the deodorant active ingredients in the overall composition.
6. Zusammensetzung nach einem der vorstehenden Ansprüche, dadurch gekennzeichnet, dass mindestens ein Monosaccharid mit 5 oder 6 Kohlenstoffatomen und/oder mindestens ein Disaccharid enthalten ist.6. Composition according to one of the preceding claims, characterized in that at least one monosaccharide having 5 or 6 carbon atoms and / or at least one disaccharide is contained.
7. Zusammensetzung nach Anspruch 6, dadurch gekennzeichnet, dass das Monosaccharid Kohlenstoffatomen ausgewählt ist aus Glucose, Fructose, Galactose, Arabinose, Ribose, Xylose, Lyxose, Allose, Altrose, Mannose, Gulose, Idose, Talose, Fucose und Rhamnose.7. A composition according to claim 6, characterized in that the monosaccharide carbon atoms is selected from glucose, fructose, galactose, arabinose, ribose, xylose, lyxose, allose, altrose, mannose, gulose, idose, talose, fucose and rhamnose.
8. Zusammensetzung nach Anspruch 6, dadurch gekennzeichnet, dass das Disaccharid mit 5 oder 6 Kohlenstoffatomen ausgewählt ist aus Saccharose, Lactose und Trehalose.8. The composition according to claim 6, characterized in that the disaccharide having 5 or 6 carbon atoms is selected from sucrose, lactose and trehalose.
9. Zusammensetzung nach einem der vorstehenden Ansprüche, dadurch gekennzeichnet, dass mindestens ein Monosaccharid mit 5 oder 6 Kohlenstoffatomen und/oder mindestens ein Disaccharid in einer Gesamtmenge von 0,001 bis 2,0 Gew.-%, bevorzugt 0,005 - 1 ,0 Gew.-%, besonders bevorzugt 0,01 - 0,5 Gew.-% und außerordentlich bevorzugt 0,03 - 0,1 Gew.-%, jeweils bezogen auf die gesamte Zusammensetzung, enthalten ist.9. Composition according to one of the preceding claims, characterized in that at least one monosaccharide having 5 or 6 carbon atoms and / or at least one disaccharide in a total amount of 0.001 to 2.0 wt .-%, preferably 0.005 - 1, 0 wt. %, more preferably 0.01 to 0.5 wt .-% and exceptionally preferably 0.03 to 0.1 wt .-%, each based on the total composition is included.
10. Zusammensetzung nach einem der vorstehenden Ansprüche, dadurch gekennzeichnet, dass der kosmetisch oder dermatologisch verträgliche Träger als Puder, in Stiftform, als Aerosolspray, Pumpspray, flüssige oder gelförmige Roll-on-Applikation, Creme, Lotion, Lösung, Gel oder auf einem Substrat aufgebracht vorliegt.10. The composition according to any one of the preceding claims, characterized in that the cosmetically or dermatologically acceptable carrier as a powder, in stick form, as aerosol spray, pump spray, liquid or gel roll-on application, cream, lotion, solution, gel or on a substrate applied present.
11. Verwendung von mindestens einem Yoghurt-Protein und/oder mindestens einem Hydrolysat eines Yoghurt-Proteins und/oder mindestens einem N-C2-C24-Acylderivat und/oder mindestens einem C2-C24-Ester und/oder mindestens einem physiologisch verträglichen Salz dieser Substanzen, sowie Mischungen dieser Protein-Wirkstoffe, in einem kosmetisch oder dermatologisch verträglichen Träger, enthaltend mindestens einen Deodorant- oder Antitranspirant-Wirk- stoff, zur Verbesserung der Hautverträglichkeit und/oder der Pflegewirkung der Zusammensetzung und/oder zur Verringerung oder Vermeidung von Hautbrennen, einem Spannungsgefühl, Juckreiz und/oder sichtbaren Irritationen, wie Hautrötungen, das/die durch Kontakt der Haut mit der Zusammensetzung hervorgerufen wird/werden.11. Use of at least one yoghurt protein and / or at least one hydrolyzate of a yoghurt protein and / or at least one NC 2 -C 24 acyl derivative and / or at least one C 2 -C 24 ester and / or at least one physiologically acceptable Salt of these substances, as well as mixtures of these protein active ingredients, in a cosmetically or dermatologically acceptable carrier, containing at least one deodorant or antiperspirant active substance, to improve the skin compatibility and / or the care effect of the composition and / or to reduce or avoid Skin burning, a feeling of tightness, itching and / or visible irritations, such as skin redness, which is / are caused by contact of the skin with the composition.
12. Verwendung gemäß Anspruch 11 , dadurch gekennzeichnet, dass das mindestens eine Yoghurt-Protein, mindestens eine Hydrolysat eines Yoghurt-Proteins und/oder das mindestens eine N-C2-C24-Acylderivat und/oder der mindestens eine C2-C24-Ester und/oder das mindestens eine physiologisch verträgliche Salz dieser Substanzen in Form von Yoghurt oder sprühgetrocknetem Yoghurt oder gefriergetrocknetem Yoghurt oder lyophilisiertem Yoghurt oder einem auf andere Art getrockneten Yoghurt enthalten ist.12. Use according to claim 11, characterized in that the at least one yoghurt protein, at least one hydrolyzate of a yoghurt protein and / or the at least one NC 2 -C 24 acyl derivative and / or the at least one C 2 -C 24 - Ester and / or the at least one physiologically acceptable salt of these substances in the form of yogurt or spray-dried yoghurt or lyophilized yoghurt or lyophilized yoghurt or otherwise dried yoghurt.
13. Verwendung gemäß Anspruch 11 oder 12, dadurch gekennzeichnet, dass das Yoghurt- Protein, das Yoghurt-Proteinhydrolysat, das N-C2-C24-Acylderivat, das C2-C24-Esterderivat und/oder deren physiologisch verträgliches Salz in einer Gesamtmenge von 0,001 bis 0,1 Gew.-%, bevorzugt 0,005 - 0,07 Gew.-%, besonders bevorzugt 0,01 - 0,05 Gew.-% und außerordentlich bevorzugt 0,02 - 0,04 Gew.-%, jeweils bezogen auf die gesamte Zusammensetzung, enthalten ist.13. Use according to claim 11 or 12, characterized in that the yoghurt protein, the yoghurt protein hydrolyzate, the NC 2 -C 24 acyl derivative, the C 2 -C 24 ester derivative and / or their physiologically acceptable salt in a total amount from 0.001 to 0.1% by weight, preferably 0.005-0.07% by weight, more preferably 0.01-0.05% by weight and most preferably 0.02-0.04% by weight, each based on the total composition is included.
14. Verwendung gemäß einem der Ansprüche 11 - 13, dadurch gekennzeichnet, dass der mindestens eine Antitranspirant-Wirkstoff in einer Gesamtmenge von 3 - 25 Gew.-%, vorzugsweise 5 - 22 Gew.-% und insbesondere 10 - 20 Gew.-%, enthalten ist, bezogen auf das Gesamtgewicht der Aktivsubstanz in der gesamten Zusammensetzung, enthalten ist.14. Use according to any one of claims 11-13, characterized in that the at least one antiperspirant active ingredient in a total amount of 3 - 25 wt .-%, preferably 5 - 22 wt .-% and in particular 10 - 20 wt .-% , is contained, based on the total weight of the active substance in the entire composition.
15. Verwendung gemäß einem der Ansprüche 11 - 14, dadurch gekennzeichnet, dass der mindestens eine Deodorant-Wirkstoff in einer Gesamtmenge von 0,1 - 10 Gew.-%, bevorzugt 0,2 - 7 Gew.-%, besonders bevorzugt 0,3 - 5 Gew.-% und außerordentlich bevorzugt 0,4 - 1 ,0 Gew.-%, jeweils bezogen auf das Gesamtgewicht der Aktivsubstanz des Deodorant-Wirkstoffs oder der Deodorant-Wirkstoffe in der Gesamtzusammensetzung, enthalten ist.15. Use according to any one of claims 11-14, characterized in that the at least one deodorant active ingredient in a total amount of 0.1 to 10 wt .-%, preferably 0.2 to 7 wt .-%, particularly preferably 0, 3 - 5 wt .-% and most preferably 0.4 - 1, 0 wt .-%, each based on the total weight of the active substance of the deodorant active ingredient or the deodorant active ingredients in the overall composition.
16. Verwendung gemäß einem der Ansprüche 11 - 15, dadurch gekennzeichnet, dass mindestens ein Monosaccharid mit 5 oder 6 Kohlenstoffatomen und/oder mindestens ein Disaccharid enthalten ist.16. Use according to any one of claims 11 - 15, characterized in that at least one monosaccharide having 5 or 6 carbon atoms and / or at least one disaccharide is contained.
17. Verwendung gemäß einem der Ansprüche 11 - 16, dadurch gekennzeichnet, dass das Monosaccharid Kohlenstoffatomen ausgewählt ist aus Glucose, Fructose, Galactose, Arabinose, Ribose, Xylose, Lyxose, Allose, Altrose, Mannose, Gulose, Idose, Talose, Fucose und Rhamnose.17. Use according to any one of claims 11-16, characterized in that the monosaccharide carbon atoms is selected from glucose, fructose, galactose, arabinose, ribose, xylose, lyxose, allose, altrose, mannose, gulose, idose, talose, fucose and rhamnose ,
18. Verwendung gemäß einem der Ansprüche 11 - 17, dadurch gekennzeichnet, dass das Disaccharid mit 5 oder 6 Kohlenstoffatomen ausgewählt ist aus Saccharose, Lactose und Trehalose.18. Use according to any one of claims 11 - 17, characterized in that the disaccharide having 5 or 6 carbon atoms is selected from sucrose, lactose and trehalose.
19. Verwendung gemäß einem der Ansprüche 11 - 18, dadurch gekennzeichnet, dass mindestens ein Monosaccharid mit 5 oder 6 Kohlenstoffatomen und/oder mindestens ein Disaccharid in einer Gesamtmenge von 0,001 bis 2,0 Gew.-%, bevorzugt 0,005 - 1 ,0 Gew.-%, besonders bevorzugt 0,01 - 0,5 Gew.-% und außerordentlich bevorzugt 0,03 - 0,1 Gew.-%, jeweils bezogen auf die gesamte Zusammensetzung, enthalten ist.19. Use according to any one of claims 11-18, characterized in that at least one monosaccharide having 5 or 6 carbon atoms and / or at least one disaccharide in a total amount of 0.001 to 2.0 wt .-%, preferably 0.005 - 1, 0 wt .-%, especially preferably 0.01 to 0.5 wt .-% and most preferably 0.03 to 0.1 wt .-%, each based on the total composition is included.
20. Verwendung gemäß einem der Ansprüche 11 - 19, dadurch gekennzeichnet, dass der kosmetisch oder dermatologisch verträgliche Träger als Puder, in Stiftform, als Aerosolspray, Pumpspray, flüssige oder gelförmige Roll-on-Applikation, Creme, Lotion, Lösung, Gel oder auf einem Substrat aufgebracht vorliegt.20. Use according to any one of claims 11 - 19, characterized in that the cosmetically or dermatologically acceptable carrier as a powder, in stick form, as aerosol spray, pump spray, liquid or gel roll-on application, cream, lotion, solution, gel or on applied to a substrate.
21. Verfahren zur nicht-therapeutischen Behandlung der Haut, dadurch gekennzeichnet, dass eine Zusammensetzung gemäß einem der Ansprüche 1 - 10 auf die Haut, insbesondere die Achselhaut, aufgetragen wird.21. A method for the non-therapeutic treatment of the skin, characterized in that a composition according to any one of claims 1-10 on the skin, in particular the armpit skin, is applied.
22. Verfahren gemäß Anspruch 21 , dadurch gekennzeichnet, dass eine Zusammensetzung gemäß einem der Ansprüche 1 - 10 nach einer Rasur aufgetragen wird. 22. The method according to claim 21, characterized in that a composition according to any one of claims 1-10 is applied after a shave.
EP07802740A 2006-08-29 2007-08-21 Antiperspirant and deodorant compositions with improved care effect Withdrawn EP2056789A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE102006040302A DE102006040302A1 (en) 2006-08-29 2006-08-29 Antiperspirant and deodorant compositions with improved care properties
PCT/EP2007/058644 WO2008025698A1 (en) 2006-08-29 2007-08-21 Antiperspirant and deodorant compositions with improved care effect

Publications (1)

Publication Number Publication Date
EP2056789A1 true EP2056789A1 (en) 2009-05-13

Family

ID=38826564

Family Applications (1)

Application Number Title Priority Date Filing Date
EP07802740A Withdrawn EP2056789A1 (en) 2006-08-29 2007-08-21 Antiperspirant and deodorant compositions with improved care effect

Country Status (6)

Country Link
US (1) US20090220444A1 (en)
EP (1) EP2056789A1 (en)
AU (1) AU2007291317A1 (en)
DE (1) DE102006040302A1 (en)
RU (1) RU2009111202A (en)
WO (1) WO2008025698A1 (en)

Families Citing this family (43)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8067037B2 (en) * 2008-06-24 2011-11-29 Marchese Frank P Trehalose-containing topical drying composition and method of using same
DE102008059765A1 (en) * 2008-12-01 2010-06-02 Henkel Ag & Co. Kgaa New deodorants and antiperspirants with hair growth inhibiting effect
US20110038823A1 (en) * 2009-08-13 2011-02-17 The Dial Corporation Antiperspirant emulsion products with improved efficacy and processes for making the same
US20110038822A1 (en) * 2009-08-13 2011-02-17 The Dial Corporation Antiperspirant emulsion products and processes for making the same
US8263052B1 (en) * 2009-09-22 2012-09-11 Marchese Frank P Topical drying composition comprising encapsulated trehalose and method of using same
IL201567A (en) * 2009-10-15 2014-06-30 Zahava Shalom Facial antiperspirant moisturizing composition and method for preparing same
DE102010028420A1 (en) * 2010-04-30 2011-11-03 Henkel Ag & Co. Kgaa Deo foams
FR2961510A1 (en) * 2010-06-17 2011-12-23 Oreal USE AS A TREATMENT AGENT FOR HUMAN PERSPIRATION; NOVEL AMINO ACID DERIVATIVES; COMPOSITIONS CONTAINING THEM
US8802653B2 (en) 2010-10-01 2014-08-12 C.B. Fleet Company, Inc. Deodorant compositions
US8685380B2 (en) * 2010-10-25 2014-04-01 C.B. Fleet Company, Inc. Deodorant spray
DE102010063250A1 (en) * 2010-12-16 2012-06-21 Henkel Ag & Co. Kgaa Hydrous antiperspirant compositions with improved residue masking
US9480633B2 (en) * 2011-04-28 2016-11-01 Kimberly-Clark Worldwide, Inc. Temperature management composition
DE102011083293A1 (en) * 2011-09-23 2013-03-28 Henkel Ag & Co. Kgaa Anhydrous formulations with cooling effect
US8663611B2 (en) * 2012-06-08 2014-03-04 L'oreal S.A. Perspiration and odor control compositions
US20140134122A1 (en) * 2012-11-15 2014-05-15 The Dial Corporation Skin care compositions including sorbed compounds and methods for making same
EP2934695B1 (en) * 2012-12-19 2016-11-30 Colgate-Palmolive Company Antiperspirant products with protein and antiperspirant salts
KR20150097494A (en) 2012-12-19 2015-08-26 콜게이트-파아므올리브캄파니 Oral care products comprising a tetrabasic zinc - amino acid - halide complex
CA2892468C (en) 2012-12-19 2019-10-08 Colgate-Palmolive Company Oral care products comprising tetrabasic zinc chloride and trimethylglycine
US9504858B2 (en) 2012-12-19 2016-11-29 Colgate-Palmolive Company Zinc amino acid halide complex with cysteine
US9498421B2 (en) 2012-12-19 2016-11-22 Colgate-Palmolive Company Two component compositions containing tetrabasic zinc-amino acid halide complexes and cysteine
AU2012397263B2 (en) 2012-12-19 2015-09-24 Colgate-Palmolive Company Zinc amino acid halide mouthwashes
EP2934443B1 (en) 2012-12-19 2017-09-06 Colgate-Palmolive Company Oral care compositions comprising zinc amino acid halides
BR112015014501B1 (en) 2012-12-19 2019-04-02 Colgate-Palmolive Company Personal care composition for skin or hair application and use of a zinc halide complex X
KR20150094651A (en) 2012-12-19 2015-08-19 콜게이트-파아므올리브캄파니 Oral gel comprising zinc - amino acid complex
EP2934445B1 (en) 2012-12-19 2017-10-04 Colgate-Palmolive Company Teeth whitening methods, visually perceptible signals and compositions therefor comprising zinc amino acid halides
BR112015014445A2 (en) 2012-12-19 2017-07-11 Colgate Palmolive Co zinc-lysine complex
US9675823B2 (en) 2012-12-19 2017-06-13 Colgate-Palmolive Company Two component compositions containing zinc amino acid halide complexes and cysteine
KR20150097492A (en) 2012-12-19 2015-08-26 콜게이트-파아므올리브캄파니 Oral care products comprising zinc oxide and trimethylglycine
RU2638791C2 (en) 2012-12-19 2017-12-15 Колгейт-Палмолив Компани Composition with halide precursors of amino acid / zinc trimethylglycine
US9750670B2 (en) 2012-12-19 2017-09-05 Colgate-Palmolive Company Zinc amino acid complex with cysteine
US10188112B2 (en) 2012-12-19 2019-01-29 Colgate-Palmolive Company Personal cleansing compositions containing zinc amino acid/trimethylglycine halide
DE102013225617A1 (en) * 2013-12-11 2015-06-11 Henkel Ag & Co. Kgaa Antiperspirant cosmetic products without aluminum-containing compounds I
DE102013225616A1 (en) * 2013-12-11 2015-06-11 Henkel Ag & Co. Kgaa Antiperspirant cosmetic products containing lysozyme and / or bovine serum albumin and / or yoghurt protein
DE102013225620A1 (en) * 2013-12-11 2015-06-11 Henkel Ag & Co. Kgaa Antiperspirant cosmetic products without aluminum-containing compounds II
AU2015202609B2 (en) 2014-05-30 2019-08-01 Johnson & Johnson Consumer Companies, Inc. Aerosol deodorant antiperspirant compositions
DE102014211204A1 (en) * 2014-06-12 2015-12-17 Henkel Ag & Co. Kgaa Use of cosmetic cleaning compositions as prebiotic
DE102014213223A1 (en) * 2014-07-08 2016-01-14 Henkel Ag & Co. Kgaa Antiperspirant cosmetic preparations containing specific proteins from animal secretions, secretions from insects or human secretions which do not contain halides and / or hydroxyhalides of aluminum and / or zirconium
WO2016030044A1 (en) * 2014-08-26 2016-03-03 Henkel Ag & Co. Kgaa Antiperspirant cosmetic comprising specific proteins from human or animal sources or specific proteins from fish or birds or eggs, which are exempt of aluminium and/or zirconium halides and/or hydroxy halides
WO2016030045A1 (en) * 2014-08-26 2016-03-03 Henkel Ag & Co. Kgaa Antiperspirant cosmetics containing specifically isolated proteins from bacteria or fungi or algae and which is exempt of alumiinum and/or zirconium halides and/or hydroxy halides
CN107106425B (en) * 2014-12-26 2021-01-22 高露洁-棕榄公司 Personal care compositions with zinc phosphate actives
CN111372658A (en) 2017-12-07 2020-07-03 高露洁-棕榄公司 Personal care compositions
IL299847A (en) 2020-07-21 2023-03-01 Chembeau LLC Diester cosmetic formulations and uses thereof
AU2024241686A1 (en) * 2023-03-31 2025-09-25 Colgate-Palmolive Company Personal care compositions

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR800001462B1 (en) * 1979-05-01 1980-12-10 강원명 How to prepare cosmetic raw materials from skim milk
US5928631A (en) 1997-06-09 1999-07-27 The Procter & Gamble Company Methods for controlling environmental odors on the body using compositions comprising uncomplexed cyclodextrins
DE10021056A1 (en) * 2000-04-28 2001-10-31 Henkel Kgaa Anhydrous antiperspirants, used for application to the skin, comprises a combination of particulate polysaccharides and/or derivatives, an astringent and a lipid component all contained in a liquid carrier
NZ540406A (en) 2002-11-29 2008-04-30 Campina Bv Method for improving the functional properties of a globular protein, protein thus prepared, use thereof and products containing the protein
GB0513193D0 (en) 2005-06-29 2005-08-03 Quest Int Serv Bv Improvements in skin and hair care

Non-Patent Citations (4)

* Cited by examiner, † Cited by third party
Title
"International Cosmetic Ingredient Dictionary and Handbook", 2002, THE COSMETIC, TOILETRY AND FRAGRANCE ASSOCIATION, Washington, ISBN: 1-882621-29-8, article "Lactose", pages: 863 *
"Sojamilch", Römpp Online, Version 3.6, Georg Thieme Verlag, 2009 *
"Yoghurt Protein GBU", Article 141500/0/2, 5.11.2001, Cosmetochem International Ltd., S. 1, 3 *
See also references of WO2008025698A1 *

Also Published As

Publication number Publication date
DE102006040302A1 (en) 2008-03-20
WO2008025698A1 (en) 2008-03-06
US20090220444A1 (en) 2009-09-03
RU2009111202A (en) 2010-10-10
AU2007291317A1 (en) 2008-03-06

Similar Documents

Publication Publication Date Title
EP2056789A1 (en) Antiperspirant and deodorant compositions with improved care effect
EP1773454B1 (en) Low-residue deodorant or antiperspirant stick based on an oil-in-water dispersion
DE102010063250A1 (en) Hydrous antiperspirant compositions with improved residue masking
DE102012222692A1 (en) Cosmetic composition useful as antiperspirant and deodorant, comprises 2-benzylheptan-1-ol, and rosemary extract
DE102006004957A1 (en) Deodorant or antiperspirant oil-in-water dispersion stick useful for reducing body odor comprises lipid or wax component, non-ionic oil-in-water emulsifiers, oil component, water-soluble polyhydric alkanol, water, and active substance
DE102010055816A1 (en) Deodorant and antiperspirant compositions Compositions for the prevention of body odor
DE102009029423A1 (en) Antibacterial cosmetic or pharmaceutical body odor deodorant compositions against body odor
DE102009027604A1 (en) Cosmetic compositions with suspensions of silver salts
DE102010027947A1 (en) Skin-friendly deodorants and antiperspirants
DE102008053884A1 (en) Anti pimple skin treatment
DE102011118016A1 (en) Cosmetic agents containing oxytocin and fragrances
EP2011476A2 (en) Moisture-emitting cosmetic and dermatological compounds with enhancers
EP2370050B1 (en) Novel deodorants and antiperspirants having hair growth inhibiting effect
WO2009101000A2 (en) Deodorants and/or antiperspirants having an improved odoriferous effect and absorption of odors
DE102005029777A1 (en) Deodorant or antiperspirant stick in oil-in water dispersion, useful e.g. in cosmetic to reduce body smell comprises e.g. lipid/wax component, non-ionic oil-in-water emulsifying agent, non-ionic water-in-oil emulsifying agent and oil
DE102016220085A1 (en) odor-reducing body care products
DE102007024381A1 (en) Topical composition for treating acne, pimples, bad skin or seborrhea comprises an antibody that is directed against a defined microorganism and is isolated from egg yolk
DE102012222764A1 (en) Cosmetic composition, useful for deodorization and protection against long-lasting body odor, comprises, in a cosmetic carrier, steroid consisting of 16-androstenedione and estrene steroids, and phospholipid
EP2059225A1 (en) Antiperspirant and deodorant compositions with reduced irritancy potential
DE102017215322A1 (en) Low molecular weight polyethyleneimine as an antiperspirant active
EP2884958B1 (en) Cosmetic compounds having time-delayed active ingredient release
WO2010145921A2 (en) Cosmetic compositions comprising selected silver salts
WO2014187576A1 (en) Deodorizing active ingredient combination
EP2442780A2 (en) Cosmetic compositions comprising silver lactate
DE102007024383A1 (en) Ddeodorant or antiperspirant composition comprises an antibody that is directed against a defined microorganism and is isolated from egg yolk

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

17P Request for examination filed

Effective date: 20090325

AK Designated contracting states

Kind code of ref document: A1

Designated state(s): AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IS IT LI LT LU LV MC MT NL PL PT RO SE SI SK TR

AX Request for extension of the european patent

Extension state: AL BA HR MK RS

17Q First examination report despatched

Effective date: 20090619

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN

18D Application deemed to be withdrawn

Effective date: 20100819